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ABSTRACT
Artificial insemination (Al) and embryo transfer (ET) in the ewe are severely 
restricted by the rigid, impassable cervix that resists catheterization. This 
thesis deals with the ripening effect of intravaginal prostaglandin E2 (PGE2) 
in the luteal phase ovine cervix. The potential of this drug to induce cervical 
ripening has been extensively studied in peri parturient sheep and other 
mammalian species to facilitate labour, but not as a mean of softening the 
cervix during the cycle. Physiological cervical ripening is characterised by 
macroscopical, ultrasonographical, microscopical, mechanical and 
biochemical changes. Studies during pregnancy and at term suggest that 
PGE2 mimics these changes, but there are no studies during the cycle. The 
sensitivity of the cervix to PGE2 during the cycle may be lower than at term, 
but there have been no attempts to characterise the PGE2 receptors (EPr  
EP4) in the cervix.
The ultrasonographic appearance of the cervix has been described in 
other species, but not in sheep. In chapter V, ultrasound is evaluated in the 
monitoring of cervical changes during the cycle, the ovine cervix was imaged 
at oestrus and during the early luteal phase. This was achieved employing 
the transrectal technique and two probes of 5 MHz and 7.5 MHz (Toshiba) 
and a linear scanner (Capasee, Toshiba).
In chapter III, several sheep in the luteal phase and early pregnancy 
(n=15), were treated with different regimes of PGE2 alone or together with 
oestradiol, to induce cervical ripening. Catheterization was incomplete, but 
deeper scores (4 cm) than in control sheep (0.1-3 cm) were achieved. 
Following PGE2 treatment on day 6  of the cycle, microscopical changes 
similar to an inflammatory response and therefore similar to those during 
labour were observed. There was activation of polymorphonuclear 
leukocytes (PML), eosinophils, mast cells and platelets. Vasodilatation and 
extravasation of red blood cells were also prominent.
The findings in chapter III, suggested that there was a response to 
PGE2 during the luteal phase and that receptors for PGE2 may be present in 
the cervix. The observation of PML degranulation is in line with current 
theories of physiological cervical ripening. These cells, when activated, 
release collagenolytic enzymes, like elastase, MMP- 8  and MMP-9 capable of 
softening the cervix by degrading the extracellular matrix. It was 
hypothesised here that the EP3 R, one of the four PGE2 receptor subtypes, 
may be involved in the activation of PMLs.
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At the beginning of these studies, the only reagents available for the 
characterisation of the EP3R in the ovine cervix were a few cDNA sequences 
in other mammalian species. The first objective therefore was to isolate and 
sequence cDNA encoding for the ovine EP3R, using RT-PCR techniques 
and bovine primers. The successful isolation and sequencing of a cDNA from 
kidney, using RT-PCR, is described in the first part of chapter IV. The 
sequence of the fragment isolated was highly homologous to the bovine 
cDNA sequence, indicating very strongly that it corresponded to the ovine 
homologue.
In the second part of chapter IV, mRNA expression studies are 
described. The same primers as the cDNA isolation were used to study 
mRNA expression, DNAse I incubations of the RNA were necessary 
because the fragment amplified was found to be intronless. Using this 
method, the presence of mRNA was demonstrated in kidney, liver, uterus, 
adrenal gland and skin. This distribution pattern is similar to other species 
and further confirms the identity of the cDNA fragment as the ovine EP3 
receptor. Expression of this message was also found for the first time in the 
oestrous and luteal cervix, by RT-PCR and on the periparturient cervix by 
Southern analysis. These preliminary data suggest that the EP3R may have 
a function in the ovine cervix. It is reasoned, based on these findings and 
other publications, that EP3 R may act as a proinflammatory receptor, 
activating the cellular response observed in chapter III.
iii
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CHAPTER 1
GENERAL INTRODUCTION
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1.1 THE ANATOMY OF THE OVINE CERVIX: IMPORTANCE AT 
OESTRUS AND DURING THE EARLY LUTEAL PHASE FOR 
ARTIFICIAL INSEMINATION (Al) AND EMBRYO TRANSFER (ET).
The cervix uteri is a thick walled fibromuscular tube, extending from the 
internal uterine orifice to the external uterine orifice and connecting the 
body of the uterus with the vagina. The morphology of this organ can vary 
markedly between species, reflecting differences in copulation, sperm 
transport, parturition and embryonic development (Hafez, 1973, Kanagawa 
and Hafez, 1973; Meiter and Fentener van Vlissingen, 1993; Maltier et al., 
1993b). The cervix uteri, uterus proper and cranial vagina, evolve from 
fusion of the right and left paramesonephric or Mullerian ducts in a 
caudocranial direction and different degrees of fusion can be observed 
through evolution (Meiter and Fentener van Vlissingen, 1993; Maltier et al., 
1993b). This explains the existence of species differences in the type of 
uterus: duplex (marsupials and rabbits), semiduplex (rats), bicornuated 
(ungulates and carnivora), bipartite (pigs) and simplex (primates). Similarly, 
as a result of insufficient fusion of the ducts, congenital abnormalities are 
commonly observed, as the duplicity of the cervix and vagina in ewes and 
cows (Hafez, 1973; McEntee, 1990).
The ewe has a single cervix, which in the non-pregnant animal 
measures 5-10 cm long and 2-3 cm wide (see Plate 1.1). The lumen of the 
cervical canal is narrow in most species, but in the sheep and other 
ruminants (cow and goat) it is also very tortuous due to the presence of 
mucosal folds (Plate 1.2 B) (Hafez, 1973). In the ewe, the toughness, the 
shape and the orientation of these folds render the cervical canal 
impassable with rigid instruments during the luteal phase and also during 
oestrus, despite the slight relaxation that occurs under the influence of 
oestrogens (El-Banna and Hafez, 1972).
2
This has practical implications for artificial insemination (Al) and 
embryo collection and transfer (ET). In cattle, non-surgical techniques have 
been developed, involving the passage of a stainless steel catheter through 
the cervical canal. This type of catheterization is difficult in the goat and 
impossible in the sheep. The lumen is smaller and the folds are more 
numerous and less concentric, especially in the sheep. Transrectal 
manipulation of the cervix, which helps to guide the catheter, is not possible 
either in the small ruminants. Artificial insemination (Al) with fresh semen is 
intracervical rather than transcervical in the ewe. Al with frozen semen and 
ET require access to the uterus and therefore laparoscopy is required 
(Evans and Maxwell, 1987; Nellenschulte and Niemann, 1992). 
Laparoscopic Al and ET are invasive techniques and have to be carried out 
by a veterinary surgeon, this adds to their cost and limits the commercial 
application of the techniques (Stubbings, 1991). Laparoscopic ET has 
repeatability problems; from the fourth flushing lower recovery rate is 
observed and improper healing of the uterine wounds may occur 
(Nellenschulte and Niemann, 1992). There is also concern from the welfare 
point of view, this makes the search for non-invasive techniques a priority 
(Stubbings, 1991).
The drawbacks of laparoscopic Al and ET and the unavailability of 
an alternative transcervical technique, is restricting the breeding potential of 
sheep by preventing the export of genetic material, breed improvement 
programmes, disease control and research. As a consequence, the 
research on the cervix has concentrated on studying the structure of this 
organ, the aim being to improve Al and ET techniques.
3
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Plate 1.1
Gross anatomy of the ovine reproductive tract at the early luteal 
phase. 1: external os, 2: mid cervix and 3: internal os of the 
cervix uteri. 4: corpus uteri, 5: uterine cornua and 6 : ovaries
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Plate 1.2
Gross anatomy of the ovine reproductive tract at the early luteal 
phase, showing the cervix uteri and the obstacles for 
catheterization.
Upper. Longitudinal section of the caudal part of the tract to 
show the external os (1 ) of the cervix uteri.
Lower. Longitudinal section of the ovine reproductive tract, 
showing the mucosal folds of the cervix. 1 : external os, 2 : mid 
cervix and 3: internal os

There have been a number of studies on the anatomy of the cervix 
aimed at the improvement of artificial insemination techniques. The early 
studies looked at the external os (Dun, 1955; Fukui and Roberts, 1978). 
Dun (1955) observed extreme variability in this structure within the Merino 
breed and attempted to classify the os types in order to improve the 
recognition of the opening of the cervical canal. He also tried to predict the 
success in cervical passage based on the external appearance of the 
cervix. It was concluded that pregnancy and parturition increase the size 
and complexity of the external os and therefore the identification of the 
cervical opening would be more difficult in aged ewes. Fukui and Roberts 
(1978) in similar studies, concluded that although the finding of the cervical 
orifice becomes more difficult within aged pluriparous ewes, the penetration 
of the cervical canal is easier. They proposed a method for non-surgical 
intrauterine insemination, based on the incomplete penetration of the 
cervical canal and the aid of C02 gas at high pressure to force the semen 
into the uterus.
The anatomy of the cervical canal was studied in detail using casts, 
these studies have shown that the cervical lumen has the shape of a row of 
cones out of alignment whose bases are cranial (More, 1984; Kristinsson 
and Wibdorf, 1985; Reinhold et al., 1987). Other techniques have been 
used, like fluoroscopy, ultrasound, xerography with Conray 400, Computer 
Axial Tomography and X-rays (Halbert et al., 1990a), and some of these 
have provided a good knowledge of the cervical canal in relation to Al. The 
cervical folds fit together closely, especially in the caudal part of the cervix, 
they are out of alignment and funnel shaped with the narrow opening 
oriented caudal (Halbert et al., 1990a). Reinhold et al. (1987) concluded 
that there were no anatomical variations between individual sheep in the 
portio vaginalis, orificium uteri externum or canal cervical, in relation to age 
or oestrous phase that could be exploited for the improvement of
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transcervical Al techniques. More recent studies of the external os shape in 
cross breed ewes in relation to Al, also concluded that unfortunately this 
parameter is not related to internal parameters like mean cervical length, 
number of folds and width (Halbert et al., 1990a). Kristinsson and Wibdorf 
(1985) demonstrated the cervical lumen is not completely occluded by the 
folds, and suggested that a transcervical method is possible but has to be 
adapted to the peculiar anatomy of the ovine cervix. Halbert and colleagues 
from Guelph University have develop such a method based on their 
anatomical studies for different breeds (Halbert et al., 1990b; Buckrell et al., 
1994).
The Guelph transcervical method of Al has been developed in 
Canada (Halbert et al., 1990c) but very poor results have been obtained, 
using the same technique, in countries like the UK (Mylne and Dingwall, 
1993a; Mylne et al., 1993b) and Australia (Windsor et al., 1994). The 
problems in the UK have been embryonic loss and physical damage to the 
cervix and peri-cervical organs, like peri-cervical abscessation, metritis, and 
peritonitis associated with a track to a penetrated cervix.
A different approach was undertaken in this thesis, based on the 
pharmacological dilatation of the cervix with prostaglandin E2 (PGE2 ) to 
facilitate Al and ET. An effort was made to understand the physiological 
mechanisms of cervical ripening during parturition, that may give clues for 
the development of pharmacological regimes that could induce ripening 
during the cycle. This method may be an alternative or a complement to the 
Guelph and other similar methods.
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1.2 MICROSCOPY OF THE CERVIX
The histology of the ovine cervix has been described in early studies (Cole 
and Miller, 1935; Restall, 1966; Restall and Lightfoot 1970; Hafez, 1973) 
and more recently reviewed (More, 1984; Dobson, 1988). In general the 
microscopic structure of the ovine cervix is similar to other species (Dobson, 
1988). There are three different layers in transverse tissue sections: a) the 
endocervix, b) the fibromuscular wall and c) the serosa.
a) The endocervix
The external os of the cervix is an area of transition between the typical 
epithelium of the cervix (columnar) and the typical epithelium of the vagina 
(squamous). The lumen of the rest of the cervix is lined by a single layer of 
tall columnar cells. Three cell types can be differentiated, mucous secretory 
cells, tall ciliated cells and short peg-shaped cells; their nuclei are at 
different level giving a pseudostratified appearance. The epithelium shows 
regional variations, there are fewer mucous secreting cells in the cranial 
cervix near the internal os and the number of ciliated cells decreases 
caudally (Restall, 1966; Restall and Lightfoot, 1970; Hafez, 1973).
The epithelium undergoes similar cyclical changes to the rest of the 
reproductive tract, the secretory activity of the goblet cells peaks at 
proestrus (Restall, 1966). Two cell types have been identified using 
scanning electron microscopy at the early luteal phase, about 30% are 
ciliated and the rest are non-ciliated secretory cells. Before oestrus (days 
15 and 16 of the cycle) the secretory cells further differentiate into two cell 
populations, the dilated secretory cells and the convex secretory cells 
(Wergin, 1979).
The subepithelial connective tissue consists of supporting cells, 
fibroblasts and fibrocytes, which are surrounded by ground substance, rich 
in fibroproteins and glycosaminoglycans (GAGs). This tissue is vascular
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and white cells can be observed (Aughey et al., 1981).
The endocervix is arranged in large folds or cervical crypts, at the 
base of the crypts it is common to find stratification of the epithelium of 4-6 
layers deep (Cole and Miller, 1935). The number of crypts is smaller during 
dioestrus (Restall, 1966) and anoestrus (Cole and Miller, 1935).
b) The fibromuscular wall
The cervix is now considered a separate organ from the uterus structurally 
as well as functionally by most authors, because the fibromuscular wall is 
composed mainly of fibrocollagenous tissue and some smooth muscle, 
whereas the uterus is predominantly muscular. Danford suggested these 
ideas for the first time in the late 1940s and early 1950s, demonstrating with 
histologic methods in women that the predominant component (85%) of the 
cervix, unlike the uterus is connective tissue (reviewed by Danforth, 1983). 
Similarly, the muscular content in the cervix is highest near the uterus 
(25%) and decreases caudally, being 16% in the middle segment and 6 % 
in the lower segment (Challis and Olson, 1988). Similar studies have not 
been done in sheep but studies in the rat confirm the fibrous nature of the 
cervix and the regional differences found in humans, suggesting that a 
common basic structure may exist within mammals (Koob and Ryan, 1980). 
The histology of the non-pregnant ovine cervix has been well documented, 
with studies of light (LM), scanning (SEM) and electron microscopy (TEM). 
The cervical wall consists of heavy, densely-packed collagen fibres 
interspersed with some fibrocytes and the occasional fibroblast (Ward, 
1968; Aughey et al., 1981; Fosang et al., 1984; Owiny et al., 1987). There 
are very few elastic fibres (2-10 %) in the ovine cervix (Ward, 1968).
However, another group of authors have claimed that the ovine and 
human cervices are predominantly muscular. More (1984) compares the 
smooth muscle of the ovine cervix with organs of propulsive activity such as
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the uterus, the oesophagus, biliary pathways and the ureter, Hafez (1973) 
compares the cervix of primates with the iris diaphragm. In contrast, Aughey 
et al. (1983) claim that the muscular fibres form an incomplete muscularis in 
the ovine cervix and cannot have a sphincter-like function. There are 
different descriptions of the arrangement of the smooth muscle fibres. 
Raynaud (1973) describes the cervical musculature of the ewe divided into 
two layers, an inner layer composed of circular bundles and an outer layer 
composed of longitudinal bundles. Fosang et al, (1984) found bundles, 
running both longitudinal and transversely, present in the middle and 
deeper layers. Aughey et al. (1981), as mentioned earlier, describe an 
incomplete muscularis. More (1984) describes a more complicated 
organisation of the smooth muscle into five distinct layers.
c) The serosa
The peritoneum externally limits the cervix and consists of a thin layer of 
loose connective tissue covered by mesotheHal cells (More, 1984). It does 
not merit further comments because it does not have much functional 
significance.
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1.3 BIOCHEMICAL COMPOSITION OF THE CERVIX
The cells in the cervical connective tissue represent only 20% of its volume, 
thus the major components of the cervix are water and extracellular matrix 
(reviewed by Leppert and Yu, 1991). In sheep, several authors sustain that 
the rigidity of the cervix is due to its collagenous nature, collagen 
constitutes 50% of the dry matter in the non pregnant animal (Ward, 1968; 
Fitzpatrick, 1977; Fitzpatrick and Dobson, 1979). Similarly, in humans, 
chemical measurements of actomyosin have confirmed the histologic 
findings cited before that the cervix is predominantly connective tissue 
(reviewed by Leppert and Yu, 1991).
1.3.1 Extracellular matrix
In cell biology the ground substance of the connective tissue (see histology 
section) is often termed as extracellular matrix, which refers to an organised 
assembly of macromolecules located outside the cell. This matrix is 
produced locally by support cells, in the cervix the fibroblast/fibrocyte. The 
extracellular matrix is composed of two major macromolecules: (1) the 
fibrous proteins, of two functional types: structural, collagen and elastin, or 
adhesive, fibronectin and laminin, and (2) polysaccharide chains of the 
class named glycosaminoglycans (GAGs) normally associated to proteins 
in the form of proteoglycans (Woessner, 1993; Alberts et al., 1994a).
The extracellular matrix is a dynamic structure, subject to 
degradation by support cells and resident or infiltrated inflammatory cells. 
Two groups of proteinases are important in the remodelling of the 
extracellular matrix, the matrix metalloproteinases and the serine 
proteinases.
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1.3.1 i Fibrous proteins
Collagens
In all collagens, three polypeptide chains called a chains, are wound 
around one another in a rope-like helix, leaving relatively short non helical 
telopeptides on either side, this constitute a tropocollagen molecule. So far, 
about 25 genetically distinct types of a chains have been identified, each 
with distinct amino acid composition. A high content of the amino acids, 
proline and glycine, is typical of collagen, they are important for the 
formation and stability of the triple helix. So far, 15 types of triple stranded 
collagen (types l-XV) have been found, they differ in the a chain 
composition, strength of the bonds between the a chains, tissue distribution 
and supraorganization of the tropocollagens into: fibres (collagens type I, II, 
III, V and XI), fibre-associated (IX and XII) and networks (IV and VII) (Nimni, 
1988; Alberts, et al., 1994a). In the reproductive tract, only a few types of 
collagen have been detected, but as newer tools for research become 
available other types may be found in this expanding family (Kokenyesi,
1991).
The ovine cervix is made up of the “classical” fibrillar collagens, 
mainly type I and III but also type V (Raynes et al., 1994). In other species 
(rats and humans) only types I and III of the fibrillar collagens have been 
reported and quantitative studies have shown that type I is the most 
abundant. In humans, type I constitutes about 2/3 of the total and 1/3 is type 
III collagen, this ratio is similar to that found in the skin (Uldbjerg, 1989; 
Kokenyesi, 1991). Tropocollagen molecules in collagens I and III, are 
arranged into the "quarter stagger array", that produces the characteristic 
cross-striation seen in electron micrographs. This structure is secured by 
the formation of "cross links" between the tropocollagen molecules 
(intermolecular cross-links), which are located between telopeptides and
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triple helices. Cross links therefore, provide great tensile strength in the 
collagen fibres, keeping the tropocollagen fibres together and avoiding 
tearing (reviewed by Uldbjerg, 1989).
The mesh-forming type IV collagen has also been found in the 
human cervix and it is also expected to be found in sheep and other 
species. Type IV usually is present in the basement membranes, the 
tropocollagens do not form cross links in this type of collagen (reviewed by 
Uldbjerg, 1989 and Kokenyesi, 1991).
Elastic fibres
The presence of elastic fibres in the extracellular matrix is responsible for 
the elastic properties of a number of tissues like lung, dermis and large 
blood vessels (reviewed by Boyd et al., 1991; Rosenbloom et al., 1993; 
Alberts et al., 1994a), including the cervix (Leppert and Yu, 1991). 
Histological studies, have shown that there are very few elastic fibres (2-10 
%) in the ovine cervix (Ward, 1968). Elastic fibres of the cervix and uterus 
are thinner, and may be easier to degrade than those of the lung or the 
aorta (Leppert and Yu, 1991).
Elastic fibres are composed of an amorphous component and a 
microfibrillar component. The protein elastin makes up the amorphous 
component and is responsible for the elastic properties of the fibres. There 
is a 0.95-2.45% of elastin in the cervix of primates (Leppert and Yu, 1991), 
which is similar to the skin (2-4%) and lower than large arteries (50%) 
(Rosenbloom et al., 1993).
Elastin is highly hydrophobic, this is consistent with its physical 
properties, the gene has been characterised in sheep and many other 
species. The biosynthetic precursor (tropoelastin) is released into the 
extracellular space, where it becomes strongly cross linked into a rubber­
like network. The exact composition of the microfibrills in unknown, but they
1 5
contain several glycoproteins including fibrillin. They probably act as an 
organising scaffold in the formation of the elastin network.
Adhesive glycoproteins
These proteins have the ability to interact with cells and other 
macromolecules of the matrix, by coupling to receptors. The significance of 
this group therefore is not the provision of mechanical strength, but the 
alteration of the behaviour of cells in contact with them and the organisation 
of the matrix. The best studied is fibronectin involved in migration of cells, 
protease production and haemostasis/thrombosis (Alberts et al., 1994a). 
There are reports of the presence of fibronectin in the cervix, in the human 
and the rat (Leppi et al., 1982).
Laminin is a major component of the basement membrane and 
participates in attachment, migration, angiogenesis, protease production, 
tumour growth, metastasis and chronic inflammation (Alberts et al., 1994a).
1.3.1 ii Proteoglycans and Hyaluronic acid
Proteoglycans are special glycoproteins composed of a core protein and 
glycosaminoglycan (GAG) side-chains (chondroitin sulphate, dermatan 
sulphate, heparan sulphate, heparin and keratan sulphate). The old 
nomenclature was based on the GAG composition, the new nomenclature 
refers to the protein core composition and/or the function of the 
proteoglycan.
GAGs are sulphated polysaccharides composed of repeating 
disaccharide units (glucuronic acid, iduronic acid, N-acetyl galactosamine, 
N-acetylglucosamine and galactose). GAGs do not exist free of the protein 
core in the tissue with the exception of hyaluronic acid.
The mechanical significance of these substances is based on their 
ability to bind to collagen with variety of affinities, due to high sulphate
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content they have a characteristic negative charge, this allows electrostatic 
interactions and made them highly hydrophilic. They have a role resisting 
compressive forces (reviewed by Christiansen et al., 1991).
The non-pregnant cervix contains similar proportion of GAGs (1% of 
the dry defatted tissue) as other connective tissues (reviewed by Uldbjerg,
1989). The most abundant proteoglycan in the cervix of all the species 
studied (sheep, human, guinea pig and rat) is decorin, also known as 
dermatan sulphate proteoglycan-11 (DSPG-II), with a small (45 kDa) protein 
core and a single chain of either chondroitin sulphate or dermatan 
sulphate. Estimates of decorin as a percentage of the total of proteoglycans 
range from 50-80% in the non-pregnant cervix (reviewed by Dobson, 1988; 
Uldbjerg, 1989; Kokenyesi, 1991). This small proteoglycan is known to 
interact with collagen, there is microscopical and biochemical evidence of 
this (Uldbjerg, 1989). Medium size proteoglycans have not been detected 
by some authors and have been detected in variable proportion by others 
(reviewed by Dobson, 1988; Uldbjerg, 1989).
1.3.1 iii Degradation of the matrix by proteinases  
(endopeptidases): matrix metalloproteinases and serine
proteinases.
Matrix metalloproteinases
Matrix metalloproteinases (MMPs) constitute the main proteolytic group 
capable of degrading all the components of the extracellular matrix at a 
physiological pH. This family has many other names that define some of 
their characteristics as a group, like neutral proteases, collagenase gene 
family and matrixins (reviewed by Nagase, 1991; Woessner, 1991; 
Matrisian, 1992; Birkedal-Hansen et al., 1993; Woessner, 1994).
The interest in MMP is increasing because they seem to be involved
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in multiple biological processes requiring remodelling of the connective 
tissue. Apart from cervical ripening at parturition, they are also involved in 
other reproductive (ovulation, embryogenesis, implantation and postpartum 
uterine involution), physiological events (wound healing and bone 
resorption), and several pathological processes (rheumatoid arthritis, 
periodontal disease, metastasis and inflammation in general) (Woessner, 
1994). MMPs are secreted from connective tissue cells or inflammatory 
cells as inactive zymogens (proenzymes). Most matrixins are not stored in 
the cell, are only synthesised upon demand and stimulated by a number of 
factors (PGE2, interleukins, steroids, growth factors, oncogenes etc.) 
(Birkedal-Hansen et al., 1993). The MMPs of PMLs are exceptions, and 
they are stored in granules (Doherty and Janusz, 1994). The extracellular 
activity of MMPs is regulated in a complex fashion. They are activated when 
cleavaged by other proteinases in a cascade. The PML collagenase is also 
an exception in this, and is activated as part of the PML activation 
mechanisms (Doherty and Janusz, 1994). In the active form 
metalloproteinases are regulated by inhibitors present in plasma (a- 
macroglobulin) or in the extracellular matrix by tissue inhibitors of the 
metalloproteinases (TIMPs). These are generally secreted by the same cell 
as the metalloproteinases and form inactive complexes with these 
enzymes. Three different TIMPs (TIMP-1, TIMP-2 and TIMP-3) have been 
identified and cloned in women (Woessner, 1991; Woessner, 1994). So far 
only ovine TIMP-1 has been cloned (Smith et al., 1994).
Up to the present moment, 12 members of the MMP family have 
been identified and well characterised from cDNA sequencing, mainly in 
women (Woessner, 1994). They belong to three major subclasses 
according to their main matrix substrate and structural homology, namely 
collagenases, gelatinases and stromelysins (Nagase, 1991; Woessner, 
1991; Matrisian, 1992).
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Collagenases
Two collagenases have been cloned in women, interstitial collagenase 
(MMP-1) and PML collagenase (MMP-8). So far none of them have been 
characterised at the molecular level in sheep, although there is evidence of 
collagenase activity in sheep (Ellwood et al., 1981; Raynes et al., 1988). 
Ovine MMP-1 appears to cross react with the human enzyme since its 
activity has been detected in ovine tissues using human probes 
(Salamonsen et al., 1993). MMP-8 has only been studied in women, but 
MMP-1 has been sequenced in the bovine and other species (Sudbeck et 
al., 1992; Woessner, 1994). Studies of bovine MMP-1 have shown poor 
cross-reactivity with other species but similar sequence and cleavage point 
(Sudbeck et al., 1992).
MMP-1 is the collagenase found in fibroblasts and macrophages 
and was the first MMP to be described. It degrades the interstitial collagens 
of the cervix and also type II, in the order: lll>l>ll (Docherty and Murphy,
1990). It cleaves in the helical portion of the collagen molecule specifically, 
breaking the 3 a chains at a single site and generates two 3/4 (TCA) and 
1/4 fragments (TCB). The specific degraded products of collagenase (TCA 
and TCB) denature and unfold at body temperature (gelatine) and are 
susceptible to degradation by gelatinases and non-specific neutral 
proteases.
PML collagenase (MMP-8) is 57% homologous to the amino acid 
sequence of MMP-1 and heavier in its molecular weight. It can also 
degrade interstitial collagens with the same specificity as the MMP-1 but its 
rate of hydrolysis is different being in the order: l>ll>lll (Doherty and Murphy,
1990).
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Serine proteinases
The serine proteinases group, includes plasminogen activators, plasmin, 
elastases, thrombin, trypsin, chymotripsin, and cathepsins G and E. Some 
of these enzymes participate in the remodelling of the matrix by direct 
degradation of several matrix components or by participating in the 
activation of the MMPs. Their actions are regulated by specific inhibitors 
(Masure and Opdenakker, 1989; Caughey, 1994; Alberts et al., 1994a).
Leukocyte eiastase
Little is known about leukocyte eiastase in sheep, but recent studies have 
reported the isolation of a similar enzyme to the human leukocyte eiastase 
(HLE) from the ovine PML (Junger et al., 1992). Interspecies variability has 
been reported in the levels of activity of leukocyte eiastase in PMLs. 
Rabbits, for example have twice the activity of human PMLs, whereas other 
species have only one third (equine and porcine) or 50 times less (bovine) 
(Styrt, 1989; Brown and Roth, 1991).
Human leukocyte eiastase (HLE) can degrade elastin, collagens 
type III and type IV and other components of the matrix (proteoglycans, 
fibronectin and fibrin) (Masure and Opdenakker, 1989; reviewed by 
Uldbjerg, 1989). HLE degrades the telopeptides of collagen, thus removing 
intermolecular cross links which are important for the stability of the 
collagen fibre. This action may facilitate access of collagenase to its 
substrate, increasing its cleavage rate (reviewed by Uldbjerg, 1989). 
Another synergistic action of HLE with collagenase is that it can activate 
stromelysin-1 (MMP-3), which is the activator of proMMP-1 (Leppert, 1992). 
Leukocyte eiastase and other serine proteinases, like trypsin and a- 
chymotripsin, can upregulate the activity of several MMPs by blocking the 
inhibitory action of TIMPs (reviewed by Docherty and Murphy, 1990).
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The three most important HLE inhibitors or antiproteinases are: a1 
proteinase inhibitor (A1PI, formerly called antitripsin), a2-macroglobulin, 
and secretory leukoproteinase inhibitor (SLPI). Secretory leukoprotease 
inhibitor (SLPI) is found in mucous secretions (seminal plasma, cervical 
mucus, bronchial and nasal secretions) and interstitial fluids. It has a role in 
the protection of mucous membranes during inflammation (Leff and Repine, 
1993; Uldbjerg, 1989). But the most potent inhibitor is probably A1PI, which 
forms a complex with eiastase, inactivating it irreversibly. Despite this tight 
control, tissue damage occurs at inflammatory sites, since the three 
inhibitors are susceptible to oxidative inactivation.
Summarising, the triple helix of collagen is resistant to most 
enzymes and therefore the action of collagenase (MMP-1 or MMP-8) is 
considered essential and rate-limiting in the degradation of collagen. But it 
is also recognised that collagenolysis is the result of the action of a group of 
enzymes in a cascade. Stromelisins may facilitate degradation of collagen 
by removing the surrounding proteoglycans. PML eiastase can activate the 
proMMP3, and MMP3 in turn activates proMMPI (Leppert, 1992). 
Additionally serine proteinases from white cells also act synergistically by 
disrupting the matrix with their degradative action on proteoglycans, cross 
links and elastin. Gelatinases further degrade the products of collagenase. 
Cathepsins act intracellularly degrading collagen that has been 
phagocytosed and partially degraded.
1.4. CERVICAL PHYSIOLOGY DURING THE CYCLE AND 
PREGNANCY.
The cervix adapts to its different roles (sperm transport, protection of the 
uterus against infection and delivery) with changes in the composition of 
the mucus produced and of its own structure. During oestrus, there is an 
increase in vascularity, accompanied by congestional oedema, relaxation 
in the cervical muscular tone and opening of the cervical canal. At oestrus 
the mucus production increases and it acquires special characteristics 
which are permissive to sperm transport; mucus becomes thinner, the 
sodium chloride content and alkalinity increase, whereas the cell content 
decreases. The oestrous mucus, due to a high content of sodium chloride, 
when spread on glass slides crystallises in a pattern that resembles a fern, 
the phenomenon is known as fernlike crystallisation or arborisation 
(reviewed by El-Banna and Hafez, 1972). At other times, under the 
influence of progesterone, the cervical canal remains closed to protect the 
uterus from infection and only a small amount of highly viscous mucus is 
present in the canal. During gestation, the cervix grows and secretes large 
masses of viscous mucus, which forms a plug that occludes the canal, 
acting as a barrier to bacteria and sperm (Hafez, 1973). During the second 
half of pregnancy, the ovine cervix experiences gross anatomical changes 
in consistency, size and shape that are known as softening that culminate 
with “ripening” during full term and the onset of labour, that occurs over a 
period of five hours or less (Ward, 1968; Owiny, 1986; Fitzpatrick, 1977).
During mid (crown-rump length of the fetuses: 13-19.5 cm) and late 
pregnancy (crown-rump length of the fetuses: 23-39 cm) the cervix 
experiences softening, becoming oedematous and floppy and there is a 
small increase in compliance and a marked increase in size (Aughey et al., 
1981; Owiny et al., 1994). The cervical mucus plug is dissolved just prior to 
labour (Aughey, personal communication). In the sheep most of the
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softening and increase in compliance occurs 12 hours before the onset of 
labour (Fitzpatrick and Liggins, 1980). Similar changes, but over a longer 
period of time occur in other species (human: Calder, 1981; rat: 
Hollinsworth, 1981). Postpartum the cervix experiences a rapid involution 
and returns to its original shape (Datta et al., 1968; Lo Stumbo and 
Pellegrini, 1970; Fosang et al., 1984). Of all these functions, ripening at 
prepartum has been the most extensively studied.
Cervical ripening during labour has been extensively reviewed on 
its own in several books and review articles (Fitzpatrick, 1977; Danforth, 
1983; Dobson, 1988; Uldbjerg, 1989; Uldbjerg and Ulmsten, 1990; Huzar, 
1991; Hayashi, 1993) or as a chapter of parturition reviews (Challis and 
Olson, 1988; Taverne, 1992; Porter, 1993; Maltier et al., 1993a; Challis and 
Lye, 1994; Kelly, 1994). Most of the information refers to human physiology, 
because the unripe cervix is a frequent problem in obstetrics and premature 
dilatation increases the risk of uterine infection and possible loss of the 
fetus. The pregnant and periparturient ovine cervix has been more 
extensively studied than in other domestic or experimental species from the 
1970s (Ward, 1968; Fitzpatrick and Dobson, 1979; Owiny, 1986; Owiny and 
Fitzpatrick, 1992). The ewe was adopted as a experimental model for a 
number of reasons, the toughness and collagenous nature of the cervix, the 
well known endocrinology of birth (Thorburn and Rice, 1990). Like humans, 
sheep is a placental-dependent species for the production of progesterone 
at late pregnancy (Liggins, 1983) and there is a clinical condition when the 
cervix fails to ripen (ringwomb) (Ward, 1968). However the endocrinology of 
the guinea pig at parturition appears to be more similar to humans than 
than ovine endocrinology and this laboratory species is gaining more 
importance as an experimental model for cervical ripening, in recent years 
(Rajabi et al., 1990; Chwalisz, 1994). Extensive studies have also been 
done in the mouse, rat, rabbit and pig (Dobson, 1988).
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1. 5 PHYSIOLOGICAL CERVICAL RIPENING OF THE
PERI PARTURIENT CERVIX: MICROSCOPICAL, MECHANICAL 
AND BIOCHEMICAL CHANGES
1.5.1 Microscopy
The gross anatomical changes of cervical ripening are correlated with 
microscopical changes in the connective tissue in sheep with separation of 
collagen fibres that have been observed with light, transmission and 
scanning electron microscopy (LM: Ward, 1968; Aughey et al., 1981 and 
1983, TEM: Fitzpatick, 1977; Parry and Ellwood, 1981; Aughey et al., 1981 
and 1983; Fosang et al., 1984; Owiny, 1986, SEM: Owiny et al., 1987). 
Similar changes have been observed in other species (women: Danforth, 
1960; Minamoto et al, 1987; Yoshida and Manabe, 1990; rats, mouse, pig, 
rabbit: Dobson, 1988; guinea pigs: Rajabi et al., 1991b). There is an 
infiltration of PML (Junqueira et al., 1987) and other inflammatory cells and 
therefore changes have been compared to an inflammatory response 
(Liggins, 1981) and with other reproductive or pathological processes of 
rapid tissue remodelling and collagenolysis (Luque and Montes, 1989). In 
sheep, microscopical changes with evidence of tissue breakdown have 
been observed during the last third of pregnancy, approximately from about 
day 100-120 of pregnancy (determined by crown-rump length of the 
fetuses) (Aughey et al., 1981) and from day 140 of gestation onwards 
(Fosang et al, 1984).
Microscopical observations during the postpartum involution 
suggest that this process consists of the reorganisation of the collagen and 
restoration of the dense connective tissue and begins 18 hour postpartum 
(Fosang et al, 1984).
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1.5.2 Mechanical properties of the cervix
The mechanical properties of the cervix (compliance, extendibility and 
stretch modulus) have been measured in sheep and other species (women, 
rat, goat and guinea pig) during the physiological ripening associated with 
labour (reviewed by Dobson, 1988).
Studies on the mechanical properties of the ovine cervix around 
spontaneous or induced parturition show a very abrupt increase in 
compliance a few hours before the appearance of uterine contractions, 
within 36 hours of labour (Fitzpatrick, 1977; Fitzpatrick and Dobson, 1981; 
Ledger et al., 1985; Owiny et al., 1987). Studies throughout pregnancy, 
have shown a decrease in the stretch modulus in early pregnant sheep (SO­
SO days of gestation) that was significantly different from non pregnant 
sheep, indicating the beginning of cervical softening. Softening gradually 
increased from day 30 and day 140 of gestation, with a marked significant 
increase between term (day 140-144) and the onset of labour (145-147 
days). No further distension occurs between labour and the delivery of the 
lamb (Owiny et al., 1991). There is therefore good correlation between the 
timing of microscopical changes and changes in the mechanical properties 
of the periparturient ovine cervix.
1.5.3 Biochemical changes in the extracellular matrix
Biochemical studies have corroborated the idea that changes in the 
connective tissue are responsible for cervical ripening at term. These 
studies are more complete in women although extensive studies have also 
been done in sheep, rats and guinea pigs. The matter is not fully clarified 
and there are several theories and differences between laboratories and 
species. Changes in the biosynthesis and metabolism of collagen and 
proteoglycans and enzymatic degradation of collagen seem to be the key 
points.
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Summarising, the two main mechanisms of cervical ripening could 
be: 1) Enzymatic degradation of key constituents of the extracellular matrix, 
involving MMP-1 or MMP-8 and leukocyte eiastase. 2) Changes in the 
amount and relative composition of the proteoglycans and GAGs which 
destabilise collagen.
In the guinea pigs and rabbits there is evidence of the enzymatic 
degradation of collagen, which is restricted to the activity of fibroblast 
collagenase (MMP-1) (Rajabi et al., 1990; Imada et al., 1994). But in human 
studies, there is evidence accumulating, that involves PML degranulation 
with the release of PML collagenase (MMP-8) and leukocyte eiastase 
(Doherty and Janusz, 1994) in the degradation of collagen and other 
components of the matrix (Uldberg (thesis) 1989; Rath et al., 1994; Morrison 
et al., 1994).
In the ovine cervix, collagenase activity has been detected with 
assays that do not differentiate MMP-1 from MMP-8 and its possible role in 
cervical ripening is still unclear. There is evidence for an increased activity 
of collagenase at term, using an activity based assay (Ellwood et al., 1981). 
But other collagenase assays have not been able to detect the increase: 
such as the less sensitive hydroxyproline assay (Fitzpatrick and Dobson, 
1981) or another activity based assay (Raynes et al., 1988a). Similarly, in 
rat cervical tissue, attempts to extract collagenase obtained very low levels 
(unpublished observations), and it was suggested by some authors that 
species variability may exist in the mechanisms of ripening and that 
changes in GAGs and proteoglycans could be more important in species 
like the rat and the sheep (Woessner and Kokenyesi, 1991).
Initially there were technical difficulties in demonstrating an increase 
of collagenase activity before parturition in the guinea pig (Rath et al., 1989) 
and in women, but a year later the role of collagenase prepartum was 
demonstrated in both species (women: Osmers et al., 1990; guinea pig:
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Rajabi et al., 1990). It is not clear, therefore, if the failure to detect an 
increase in collagenase activity in sheep and rats reflects true physiological 
differences in the mechanisms of cervical ripening, technical problems or 
species differences in the levels of collagenase. A common mechanism 
with the involvement of collagenase in sheep and rats may be supported 
by: (1) an increase in collagenase activity has been demonstrated, inducing 
labour in rats with RU486 (Ikuta et al., 1991), (2) the method used by Rajabi 
and colleagues in women and guinea pigs, is 3 times more sensitive than 
the one used by Raynes and colleagues in sheep (Rajabi et al., 1990) and 
(3) Osmers and colleagues (1991b) suggest that there is a limited temporal 
window of collagenase activity, which may be even more critical in the 
sheep, due to the speed of the events during cervical ripening compared to 
women.
The regulation of MMP has also been studied in relation to cervical 
ripening, which further supports the enzymatic theory. Regulation can be 
achieved in 3 ways: a) control of gene expression of MMP, b) extracellular 
activation of proenzyme to enzyme and c) by tissue inhibitors of the MMPs 
(TIMPs) (Woessner, 1991). Measurements of TIMP by ELISA showed 
elevated levels at the end of pregnancy in women (37-40 weeks) at a time 
when the collagen content decreased substantially (Clark et al., 1994). The 
authors suggest that the role of TIMP may be preventive against massive 
uncontrolled degradation by metalloproteinases. Similar findings were 
reported when studying cultured cervical tissue in the sheep. The amounts 
released of the collagenase inhibitor was greatest from tissue at peripartum 
(145-146 days, term: 147 days). However, these results were interpreted as 
conflicting with the collagen degradation theory for cervical ripening in 
sheep, because a substantial increase in collagenase activity was not 
detected (Raynes et al., 1988b). In women, although collagenase inhibitors 
increased significantly at term, collagenase increased much more (23
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times) than the sum of its inhibitors TIMP-1 and a2-macroglobulin (twofold) 
suggesting a net breakdown of the tissue. Similar imbalance between 
collagenase and its inhibitors had been observed by one of the authors in 
osteoarthritis (Rechenberger and Woessner, 1993). In vitro studies in the 
rabbit, have shown that progesterone may keep the cervix closed during 
pregnancy by increasing the production of TIMP-1 and TIMP-2; these inhibit 
the enzymes MMP-1 and MMP-3 respectively (Imada et al., 1994).
During pregnancy (100 days, 140 days and at term), the softening of 
the ovine cervix is accompanied by an overall reduction of the collagen 
content (Fosang and Handley, 1988). Similar results have been found in 
women, collagen content decreased from 10 weeks of pregnancy and in 
periparturient women is between 30-50% of that in the non-pregnant 
control. The extractability of collagen increased, from 40% in non pregnant 
cervices to 95% in ripened cervices, and shows new collagen with fewer 
cross links (Uldberg (thesis) 1989). The activity of the collagen-breaking 
enzymes collagenase and leukocyte eiastase, originated from 
chemoattracted PMLs could explain these changes in humans (Osmers et 
al., 1992; Rath et al., 1994). It is also possible that the source of 
collagenase is the fibroblast, since mRNA for MMP-1 has been detected in 
cell cultures of the late pregnant guinea pig cervix (Rajabi et al., 1990). 
There is also an increase in the water content, that can be explained by 
increased vascularity and changes in GAGs (Dobson, 1988; Uldbjerg et al., 
1983).
Although there is strong evidence for the enzymatic theory in women
and the guinea pig, the importance of the proteoglycans is not ignored in
these species (Osmers et al., 1993; Rechberger and Woessner, 1993). The
changes in the proteoglycans are not fully agreed, and it is unclear if this is
due to assays or species differences. Some authors report an increase in
the synthesis of proteoglycans in general (Fosang and Handley, 1988),
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others report changes in the proportion of the different types of GAGs, with 
an increase of hyaluronic acid whereas dermatan sulphate, the most 
abundant GAG, decreases; this has been found in sheep and in most 
studies from other species (reviewed by Dobson, 1988). The increase in 
hyaluronic acid may act by attracting water, and the decrease in dermatan 
sulphate proteoglycan may destabilize collagen and fibronectin which 
binds with high affinity to dermatan sulphate (Christiansen et al., 1991; 
Osmers et al., 1993). Chondroitin sulphate is unchanged during late 
pregnancy in the ovine species (Anderson et al., 1991), but an increase has 
been detected in humans. Unlike dermatan sulphate, chondroitin sulphate 
has a weak affinity for collagen and fibronectin and therefore an increase 
destabilises the extracellular matrix (Osmers et al., 1993). Heparan 
sulphate increases in sheep and women during late pregnancy, possibly 
acting on blood vessels and increasing the vascularisation (Anderson et al., 
1991; Osmers et al., 1993). Other authors have reported an increase in the 
small dermatan sulphate decorin (DSPG-II), which could act by separating 
collagen fibres occupying more space between them. They postulated that 
the high solubility of the collagen is not due to degradation by collagenase 
or lack of cross linking but to dispersion of collagen fibres. Elastin could fit 
in this theory as a "memory" of the initial shape to be restored postpartum 
(rat: Woessner and Kokenyesi, 1991).
1.5.4 The possible role of the smooth muscle in cervical 
fUOCtipns
The role and the function of the smooth muscle in cervical ripening and 
other cervical functions remains unclear. Most of the literature is of the 
opinion that the cervix consists mainly of connective tissue (see previous 
histology and biochemistry sections, pages 10 and 12) and that cervical 
ripening is an active process, involving remodelling of the connective tissue
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(section: 1.3, page 12). But some authors contend that the cervical 
musculature is sufficiently developed for it to show spontaneous contractility 
(histology section). Based on that view, some studies have shown 
spontaneous and drug-induced contractility during the cycle and in late 
pregnancy, but others consider the role of this contractility insignificant 
when compared to the uterus proper (reviewed by Challis and Olson, 1988; 
Hillier, 1990; Rousseau and Menezo, 1993). There is also disagreement as 
to whether or not hypertrophy of the smooth muscle occurs during cervical 
ripening in late pregnancy (sheep: Aughey et al., 1983; human; Minamoto 
et al., 1987; human; Junqueira et al., 1980).
Cervical motility has been observed in the smooth muscle during the 
cycle (Garcia Villar et al., 1982) and during pregnancy in sheep (Garcia 
Villar et al., 1984a). The smooth muscle of the cervix is responsive to drugs 
in vitro and in vivo, with either contractions or relaxation. Prostaglandins in 
the cervical muscle, unlike in the uterus proper, tend to elicit relaxation 
(humans: Najak and Hillier, 1970; Hillier, 1990). In contrast, oxytocin 
induces contractions (Garcia-Villar et al., 1982), this effect unlike the uterus 
does not require oestrogen priming (Garcia-Villar et al., 1984b). Other 
studies, however, have pointed out that the ability of the cervix to contract, 
compared to that of the uterus, is negligible (human: Najak and Hillier, 
1970).
In the ewe, two phased cycles of spontaneous contractility have 
been observed during the cycle, irregular activity and regular activity, only 
the latter occludes the cervix completely. During oestrus the irregular 
activity, which does not occlude the cervix, was more frequent than during 
the luteal phase (review Rousseau and Menezo, 1993). Forty eight hours 
before lambing, a phase of relative inhibition of electromyographic (EMG) 
activity occurred both in the cervix and the uterus and lasted for 17 hours; it 
has been suggested that the increase in cervical compliance may start
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during this phase of inhibition. Thereafter EMG activity returned and 
increased over the whole genital tract (reviewed by Taverne, 1992). An 
alternative interpretation is that unchanged contractility before and during 
lambing indicates that relaxation of the musculature is not responsible for 
cervical compliance (reviewed by Challis and Olson, 1988).
1.6 PHYSIOLOGICAL CERVICAL RIPENING AT TERM: THE 
ROLE OF PGE2 AS PART OF THE ENDOCRINE AND 
PARACRINE REGULATION
It is difficult to separate the effects of the different hormones on the uterus 
and the cervix in late pregnancy and during parturition. Both organs are 
exposed to a similar endocrinological environment during this period, but 
they respond differently. Microscopical, mechanical and biochemical 
changes in the cervix, indicating softening and tissue break down, have 
been noticed at preterm (day 140) in sheep (see previous sections). But the 
maximal changes occur very rapidly within 36 hours prior to labour and 
coinciding with dramatic changes in plasma concentrations of 
progesterone, oestrogen and PGF2 a at 24 hours before the onset of labour
(Fitzpatrick and Liggins, 1980; Owiny, 1986). There is a clear direct 
correlation between a drop in cervical compliance with falling levels of 
progesterone and rising levels of 17p oestradiol and prostaglandin F2 a
(Fitzpatrick and Liggins, 1980), suggesting an endocrinological regulation 
by these hormones of cervical ripening.
A causal role for prostaglandins in ovine parturition has been 
demonstrated. The administration of the PG synthetase inhibitor 
meclofenamic acid to late pregnant sheep prevented cervical ripening and 
uterine contractions despite steroid changes, delivery took place when the 
inhibitor was withdrawn (Mitchell and Flint, 1978). On the other hand, 
cervical tissue from late pregnant sheep can produce prostaglandins at
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high rates in vitro and there is evidence of an increase in production at 
de l ive ry  (main ly PG E 2 and P G F ia )-  Studies in vivo also show ed high 
levels of PG E 2 and 6 -oxo -P G F ia  in cervical venous plasma 6 hours before 
de live ry  o r  at de livery respective ly. These s tud ies suggested  a local 
regulation of cervical ripening by PG E2 and other prostaglandins (Ellwood 
et a l. , 1981). Studies from other species have shown that oxytocin and 
relaxin may also be involved in cervical regulation by e ither endocrine or 
paracrine m echan ism s (reviewed by Challis  and O lson, 1988; Dobson, 
1988; Hillier, 1990).
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Figure 1.0: Endocrinology of cervical ripening
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1.6.1 Decrease in the proaesterone/oestroaen ratio (P4/E2
ratio)
1.6.1 i Progesterone withdrawal
In sheep, the high plasma levels of progesterone observed in the second 
half of pregnancy are due to placental production. Progesterone withdrawal 
occurs very rapidly, one day before the onset of labour (Chamley et al., 
1973). This drop in progesterone has been attributed to the catalytic activity 
of 17a-hydroxylase in the placenta converting progesterone into androgens 
which are subsequently converted to oestrogens (reviewed by Liggins, 
1983). This mechanism produces a rapid shift in the P4/E2 ratio that occurs 
within hours in the sheep, faster than in corpus luteum- dependent species 
like the rat, where it is a matter of days rather than hours (Maltier, 1993a).
The source of progesterone is also the placenta in humans and the 
guinea pig, but the peripheral levels of progesterone remain unchanged 
before the onset of labour in these species. Therefore it was proposed that 
local concentrations of progesterone may drop in the uterus of these 
species (Challis and Olson, 1988). There is local production of steroids 
inside the uterus by fetal membranes in humans and other primates. In 
sheep steroidogenic enzymes are present in the fetal membranes too, 
suggesting a potential for a paracrine effect of steroids but it is not clear if 
systemic or paracrine effects are more important (Challis and Lye 1994).
The administration of antiprogestagens, acting at the receptor level, 
induce cervical ripening in all species studied supporting a paracrine 
regulation. Antiprogestagens induced full labour only in those species with
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physiological progesterone withdrawal at term (rats, rabbits, sheep, pigs 
and cows), but induced cervical ripening in those species without a fall in 
peripheral levels of progesterone (guinea pigs, non-human primates and 
humans) (reviewed by Chwalisz, 1994). In women the P4/E2 ratio 
decreases by 40% locally in the uterus in the last few weeks, but this type of 
information is not available for the cervix (Maltier et al., 1993a). Other 
authors have proposed that a loss of progesterone nuclear receptors (PRn) 
occurs in the rat towards the end of pregnancy and human myometrial 
receptors are also very low at parturition (Giannopoulus and Tulchinsky, 
1979; Khan-Dawood and Dawood, 1984). Similarly in the pig, 
progesterone nuclear receptors (PRn) in the cervix and myometrium, 
increased significantly at mid pregnancy and declined afterwards at the 
same time as the drop in plasma progesterone (Thilander et al., 1990). In 
the cow, parturition starts with already fallen levels of progesterone and the 
levels of myometrial progesterone receptors do not drop at parturition 
(Klauke and Hoffman, 1992). In sheep, parturition starts with declining 
levels of progesterone and myometrial receptors levels are very low 
(Klauke and Hoffman, 1992). These works suggest that in cattle removal of 
progesterone from the bloodstream occurs whereas in humans a similar 
effect may be achieved by a loss of progesterone receptors. In sheep and 
pigs both mechanisms may be important.
There is a positive correlation between plasma progesterone and 
softening of the cervix, measured by mechanical parameters, suggesting 
that progesterone withdrawal facilitates ripening (Fitzpatrick and Liggins, 
1980; Owiny, 1986). But the importance of progesterone withdrawal as a 
prerequisite for cervical ripening is not completely clear in sheep. Massive 
doses of progesterone (200 mg/day) administered to sheep at parturition, 
inhibited contractions but were unable to inhibit the increase in cervical 
compliance in sheep (Stys et al., 1980). Others have found that cervical
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ripening was blocked by the administration of high doses of progesterone 
(150 mg/day) at late pregnancy, in the presence of uterine contractions 
(Challis and Lye, 1994). Using lower and more physiological doses of 
progesterone (100 mg/day), labour progressed normally both in terms of 
cervical ripening and uterine contractions (Challis and Lye, 1994). Studies 
with the inhibitors of progesterone (epostane) and prostaglandin synthesis 
(mefenamic acid) in sheep, suggested that progesterone withdrawal was 
capable of inducing cervical ripening in the absence of an oestrogen surge 
but was dependent on prostaglandin synthesis (Ledger et al., 1985). Unlike 
the sheep, the effect of progesterone withdrawal does not seem to be 
mediated by prostaglandins in guinea pigs, man or rats. Inhibitors of 
prostaglandin synthesis did not abolish the effect of progesterone 
antagonists on the cervix. The administration of progesterone antagonists 
did not affect the synthesis of prostaglandins by cervical tissue (reviewed by 
Chwalisz et al., 1994).
Early studies in sheep showed that progesterone had an inhibitory 
effect on the production of collagenase by the cervix in vitro (Ellwood et al., 
1981). In the guinea pig procollagenase (proMMP-1) gene expression 
seemed to be regulated by progesterone and oestrogen but results were 
unclear (Rajabi et al., 1990). In rabbit cervical fibroblasts, physiological 
doses of progesterone upregulated two inhibitors of metalloproteinases 
(TIMP-1 and TIMP-2) (Imada et al., 1994) and also downregulated two 
metalloproteinases, namely pro-interstitial collagenase (pro-MMP-1) and 
pro-stromelysin (pro-MMP-3) respectively (Sato et al., 1991). in vitro studies 
in human placenta (choriodecidua) obtained at term or after labour, have 
shown downregulation of IL-8 production by progesterone and 
upregulation by progesterone withdrawal with myfepristone (Kelly et al., 
1992). These authors suggest the following mechanism of parturition, 
cervical softening and uterine contractions occur as a result of local
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progesterone withdrawal that was suppressing IL-8 and collagenolysis by 
PMLs during pregnancy. Studies of this type are not available in the sheep, 
but similarly progesterone withdrawal is followed by a PML invasion of the 
endometrium (Staples et al., 1983). In rabbits progesterone also 
suppresses IL-8 production by uterine cervical fibroblasts (Ito et al., 1994).
Summarising, studies in vitro in a wide range of species (sheep, 
rabbit, guinea pig and humans) suggest that progesterone may have a 
negative effect on cervical ripening by regulating the degradation of the 
extracellular matrix. Progesterone could downregulate the gene expression 
and activity of matrix metalloproteinases by fibroblasts. Progesterone could 
also act as anti-inflammatory agent that suppresses the influx and activation 
(degranulation and release of proteinases) of PMLs, inhibiting the 
production of IL-8, for example.
1.6.1 ii Oestrogen surge
A very sharp peak of plasma oestrogens occurs 24 hours before labour in 
sheep (Challis, 1971), oestrone (E1) was produced in larger quantities than 
oestradiol-17p (E2) (Chamley, et al., 1973). In other species the rise of E2 
occurs more gradually within 5-6 weeks prelabour (Challis and Olson, 
1988; Maltier et al., 1993a).
In the sheep, which is a "placental 17a-hydroxylase (P-450i7a) 
present species", fetal cortisol and placental progesterone are the main 
precursors of the synthesis of oestrogen by the placenta at parturition. 
Human is a "placental 17a-hydroxylase deprived species", and different 
main pathways of oestrogen production are used, the placenta imports 
dehydroepiandrosterone sulphate (DHAS) from maternal and fetal adrenal 
origin to produce oestradiol (Liggins, 1981; Robel, 1993). This alternative 
pathway may be present in sheep, contributing in a “fail-safe” mechanism 
(Challis and Olson, 1988).
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Physiological concentrations of DHAS may contribute to cervical 
ripening in women, since they increase in the cervix with gestational age 
and are higher in women with ripe cervices, compared to unripe cervices. It 
has been suggested that this androgen may be more effective than 
oestrogen in ripening the cervix. DHAS stimulated collagenase and other 
MMPs in pregnant rabbit uterine cervix in culture (reviewed by Hillier,
1991), which is also a P-450i7ttdeprived species (Liggins, 1981). DHA may 
be involved in a paracrine manner in inflammation (Kelly, 1994).
In humans oestrogen can be synthesised in fetal membranes, 
suggesting a possible paracrine regulation of the uterus and cervix (Challis 
and Olson, 1988). Oestrogen receptors (ER) have been shown first in the 
rat myometrium through pregnancy, they decreased during pregnancy in 
both cytosolic and nuclear fractions (>300 to >100 fmol/mg protein) and 
sharply increased (from >100 to 200 fmol/mg protein) with the onset of 
labour (Alexandrova and Soloff, 1980). These results are explained by 
progesterone downregulation of ERs during pregnancy and upregulation 
by the increased E2/P4 ratio before labour, since oestrogens upregulate 
ERs (Alexandrova and Soloff, 1980). Similarly, ER mRNA increases in 
human uterine tissues during labour (Mitchell et al., 1993) and 
adrenalectomy in late pregnant sheep, which prevents the increased E2/P4 
ratio, decreased markedly the mRNA expression of ER (Wu et al., 1993). 
But so far, only low levels of oestrogen receptors have been reported 
during labour in the ovine myometrium (15.3 fmol/mg protein) and a 
gradual decrease in the receptor concentration from the first trimester to 
parturition in cows (95.1 to 4.5 fmol/mg protein) (Klauke and Hoffman,
1992). In the porcine cervix and myometrium both cytosolic (ERc) and 
nuclear oestradiol (ERn) receptors increased in late pregnancy and were 
maximal at parturition. The number of ERc and ERn during parturition were 
2000 and 60000 sites/cell in the cervix and reached levels of 4000 and
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40000 sites/cell in the myometrium respectively (Thilander et al., 1990). The 
authors found difficulty in explaining the role of ER in the softening of the 
cervix at labour because they had previously concluded that ER mediates 
the constriction of the cervix during oestrus in the sow. The concentration of 
ERc and ERn in the porcine cervix at oestrus was about 7600 and 1200 
sites per cell respectively (Stanchev et al., 1984).
Oestradiol appears to promote cervical ripening in most species but 
at times inconsistently, and the mechanisms are unclear. In the sheep 
infusion of oestradiol was associated with cervical softening and 
prostaglandin production. Inhibition of the oestradiol-induced prostaglandin 
production with meclofenamic acid (MFA) partially reduced the softening 
effect of oestrogen (Owiny, 1986). Other authors have concluded that 
oestradiol-17|3 has a direct effect (not mediated by synthesis of PGs) on the 
physical and biochemical properties of the ovine cervix (Fitzpatrick and 
Dobson, 1981). In the rat, oestradiol can modify the mechanical properties 
of the cervix, but to a lesser extent than in physiological ripening, 
suggesting also an indirect effect (Maltier et al., 1993a). These experiments 
suggest the possibility of both a direct and an indirect action (through 
prostaglandin) of oestradiol in cervical softening. Oestradiol could 
upregulate prostaglandin production or the cervical sensitivity to 
prostaglandins. Stimulation of the production of relaxin by oestradiol has 
also been proposed.
Oestradiol had a positive effect on the production of prostaglandins 
by the rat uterus, but this effect has not been demonstrated in the ovine 
cervix (Ellwood et al., 1981). There is no direct evidence of upregulation of 
prostaglandin receptors by oestrogens either. This was suggested in 
women because the pharmacological potency of PGE2 in the cervix 
increases with pregnancy status and during pregnancy (reviewed by 
Uldbjerg and Ulmsten, 1990). The cervix of postmenopausal women does
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not respond to PGE2 (Calder, pers. comm.) and PGE2 binding sites were 
almost undetectable in a study carried out in postmenopausal women 
(Bauknecht et al., 1981). On the other hand, the concentration of PGE2 
binding sites in the uterus and the cervix did not change during the luteal or 
follicular phases of the cycle, and were higher in non-pregnant than in 
pregnant women (Giannopoulos et al., 1985; Adelantado et al., 1988). 
These results did not support the idea of upregulation of prostaglandin 
receptors by oestrogen. Alternatively, receptors may be less detectable at 
term because they are occupied by high levels of PGs stimulated by 
oestrogens, pretreatment with oestrogens results in a reduction of free 
PGE2 binding sites in the myometrium (Bauknecht et al., 1981). In relation 
to a direct effect on the extracellular matrix of the cervix, both collagenase 
(guinea pig: Rajabi et al., 1990) and its inhibitor TIMP-1 may be stimulated 
by oestradiol-17p (rabbit: Sato et al., 1991). Paradoxically, in sheep, 
oestrogens seem to inhibit the activity of collagenase (Elwood et al., 1981). 
In humans the clinical effect of oestradiol has also been equivocal when 
administered locally and intravenously on its own, or prior to PGE2 
(reviewed by Petersen et al., 1991).
1.6.2 PGFzty peak and other prostaglandins
In the sheep and other species, prostaglandins are thought to be the final 
mediators of parturition, causing cervical ripening and uterine contractions 
(Challis and Olson 1988). PGE2 may be the initiator of labour in sheep, PG 
biosynthesis by the placental cotyledons increases after about 110 to 120 
days of gestation (term: 147 days gestational age) (Thorburn and Rice, 
1990; Thorburn, 1991). From about day 100 there is a progressive increase 
in PGE2 concentrations in the maternal plasma (Thorburn and Rice, 1990; 
Thorburn, 1991). Although these early increases in prostagladin synthesis 
coincide in time with the first microscopical and mechanical changes of the
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cervix, the author is not aware of studies correlating the two.
There is a peak of PGF2<x metabolite (PGFM) in maternal plasma, 24
hours prior to labour, that follows in time the change in 
progesterone/oestrogen ratio, the maximal changes in compliance also 
occur on that day but probably precedes this peak (Fitzpatrick and Liggins, 
1980; Owiny, 1986). Other prostagladins, including PGFia (PGI2
metabolite), PGE  ^ and PGE2 remain at low level in the uterine vein blood 
(Liggins et al., 1977) and jugular venous plasma (Ellwood et al., 1981). But 
changes are observed in the cervical venous plasma, 6 -oxo-PGFia starts to
rise 24-36 hours before labour and peaks during labour and PGE2 
increases during 6  hours preceding delivery, supporting the idea of local 
production of PGE2 and prostacyclin (PGI2 ) in the cervix (Ellwood et al., 
1981).
As in sheep, there is also a significant increase in circulating PGFM 
in women, the major metabolite of PGF2 0C. but an increase of PGE2
metabolite has not been detectable (Mitchell et al., 1982; reviewed by 
Keirse, 1990). PGE2 was expected to be high because it is ten times more 
potent than PGF2 0C in the induction of uterine contractions and cervical 
ripening (Thiery, 1979). But a rise of both prostaglandins (PGF2 0C and 
PGE2) in amniotic fluid during labour and a direct correlation between these 
levels and cervical dilatation has been demonstrated (reviewed by Keirse, 
1990; reviewed by Hayashi, 1993; reviewed by Maltier et al., 1993a). 
However, there has been some controversy as to whether PGF20C and PGE2
increase early enough in amniotic fluid to believe that they are causing 
cervical ripening and contractions, since a late rise may be a consequence 
rather than the cause of labour, this is a question of debate (McDonald and 
Casey, 1993; Romero et al., 1994).
Early studies of the prostacyclin metabolite PGF1a were unable to
show increased levels of this metabolite during labour, with improved
4 0
assays this has been shown in late pregnancy suggesting that increased 
production of prostacyclin may precede an increase in cervical ripening in 
women and sheep (Fitzpatrick and Liggins, 1980). Recent studies in sheep 
and women show an increasing capacity in the production of PGs from the 
last third of pregnancy with maximal levels observed immediately before 
labour, showing that the production of PGs drives labour rather than the 
other way around. The activity of PGHS-2, a rate limiting enzyme in the 
production of prostaglandins, increases in late pregnancy. This is an 
inducible enzyme, and in other tissues is known to be stimulated by 
proinflammatory mediators (Wimsatt et al., 1993; Texeira et al., 1993). 
There is also some evidence in sheep and women that the concentration of 
an endogenous inhibitor of PG synthesis (EIPS) decreases as term 
approaches (Porter, 1993). The synthesis of PGs in late pregnancy and 
labour is still a subject of discussion.
It is not clear whether peripheral levels of prostagladins are difficult 
to measure or are not really controlling cervical ripening. However 
prostaglandins, with the exception of prostacyclin are known to be 
hormones of local control that are synthesised and released on demand 
(see next section on prostaglandin receptors). The idea of a paracrine 
control is supported by evidence of local production of prostaglandins by 
the ovine (Ellwood et al., 1981) and human cervix (reviewed by Hillier,
1990), an increase in the rate of production and a change in the pattern 
have been observed in association with parturition. Calder and Greer 
(1992) have suggested that while production within the cervix is important, 
the most potent sources of PGs may be the decidua (PGF2 cc) and the
amniotic membrane (PGE2 ), PGE2 could reach the internal os of the cervix 
migrating across the chorion. Similarly, the ovine cotyledons are a well 
known source of PGs at late pregnancy (Porter, 1993).
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Receptor studies in the cervix are confined to binding sites studies 
(reviewed by Rao, 1990) and the investigation of cAMP as a possible 
second messenger for PGE2 , both only in women (Norstrom et al., 1983). 
The PGE series seem to have greater affinity for its receptor than PGF2a 
which may explain the higher potency of PGE2 inducing contractions 
(Hofmann et al., 1983). Binding sites for prostaglandins of the E and F 
series have been found in the human cervices. Binding sites for PGE1 
(Hofmann et al., 1983; Gianopoulos et al., 1985) and PGE2 (Adelantado et 
al., 1988) were present in the cervix of premenopausal non-pregnant 
women undergoing hysterectomy due to various pathological conditions. 
PGF binding sites were reported to be present in the cervix during the cycle 
(Hofmann et al., 1983; Gianopoulos et al., 1985) but others found them 
during pregnancy and not during the cycle (Adelantado et al., 1988). The 
presence of PGE2 and PGF2CC binding sites has been reported but they
were almost undetectable in postmenopausal specimens (Bauknecht et al., 
1981). Despite the important function of PGE2 in cervical softening, in all 
these studies more binding sites were detected in the uterus than in the 
cervix. In the cervix more PGE2 binding sites were observed in pregnancy 
(term) and the follicular phase than in the luteal phase; whereas in the 
uterus more binding sites were detected during the cycle (follicular phase > 
luteal) than at term (Adelantado et al., 1988). Binding sites results are 
difficult to interpret in relation to the function of PGE2 in the cervix.
Further evidence for the physiological role of prostaglandins in 
cervical ripening is that inhibition of their synthesis can also inhibit cervical 
ripening at term or during labour in sheep (Mitchell and Flint, 1978; Owiny, 
1986; Owiny et al., 1987), the effect occurring despite low levels of 
progesterone (Owiny and Fitzpatrick, 1992). PG synthesis inhibitors seem 
to have a similar effect in women (reviewed by Calder, 1990). PG 
synthetase inhibitors act on the synthesis (60%) but they may also act on
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the receptors as antagonists since they bind to PGE2 and PGF binding sites 
(Rao, 1990).
The pharmacological effects of prostaglandins in the cervix also 
support their physiological role. Prostaglandins have the capacity to ripen 
the cervix and to induce contractions in the uterus. There is experimental 
evidence suggesting that these two effects are independent. It is generally 
admitted that tocolysis with (3-mimetics or physical disconnection of the two 
organs does not inhibit the cervical ripening effect of prostaglandins 
(reviewed by Challis and Olson, 1988; Owiny and Fitzpatrick, 1992; Calder, 
1990). The effect of exogenous PGE2 has been studied in microscopical, 
biochemical and mechanical studies during pregnancy (sheep: Fitzpatrick 
and Liggins, 1980; Stys et al., 1981; Owiny and Fitzpatrick, 1990; women: 
Conrad and Ueland, 1976; Uldbjerg et al., 1981; Uldbjerg et al., 1983; Rath 
et al., 1987; Osmers et al., 1991a; Greer et al., 1992; Rath et al., 1993). 
These studies have shown that PGE2 induces changes in the cervix, similar 
to physiological ripening at term. An inflammatory response has been 
observed in the cervix following PGE2 treatment (sheep: Fitzpatrick and 
Liggins, 1980; Owiny, 1986; women: Greer et al., 1992), with release of 
collagenase and elastase (Rath et al., 1993).
PGE2 can induce cervical ripening in late pregnant sheep of 124- 
140 gestational age, the mechanical properties of the ovine cervix were 
changed with local application of PGE2 and were comparable in magnitude 
with physiological ripening (Stys et al., 1981; Owiny and Fitzpatrick, 1990). 
In women, PGE2 acts during the cycle, early pregnancy and late pregnancy, 
but sensitivity increases with gestational age (Uldbjerg and Ulmsten, 1990; 
Calder and Greer, 1992). In sheep both PGE2 and PGF2tt stimulate cervical 
ripening administered generally or locally with variable results (Fitzpatrick 
and Liggins, 1980). Direct comparisons of the two PGs have not been done 
in sheep, but in women they suggest that PGE2 is more potent than PGF20C
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(reviewed by Keirse, 1990). PGE2 has also an effect relaxing cervical 
muscle in vitro, which is the opposite to the effect in the uterus (reviewed by 
Hillier, 1990).
The mechanism of action of PGF2a and PGE2 in the connective 
tissue of the cervix has not been completely clarified. Early work suggested 
that PGE2 administration is not mediated by increased collagenase activity 
(Uldbjerg et al., 1983; Rath et al., 1987). Later, an increase in collagenase 
activity was found during a limited time period (only 1 and 2  hours) after the 
PGE2 treatment (Osmers et al., 1991b). Changes in GAGs have also been 
reported (reviewed by Calder, 1994). in vitro, PGE2 has been shown to 
stimulate pro-collagenase activity of the guinea pig cervix (Rajabi et al.,
1990). Other authors have not been able to stimulate the collagenolytic 
activity of the human cervix in vitro and believe that cultures are almost 
devoid of PMLs and these cells may be the source of collagenase 
(reviewed by Uldbjerg, 1989). A current theory is that PGE2 may act as a 
pro-inflammatory agent in synergism with IL-8 , PGE2 induces 
vasodilatation, and IL- 8  attracts and degranulates the PMLs, releasing the 
proteolytic enzymes to degrade the matrix (Calder, 1994).
1.6.3 Oxytocin and its receptor (OTR)
Pharmacologically, oxytocin can induce contractions of smooth muscle of 
both the uterus and the cervix of the cyclic (Garcia Villar et al., 1984b) or the 
pregnant ewe (Owiny and Fitzpatrick, 1992). There is also some evidence 
that it may have an effect on the connective tissue of the cervix at term too. It 
reduces [3 H] proline incorporation into uterine cervix proteins at term, 
suggesting inhibition of collagen synthesis. The effect on the connective 
tissue does not seem to be mediated by prostaglandin synthesis (reviewed 
by Hillier, 1990).
There is evidence of an increased release of oxytocin by the
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neurohypophysis in late gestation with further release at labour in sheep. 
But in sheep and women oxytocin becomes detectable in peripheral blood 
rather late and after the onset of parturition, in the second stage of labour 
(at least several hours after the onset of labour contractions). There is a 
further increase with the passage of the fetus, cervical or vaginal distension 
stimulates hypothalamic release of oxytocin. The highest circulating levels 
are observed during the phase of fetal expulsion (reviewed by Challis and 
Olson, 1988; Maltier et al., 1993a; Porter, 1993). In most species the plasma 
increase is quite modest, considering its important role in inducing 
contractions during labour. Oxytocin receptors (OTR) are present in the 
myometrium and placenta, the number increase in late pregnancy with a 
surge just before labour and at the onset of labour. These results are 
consistent with early work on the increased sensitivity of the uterus to 
oxytocin at term in several species and together with the finding of an extra- 
hypothalamic source of oxytocin in the myometrium, led to the hypothesis 
that local regulation (production and increase in sensitivity) was more 
important than the levels of circulating oxytocin for the role of this hormone 
in the uterus (reviewed by Porter, 1993).
Peripheral changes of oxytocin occur too late to affect cervical 
ripening, but as in the uterus, local regulation may exist in the cervix too. 
Binding sites have been detected in the human cervix during the cycle 
(human: Fuchs et al., 1984 and 1985) and studied in non-pregnant sheep 
in detail (Matthews and Ayad, 1994). The receptor was present in the 
luminal epithelium, the superficial muscle layers and inner dense 
collagenous region, the presence of receptors was maximal at oestrus. The 
significance of this finding is unknown (Matthews and Ayad, 1994). But in 
the endometrium, Stewart et al. (1993) obtained partial codings of the ovine 
OTR cDNA, and they showed variations in the expression of the receptor 
and its mRNA during the cycle. The OTR and its mRNA is greatly
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upregulated in the endometrium of non-pregnant sheep from day 12, which 
causes the release of the luteolytic PGF2a. In pregnant sheep, trophoblast
interferon is produced at the time of maternal recognition, which may inhibit 
the synthesis of endometrial OTRs protecting the corpus luteum  from 
luteolysis (reviewed by Flint et al., 1992).
In cattle very low OTR concentrations have been detected in the 
cervix at mid-late gestation (175-250 days’ gestation), but an increase was 
observed at 278 days of gestation (term 280-284) (Fuchs, 1994). These 
authors suggested that OTR may have a role in cervical ripening. OTR were 
found in the cervical mucosa, where they could mediate PGE2 release 
(Fuchs, 1994), like endometrial OTR mediates PGF2a release in women at
term or in non-pregnant ruminant at the end of the cycle (reviewed by 
Porter, 1993). OTR mRNA increases were detected in the myometrium and 
endometrium of sheep at spontaneous or cortisol-induced labour (Wu and 
Nathanielsz, 1994). But OTR mRNA in the ovine cervix has not been 
detected using northern analysis at term (Wu and Nathanielsz, 1994). 
Similarly, the concentration of oxytocin receptors found in the human cervix 
during late pregnancy was very low and lower than in the uterus (Fuchs, 
1994). There is evidence of the presence of OTR in epithelial cells, this was 
shown in scrapings of endocervical tissue from women at term (Kubota et 
al., 1994). It is possible that OTR are mainly sublocalised in the endocervix 
(Wu and Nathanielsz, 1994; Fuchs, 1994), the paucity of OTR in the 
muscular layer would prevent contractions and would facilitate relaxation 
during cervical ripening.
1.6.4 Relaxin
The physiological role of relaxin controlling cervical ripening in rats and 
pigs is not doubted (Sherwood et al., 1993). Because these two species are 
not very closely related phylogenetically, the action of relaxin in the cervix
may be a universal phenomenon in mammals, its role has been 
investigated in ruminants and women, but results are still inconclusive 
(reviewed by Sherwood, 1988 and 1994). The main source of relaxin in 
pigs and rats is the corpus luteum, the hormone is detectable in the 
peripheral circulation during the second half of pregnancy, and contributes 
to the growth of the cervix. Relaxin peaks in peripheral blood coinciding 
with the time of cervical ripening in pigs, rats and humans. In humans 
however, ovarian relaxin is not essential for cervical ripening and there is 
evidence of a paracrine action of relaxin produced in the placenta. Relaxin 
can also be produced in the uterus of rats and pigs (reviewed by 
Sherwood, 1988 and 1994).
Relaxin receptors have not been isolated in any species yet, but 
binding sites and second messenger responses have been demonstrated 
in the cervix of several species (pig, rat, human and guinea pigs), thus a 
paracrine regulation may be conserved between mammalian species 
(Sherwood, 1988; Dobson, 1988; Calder, 1990). There are morphological, 
mechanical and biochemical evidences to substantiate that relaxin is 
involved in cervical ripening, mainly in the pig and the rat but also in other 
species (Sherwood et al., 1993; Sherwood, 1994).
Surprisingly, comparison of the sequences of relaxin in a wide 
range of female vertebrates (pig, rat, human, monkey, shark, skate, whale, 
porpoise, horse, dog and guinea pig) has shown very low homology 
between some of them. Between mammals, for example, homologies of 30- 
60% have been observed and therefore ideally relaxin of the same species 
should be used when assessing the biological activity of this drug 
(Sherwood, 1994). Most studies however, have been done with purified 
porcine relaxin. There are differences between species in the major source 
of relaxin (corpus luteum, placenta or uterus) and secretory profiles. Apart 
from the relaxation of the cervix, other biological effects of relaxin includes:
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inhibition of uterine contractions, relaxation of the pubic symphysis and 
promotion of the growth and development of the mammary apparatus. All 
these effects do not occur in all the species, but cervical ripening seem to 
be the most conserved among mammals.
There have been unsuccessful attempts to isolate and characterise 
ovine relaxin and its gene from the placenta (Wathes et al., 1988; Roche et 
al, 1993). A cDNA clone was isolated by RT-PCR using primers designed 
from areas conserved between pig, rat and human relaxin. But the clone 
was probably a pseudogene, because it contained many stop codons and 
mRNA expression was not demonstrable in ovary, placenta or endometrium 
(Roche et al, 1993). Studies using porcine relaxin (bioassays, RIA and 
immunoassays) have yielded confusing results and the main source of 
relaxin remains unknown in the sheep. Very low levels have been 
observed in plasma and tissues compared to other species with no 
increase throughout pregnancy (Renegar and Larkin, 1985; Wathes et al., 
1988). Either poor cross-reactivity with porcine relaxin, extreme liability of 
the peptide or very low levels of gene expression in this species were 
suspected. However, recent studies have shown for the first time a modest 
peak of relaxin in peripheral plasma, occurring four day before normal 
parturition and using a RIA with porcine relaxin (Gazal et al., 1993). The 
situation in cattle is similar to the sheep, the bovine relaxin has been 
purified but not isolated from the ovary and remains uncharacterised. 
Heterologous RIA have shown only a small prepartum peak (reviewed by 
Taverne, 1992 and Sherwood, 1994). Pharmacological effects of porcine 
relaxin in the cervix have been also demonstrated in sheep and other 
species that will be reviewed later (section 1.8.3)
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1.7 PHYSIOLOGICAL CERVICAL RIPENING AS AN 
INFLAMMATORY RESPONSE: INFLAMMATORY CELLS,
CYTOKINES AND PROSTAGLANDIN E2 (PGE2).
Evidence is accumulating, mainly in humans but also in other species that, 
as proposed by Liggins more than a decade ago, cervical ripening in 
mammals consists of an inflammatory response (Liggins, 1981). Initially the 
involvement of inflammatory cells and prostaglandins was clear and in 
recent years the participation of cytokines has been incorporated into the 
theory.
1.7.1 Inflammatory cells
The theory that white cells have a role in the degradation of the 
extracellular matrix during cervical ripening in a general context of an 
inflammatory response was first proposed by Liggins more than a decade 
ago (Liggins, 1981). His theory was based on physical and chemical 
changes during cervical ripening in various species that resembled an 
inflammatory response. The emphasis in the early work, carried out in 
sheep and other species with light microscopy, was on the eosinophil, 
which was thought to have a great capacity to degrade collagen (Liggins, 
1981). The finding of white cells, mainly PMLs, has been confirmed later in 
several species using TEM (sheep: Parry and Ellwood, 1981; guinea pig; 
Hegele-Hartung et al.: 1989). The leukocyte invasion in preterm sheep (at 
140 gestational age) consisted of lymphocytes, monocytes and a few 
eosinophils, associating their presence with connective tissue breakdown 
(Fosang et al., 1984).
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Polymorphonuclear Leukocytes (PMLs)
Human studies by Junqueira and colleagues showed extravascular PML 
surrounded by less dense collagen in what they judged to be “a halo of 
collagenolysis”, in those same studies evidence of collagen loss was 
demonstrated histochemically by staining collagen with picrosirius red. A 
positive correlation was found between the number of infiltrating PML and 
the degree of collagenolysis (Junqueira et al., 1980). Biochemical findings 
of the presence of leukocyte elastase and its inhibitor antileukoprotease in 
the cervix changed with cervical ripening (Ito et al., 1980; Uldbjerg, 1989) 
confirming the theory that leukocytes are involved. Immunohistochemistry 
showed that the source of elastase during cervical ripening in humans is 
the PML (Kanayama and Terao, 1991).
Collagenase activity was later detected in degranulating PMLs 
during labour using an antibody specific for PML collagenase (MMP-8 ) that 
did not cross-react with fibroblast collagense (MMP-1 ) (Osmers et al.,
1992). This finding together with the inability to detect mRNA expression of 
the MMP-1 from fibroblasts, led to the following suggestion by Osmers and 
colleagues: the cell that secretes “activated collagenase” found in the cervix 
during labour is the PML rather than the resident fibroblast. Using activity- 
based assays, the two collagenases are indistinguishable and others think 
that the matter has not been clarified. The collagenase activity detected in 
the cervix, could be MMP- 8  or MMP-3, MMP-3 activates the collagenase of 
the fibroblast (MMP-1) (Leppert, 1992). Recent work using a very sensitive 
ELISA with monoclonal antibodies specific for MMP-1 failed to detect 
increased activity in relation to cervical ripening, and the authors suggest 
that the increased collagenase activity found by others with activity-based 
assays is probably attributable to MMP- 8  (Morrison et al., 1994).
Several inflammatory mediators, known as the classical 
"chemoattractans" (named for their ability to stimulate chemotaxis) can
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activate the PML acting on specific receptors, they include bacterial 
products like N-formyl-methionyl-leucyl-phenilalanine (fMLP), cytokines like 
interleukin 8  (IL-8 ), products of the complement cascade (C5a) and lipid 
mediators like platelet activating factor (PAF) and leukotriene B4 (LTB4). 
Upon recognition of any of these agents, chemotaxis, secretion of 
proteolytic enzymes and production of reactive oxygen intermediates (ROI) 
occurs (Baggiolini et al., 1992, Baggiolini et al., 1993; Doherty and Janusz, 
1994). ROI released by activated PMLs promote degradation of the 
extracellular matrix by inactivating antiproteases (see previous leukocyte 
elastase section) and by autoactivation of metalloproteinases (MMP- 8  and 
MMP9). The PML collagenase (MMP-8 ), unlike MMP-1 does not require 
cleavage by MMP-3 for activation, but the release of hypochlorous acid 
during the respiratory burst as part of the effector responses of PMLs, a 
similar mechanism exists for gelatinase (MMP-9) (reviewed by Woessner, 
1991; Leff and Repine, 1993; Doherty and Janusz, 1994). The intracervical 
administration of IL- 8  induces cervical ripening (Chwalisz et al., 1994; El 
Maradny et al., 1994), suggesting that the activation of PMLs leads to 
cervical ripening. Summarising, there is evidence to support the role of two 
PML enzymes in cervical ripening, leukocyte elastase (Kanayama and 
Terao, 1991) and collagenase (MMP-8 ) (Osmers et al., 1992).
Peripheral changes in white cells counts have been observed in 
sheep and cattle during pregnancy and parturition (Anosa and Ogbogu, 
1979; Kehrli et al., 1989). In humans there is evidence of PML activation, as 
measured by superoxide production, which is increased in peripheral blood 
of pregnant women compared to non-pregnant (Okamura et al., 1988). 
Activated PMLs did not increase with the advancement of pregnancy in 
blood but did increase in the cervix (Okamura et al., 1988).
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Eosinophils
We have already mentioned that the number of eosinophils counted per 
high power field increased greatly in ovine cervical preparations (Fosang et 
al., 1984), similarly a ten fold increase was observed in guinea pigs 
(Liggins, 1981). Activated and degranulated eosinophils have been 
observed in cervical biopsies of pregnant women at term (Knudsen et al.,
1991) and in rats (Luque and Montes, 1989) surrounded by halos of 
collagenolysis. The contents of the eosinophilic granules have been 
studied in women (reviewed by Venge, 1993), but it is not clear whether 
cationic proteins or proteinases are released during the degranulation 
observed microscopically during cervical ripening (Luque and Montes, 
1989; Knudsen et al., 1991). The release of eosinophilic major basic 
protein has been detected by immunohistochemistry in rat cervices 
(Duchesne and Badia, 1992).
Eosinophils are also known to contain several proteinases including 
an interstitial collagenase capable of degrading the major collagen types of 
the cervix, leukocyte elastase and gelatinase B (MMP-9) (Hibbs et al., 1982; 
Lungarella et al., 1992; St£hle-Backdahl and Parks, 1993). Unlike the PML, 
the eosinophil not only stores proteinases, but may have the capacity of 
synthesising them, as in the case of MMP-9 in disease states (St&hle- 
Backdahl and Parks, 1993). It has been proposed that the eosinophil may 
degrade collagen in conditions like granulomas, fibrosing alveolitis, chronic 
inflammatory disorders of the lung and metastasis (Luque and Montes, 
1989; St&hle-Backdahl and Parks, 1993). But the activity of these enzymes 
has not been studied in relation to cervical ripening or in the pathogenesis 
of other diseases implicating the eosinophil (asthma), which have put more 
emphasis on the cationic proteins (Venge, 1993; Butterfield and Leiferman,
1993).
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Infiltration of eosinophils is regulated by steroids in the rat cervix 
(Luque and Montes, 1989). Eosinophilia and eosinophil activation are 
regulated in inflammatory responses by chemokines of the CC type mainly 
(RANTES, Eotaxin, MCP-2, -3 and MIP-1a), IL-5, the lipid mediators (PAF, 
LTB4 and prostaglandins) (Giembycz and Barnes, 1993). The importance 
of these mediators in the activation of eosinophils leading to cervical 
ripening has not been evaluated yet.
Mast cells
Mast cells are resident cells of the connective tissue, strategically located 
near the surfaces exposed to the external environment. They are replete of 
mediators of the inflammatory response and designed to release some of 
them rapidly. It is the only resident cell type capable of storing tumour 
necrosis factor (TFN) in cytoplasmic granules that is rapidly released (within 
1 0  to 20 min of challenge). Some authors therefore see them as the 
initiators of the inflammatory response both in natural immunity (i.e. against 
bacteria) or acquired immunity (parasites and allergic diseases). The mast 
cells can respond rapidly because unlike the PML or the macrophage 
respectively, it does not require recruitment or synthesis of TFN (reviewed 
by Galli, 1993).
The granular contents of the human mast cells include a high 
content of a proteoglycan, heparin, responsible for the metachromatic 
staining of these cells. The GAGs of heparin are combined with neutral 
proteases (tryptase, chymase or carboxypeptidase) forming a crystalline 
structure in the granules. Tryptase is the major protein of mast cells in 
humans, whereas in the murine cells, chymases predominate (Caughey, 
1994). Heparin is also combined with the basic amine histamine. 
Histamine, heparin and neutral proteases are the major mediators stored 
by the mast cell. Other substances stored in smaller quantities include:
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exoglycosidases, chemotactic factors (eosinophil and PML), oxidative 
enzymes and kininogenase. These cells have also an action in the 
degradation of the extracellular matrix releasing tryptase and chymase 
which activate other lytic enzymes (like procollagenase and prostromelysin) 
(reviewed by Knudsen et al., 1991). They are also involved in the 
degranulation of the eosinophil (reviewed by Knudsen et al., 1991).
Mast cells have been noted in the ovine (Aughey, personal 
communication), guinea pig (Hegele-Hartung et al., 1989), and human 
cervical tissues at term (Lo Stumbo and Pelleggrini, 1970). It has been 
proposed that the mast cells could participate in cervical ripening by 
attracting and activating cells that contain collagenase and other 
proteinases (PML and eosinophil) (Knudsen et al., 1991) or with the 
release of vasoactive substances (Lo Stumbo and Pelleggrini, 1970). The 
presence of these cells in the uterus seem to change under the influence of 
oestrogens and androgens (reviewed by Knudsen et al., 1991).
Monocytes/Macrophages
These are resident cells of the connective tissue that participate in acute 
and chronic inflammatory responses and host defence against both 
bacteria and neoplastic cells, releasing proinflammatory mediators and 
proteinases (reviewed by Gallin et al., 1992). The macrophage secretes an 
extensive repertoire of products, most of them are newly synthesised and 
inducible (collagenase, elastase, plasminogen activator, TNFa, LTC4, 
PGE2 , PGFia, PGI2, PAF, hydrogen peroxide, nitric oxide, superoxide 
anion, etc.), but some are synthesised constitutively or are preformed and 
stored in granules (reviewed by Gallin et al., 1992). This cell is an important 
source of PGE2 in inflammatory responses. In acute inflammation, it is also
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capable of clearing the inflammatory site of debri by phagocytosing 
apoptotic PMLs (Savill and Haslett, 1993) and eosinophils (reviewed by 
Gallin et al., 1992).
Macrophages have also been reported in the guinea pig during 
spontaneous cervical ripening (Hegele-Hartung et al., 1989) and in the 
human cervix (Lo Stumbo and Pellegrini, 1970; Rayburn et al., 1994). In the 
sheep macrophages and lymphocytes were more prominent than 
eosinophils in late pregnancy (after day 140 and before term) simultaneous 
with the first evidence of tissue breakdown; this ratio changed at term 
(Fosang et al., 1984). Unlike the PML, there are no demonstrations of the 
monocyte/macrophage enzymatic activity during cervical ripening, although 
it is known that they release proteolytic enzymes in other tissues.
Serine proteinases may be lost during maturation from monocytes to 
macrophages, the elastolytic activity in monocytes is due to a serine 
proteinase and in macrophages to a MMP (Campbell et al., 1991c). 
Monocytes store serine proteinases in granules, less than PMLs but still 
considerable amounts, which may be useful for migration or rapid 
responses (reviewed by Caughey, 1994; Campbell et al., 1989; Kargi et al., 
1990; Campbell et al., 1991c). In arthritis, macrophages are thought to 
contribute directly with release of MMPs and also by producing 
inflammatory mediators that regulate MMP production by the fibroblast. The 
secretion of collagenase and macrophage elastase (MMP-12) is inducible 
in macrophages, taking 24 to 48 hours (reviewed by Henson et al., 1992). 
Unlike the PML, macrophages do not store collagenase (Birkedal-Hansen 
et al., 1993). Macrophages, like other leukocytes have also receptors for 
oestrogen and progesterone (reviewed by Gallin et al., 1992), this aspect 
has not been studied in relation to cervical ripening.
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Lymphocytes
Some authors have reported increased number of lymphocytes, associated 
with macrophages and a few eosinophils (Fosang et al., 1984), but others 
do not report a substantial change at the time of cervical ripening. They 
secrete mainly gelatinases (MMP-2 and 9) in small amounts that may allow 
migration through basement membranes. They are not sources of elastase, 
but other serine proteinases like granzyme A, B and met-ase (reviewed by 
Caughey, 1994).
Fibroblasts
Fibroblasts like white cells, can degrade the matrix. The repertoire of MMPs 
is similar to the macrophage (MMP-1, -2 and stromelisin) but more limited 
(no MMP-9 is produced), and the levels of production are higher in the 
fibroblast (reviewed by Gallin et al., 1992). We include the fibroblast in this 
section too because the release of collagenolytic and elastolytic activities, 
due to MMP-1 and MMP-2 respectively, can be induced from these cells in 
the skin by inflammatory mediators (Okada et al., 1993). PGE2 is a potent 
inducer of fibroblast collagenase (MMP-1) mRNA levels, promoter activity 
and secretion in the skin (Mauviel et al., 1994).
1.7.2 Cvtokines
As to how inflammatory cells are recruited into the ripening cervix at term 
and activated, there is growing evidence for the involvement of cytokines in 
man, the rabbit and the guinea pig. Cytokines are well characterised in 
mouse and man, but in sheep this work has only started in the 1990s 
(reviewed by Mclnnes, 1993). Cytokines are proteins participating in cross­
talk between white cells, endothelial cells and other cells of the body in 
inflammatory reactions (reviewed by Mclnnes, 1993).
Cervical explants from pregnant rabbits and pregnant women
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produce great amounts of the cytokines interleukin 1 (IL-1) and interleukin 8  
(IL-8 ) (Ito et al., 1987, 1988; Uchiyama et alM 1992; Barclay et al., 1993). IL-
8  is a secondary mediator of inflammation, acting at later stages of the 
inflammatory process. IL- 8  causes the PML to degranulate, releasing MMP-
9 from secretory vesicles, MMP- 8  from specific granules and elastase from 
the azurophil granules (Baggliolini et al, 1989). The release of these 
enzymes has been implicated in cervical ripening (see previous sections). 
The mRNA expression of IL- 8  can be upregulated by early mediators like 
IL-1 and tumour necrosis factor a (TNFa).
For the above reasons the involvement of TNFa, IL-1 and IL- 8  in 
cervical ripening has been studied in several species, finding that they can 
induce cervical ripening (rabbit: El Maradny et al., 1994; guinea pig: 
Chwalisz et al., 1994). These findings further support the physiological role 
of these cytokines and of the PML in cervical ripening (see section 1.8.5, 
later for more details on these treatments).
There is some information on the regulation of interleukins and the 
degradation of the extracellular matrix by white cells. Progesterone is an 
anti-inflammatory hormone that may control cytokine production in various 
intrauterine tissues, including the cervix (Hegele-Hartung et al., 1989; Ito et 
al., 1994, see other section on progesterone withdrawal, page 35). Other 
authors see the fibroblast as the main cell in cervical ripening and suggest 
that hyaluronic acid which increases in late pregnancy could stimulate the 
production of IL-1, which can in turn stimulate the production of collagenase 
by fibroblasts (reviewed by Leppert, 1992).
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1.7.3 PGE^ as a lipid mediator of the inflammatory response
Lipid mediators, derived from cell membranes, such as the platelet 
activating factor (PAF) and eicosanoids (prostaglandins and leukotrienes) 
modulate locally the inflammatory responses (Gallin et al., 1992). Liggins 
proposed that PGE2 acts in the cervix as a proinflammatory mediator, like in 
any inflammatory response, probably producing vasodilatation, which was 
the most accepted mechanism at the time (Liggins, 1981). The mechanisms 
of action of PGE2 in the inflammatory response, however are still not clear, 
because exogenous PGE2 can exert both proinflammatory and anti­
inflammatory actions (Phipps et al., 1991; Weissman, 1993). Some authors 
are trying to explain the pro and anti-inflammatory effects in terms of 
different prostaglandin receptor subtypes that mediate one or the other 
(Coleman et al., 1990; Wise and Jones, 1994). Unfortunately studies on the 
mechanisms of action of the anti-inflammatory actions of PGE2 are better 
documented than the proinflammatory actions (Reibman et al., 1990; 
Gryglewski and Salvemini, 1992).
A synergism has been demonstrated between IL8  and PGE2 to 
induce PML influx in the rabbit skin. This proinflammatory action of PGE2 is 
thought to be due to its high potency as a vasodilator and a similar 
mechanism has been proposed in the cervix (Kelly, 1994). PGE2 may 
induce plasma exudation by reducing the tone of the smooth muscle of the 
blood vessels. Since EP2 and EP4 mediate relaxation of the smooth muscle 
this action may be mediated by these receptor subtypes.
A new finding is that membrane receptors for PGE2 are not only 
localised in blood vessels, but also in white cells, which can also release 
PGE2 (Gallin et al., 1992; Coleman et al., 1990). PGE2 could also cause 
vasodilatation by acting directly on PMLs (Armstrong, 1992) which have the 
capacity of inducing exudation (Armstrong et al., 1990; Wedmore and 
Williams, 1981). PGE2 on its own also has chemoattractive properties for
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PMLs and other white cells in a variable fashion depending on the species. 
It is possible that similar synergism exists between PGE2 and monocyte 
chemotactic factor (MCP-1) in the recruitment of monocytes (reviewed by 
Kelly, 1994). PGE2 has also been implicated in the production of matrix 
metalloproteinases by monocytes/macrophages (Corcoran et al., 1992) and 
fibroblasts (Mauviel et al., 1994).
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1.8 CLINICAL INDUCTION OF CERVICAL RIPENING
In this section the compounds and methods that induce ripening are listed 
to give an overview of how to approach the cervical ripening problem. In 
ruminants, very little has been published, but recent work is addressing a 
pharmacological approach for cervical ripening:
(1 ) transcervical artificial insemination (in sheep),
(2 ) ringwomb which apart from the sheep, can affect buffalo, cattle and 
goats (reviewed by Dobson, 1988; Ghosh et al., 1992) and
(3) transcervical embryo transfer (in heifers, goats and sheep).
The subject is documented very extensively in human obstetrics for 
termination of pregnancy in the first two trimesters and induction of labour in 
cases of “unfavourable” cervices (reviewed recently by Hayashi, 1993). 
This information can be applied to other species. However, the dilatation of 
the cervix during the cycle, the most relevant topic for this thesis, has not 
been extensively addressed in women.
In laboratory animals, work has been done trying to clarify the 
mechanism of action of the different methods used in human obstetrics (rat: 
Saito et al., 1981; guinea pig: Chwalisz et al., 1991). Much work has been 
done on relaxin in guinea pigs, rats, and pigs, since its action on the cervix 
in those species is better known than in other species, including the 
humans. Comparison between methods have been done in rats (Saito et 
al., 1981) and women (Gupta and Johnson, 1992), but not in domestic 
species.
1.8.1 Prostaglandins and prostaglandin analogues
Prostaglandins of the F series for intramuscular (i.m.) administration are the 
only prostaglandins that are commercially available for veterinary use in 
reproduction. This type of preparation induces luteolysis and has found 
many applications in reproduction (Arthur et al., 1989). Intramuscular
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preparations of PGF2 a (Prosolvin, Intervet) have been tested 
experimentally to treat cases of ringwomb in goats with considerable 
success (80%), 7.5 mg were administered (Majeed and Taha, 1989 a & b). 
The PGF201 analogue Cloprostenol (Estrumate, Coopers) produced
satisfactory results (78%), using 500 mg (Ghosh et al., 1992). But because 
of the route used and because this PG is luteolytic in pregnant goats, it is 
not possible to know if the treatment had worked directly on the cervix 
(Fitzpatrick and Liggins, 1980) or by inducing luteolysis and progesterone 
withdrawal (Arthur et al., 1989).
Early experimental work used both PGE2 and PGF2 a to  induce
cervical ripening in late pregnant sheep (day 125, i.e. about three weeks 
before term), as an experimental model for obstetricians. These 
prostaglandins were first infused into the posterior aorta but because the 
effect was variable and in general antagonised by high peripheral 
progesterone levels, the intracervical route was tested, being more effective 
(Fitzpatrick, 1977). Human clinical studies nave also shown that local 
preparations are more suitable to induce cervical ripening and avoid side 
effects (Calder, 1994), but there are no suitable commercial preparations of 
this type for veterinary use. In human obstetrics, both PGF and PGE series 
(PGE1 and PGE2 ) were initially found to be effective in the induction of 
cervical ripening, but lower doses of PGE were effective and therefore the 
use of the E series dominates. The E series is not known in veterinary 
practice, but human local preparations of PGE2 , have been recently tested 
in small ruminants for cervical ripening in order to develop transcervical 
techniques of ET and Al. In cattle, these techniques can also be improved 
with PGE2 in heifers with small cervices (Humblot, personal 
communication).
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1.8.1 i Prostaglandin E2 (PGE2) used in humans
Local application (intracervical or vaginal) of PGE2 is the better known and 
most widely used method to induce cervical ripening in human obstetrics 
(reviewed by Keirse, 1990). The therapeutic action is believed to be related 
to their prominent role in physiological ripening. One problem of 
prostaglandins is their ubiquitous actions, leading to side effects. This 
problem has partially been resolved by using a local route of 
administration, that allows reduction of the dose needed, and the 
development of prostaglandin analogues (reviewed recently by Coleman et 
al., 1990; Calder, 1994). Another problem is their short half life, but 
analogues of a longer half life than the natural compounds have been 
developed and are therefore more potent, being indicated for early stage 
pregnancy termination or for exploratory purposes during the cycle 
(reviewed by Bygdeman, 1992; Calder and Greer, 1992). The clinical use of 
prostaglandins and their analogues will be expanded in the next section 
(1.9).
There are several preparations for human use in Obstetrics (Monthly 
Index of Medical Specialities; Martindale, 1993). The natural compound, 
PGE 2 (Dinoprostone) carried in tablets, lipid-based suppositories, 
embedded in pessaries and mixed in gels has been applied intravaginally 
(Prostin E2, Upjohn) in dosages ranging from 1-5 mg for ripening the cervix 
prior to induction of labour. PGE2 can also come in a viscous gel, 
containing 500 micrograms in prefilled syringes for intracervical use 
(Prepidil, Upjohn). Sulprostone is a synthetic analogue of dinoprostone 
(PGE2) for i. m. use. Carbaprost is synthetic analogue of dinoprost (PGF2a) 
for intravenous and i. m. use. Gemeprost and Misoprotol are synthetic 
analogues of alprostadil (PGE1 ), they are used intravaginally and orally 
respectively. Misoprotol is an oral preparation because it was originally 
manufactured for the treatment of duodenal and gastric ulcers, but it was
62
later found to be a cheap and accessible drug (for those countries where 
termination of pregnancy is forbidden) for the induction of cervical ripening. 
Gemeprost and Sulprostone are well known but the dose of Misoprostol is 
still being investigated (reviewed by Bygdeman, 1992; Calder and Greer, 
1992;).
1.8.1 ii Prostaglandin E2 (PGE2) used in sheep
It has been known for some time that prostaglandins of both the E and the F 
series, have a physiological role in cervical ripening and also have a 
demonstrated pharmacological effect at term (Stys et al., 1980; Fitzpatrick 
and Liggins, 1980; Stys et al., 1981; Ledger et al., 1985; Owiny and 
Fitzpatrick, 1990; Owiny and Fitzpatrick, 1992). This is further reviewed in a 
following chapter (chapter III).
During the cycle, the effect of PGE2 in the ovine cervix is now being 
investigated. Rickords and White (1988) used a lipid-base suppository for 
intravaginal human use, containing 10 mg of PGE2 (Dinoprostone), and 
showed that it can induce partial ripening in anoestrous sheep, mostly at 
the external os in most cases. Complete dilatation and catheterization was 
possible only in one ewe out of 20 animals. South African workers have 
reported very successful transcervical embryo collection in anaesthetised 
virgin and adult sheep (Barry et al., 1990) and goats (van Niekerk et al., 
1990). On day 6  following oestrus, oestradiol cypionate (1 mg) was 
administered intramuscularly in conjunction with 1 mg of PGE2 (Prostin E2, 
Upjohn), dissolved in saline and given intracervically. Using a similar 
method, results were not as successful in Scotland (Mylne et al., 1992). 
Parity and the breed affected the success in passing the cervix, ease of 
penetration was better in Texels than in Suffolks (53%-28% respectively) 
and very poor in virgin sheep (6 %). If cervical penetration was successful, 
the collection of embryos was comparable to laparoscopic collection (60%-
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58% respectively).
The prostaglandin analogue Misoprostol, adm inistered 
intravaginally has been used to facilitate transcervical artificial insemination 
with frozen semen in Brazil (Mies Filho et al., 1993). The use of this drug 
may appeal to veterinary use because is very cheap, the human dose ( 2 0 0  
pg to 1 mg cost about £4) and no refrigeration is necessary. It is an oral 
preparation, but in this work 100 pg of the PGE2 were administered 
intravaginally dissolved in saline, as a liquid solution or impregnated in 
sponges. Preliminary results with the aqueous solution revealed total 
success in catheterising the cervical canal 36 hours after administration. 
But with the sponges, only partial catheterization was possible in 15% of 
the animals (n=48) and the uterus was not reached in any animal (Mies 
Filho et al., 1993).
1.8.1 iii Prostaglandins used in heifers, cows and mares
The effect of prostaglandin E2 has also been studied in non pregnant (day 
8-10) and early pregnant (33-40 days gestation) heifers. A gel for human 
use (Minprostin, Upjohn, Sweden), containing 2 mg or 6  mg, was 
administered intracervically to non-pregnant and 2  mg to the pregnant 
heifers. There was dilatation of the cervix from 3 hour after treatment, as 
assessed by means of Hegar dilators of increasing diameters. The 2 mg 
dose appeared to be sufficient. There was systemic absorption that was 
more rapid than in women, but the effect was purely local. The viability of 
the embryo was not affected by the treatment, which was monitored by 
ultrasonography (Duchens et al, 1993).
Others have used higher doses of PGE2, 20 mg of intracervical 
Dinorprostone (Prostin, Upjohn), in cows to flush live fetuses in early 
pregnancy (33-42 of pregnancy) with variable success; the cervix was very 
dilated (14 cm) but fetuses died in some cases (Lavoir and Betteridge,
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1992). Both PGE2 and PGF2a have also been used in cows (Zerobin et al., 
1973) and mares (Volkmann and De Cramer, 1991) to terminate 
pregnancy.
1.8.2 Progesterone antagonists and steroids
1.8.2 i Progesterone antagonists
Progesterone antagonists (antigestagens) act by competing for receptors 
with progesterone, either by having more affinity for the receptors or by 
being present in greater concentrations. They also present high affinity for 
glucocorticoid and minerallocorticoid receptors, causing undesired side 
affects. Mifepristone, also known as RU 486 (Mifegyne, Roussel) was the 
first antigestagen to be developed, followed by its analogues ZK 98.299 
(Onapristone, Schering) and ZK 98.734 (Lilopristone, Schering) of lower 
antiglucocorticoid activity (Chwalisz et al., 1991).
Progesterone withdrawal is an important stimulator of cervical 
ripening (see section 1.6.1 i, page 33) and progesterone antagonists are 
able to induce ripening in various mammalian species (sheep, rats, rabbits, 
pig, cow, guinea pig, lower primates and humans) (reviewed by Chwalisz, 
1994). Onapristone has shown ripening activity in the guinea pig and 
Lilopristone was very effective in the rat, this effect can be achieved without 
the stimulation of uterine contractions (Chwalisz et al., 1991). These are 
novel drugs in human obstetrics, a ripening effect of oral Mifepristone has 
been reported in pregnant and non pregnant women (Reviewed by 
Chwalisz, 1994).
The use outside pregnancy may be interesting for Al and ET in
domestic animals. Although RU 486 has been tested in cows and sheep,
the purpose of these trials was not the induction of cervical ripening only,
but the induction of full labour, both cervical ripening and myometrial
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contractions. RU 486 decreased circulating progesterone concentrations 
within 24 hours in late pregnant sheep (Gazal et al., 1993) and cows (Li et 
al, 1991) and induced premature safe labour in sheep (Gazal et al., 1993).
1.8.2 ii Oestrogen
Oestrogen promotes cervical ripening in sheep and other species (Stys et 
al., 1980; Owiny, 1986; Steiner and Creasy, 1983; Robinson et al., 1991). 
The local application of oestradiol, is not the method of choice in women, 
but it is indicated in the presence of unexplained bleeding, when 
prostaglandins are not recommended (reviewed by Hayashi, 1993). Other 
authors believe that neither the effect nor the mechanism of action of 
oestrogens have been well studied in women yet (reviewed by Petersen et 
al., 1991). In sheep it has been used to prime PGE2 and oxytocin treatments 
(Barry et al., 1990; Khalifa et al., 1992).
1.8.2 iii DHEAS (dehydroepiandrosterone sulphate)
The rationale of using this androgen is that physiological concentrations of 
DHAS may contribute to cervical ripening in women, increases have been 
observed in the cervix with gestational age. Levels are also higher in 
women with ripe cervices, compared to unripe cervices (reviewed by Hillier, 
1990). Pharmacologically it has been administered intravenously effectively 
in women. The administration induced an increase in collagenase and 8  
oestradiol (reviewed by Hayashi, 1993). We are not aware of the 
involvement of DHEAS in physiological ripening of other species.
1.8.3 Relaxin
Relaxin has a demonstrated physiological role in the dilatation of the cervix 
and separation of the pubic symphysis in some species (rats and pigs: 
reviewed by Sherwood, 1994). But, the physiological role of relaxin during 
parturition has not been clarified in species like sheep, cattle and humans 
(see section 1.6.4, page 46).
Since the 1930s relaxin was extracted from pregnant sows’ ovaries 
and used experimentally in other species, these extracts were not fully 
purified until the late 1970s. The use of relaxin to induce ripening is a 
method under investigation at the present time in human obstetrics. Porcine 
relaxin administered by intravaginal or intracervical gel has been found to 
be useful to induce cervical ripening in women at term without increasing 
the uterine contractility (reviewed by MacLennan et al., 1991). But 
paradoxically, recombinant human relaxin (Genentech Inc. USA), which 
has recently become available, had no appreciable effect on cervical 
ripening in women (Brennand et al., 1993). These preliminary results were 
obtained in Scotland, using an intravaginal gel (containing either 0 ,1 ,2 , or 4 
mg of relaxin).
In ruminants only porcine relaxin has been used (pRLX) for the 
induction of cervical ripening. In cattle, purified porcine relaxin (3000 U/mg) 
administered either into the cervical os or intramuscularly, seem to have a 
pharmacological action ripening the cervix at term (Perezgrovas and 
Anderson, 1982; Bagna et al., 1991). An extract of relaxin was also effective 
5 days post oestrus in cows primed with oestrogen, several doses were 
titrated (Graham and Dracy, 1953). This type of regime produced 
histological changes similar to those seen at labour (Eggee and Dracy, 
1966).
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In sheep, the action of porcine relaxin is not clear, similar or higher 
doses than in cattle do not always produced a positive result, 0.5 mg pRLX 
(>3000 U/mg) intramuscular following oestrogen priming with or without 
progesterone, increased the efficacy of transcervical catheterisation in 
ovariectomized ewes (Nemec et al., 1988). Akinbami and colleagues 
(1990) found that relaxin (3000-4500 U per ewe) was totally effective or 
ineffective facilitating cervical penetration, depending on the postpartum 
stage of the ewe.
Salamon and Lightfoot (1970), using doses of 100 to 12500 U per 
ewe, did not achieve deeper insemination, when relaxin was given 1 and 
1 2  hours after the onset of oestrus.
1.8.4 Oxvtocin
It has been suggested that oxytocin may change the connective tissue of 
the cervix (Hillier, 1990), but this action has not been exploited clinically in 
human obstetrics and oxytocin is mainly used to induce uterine 
contractions, when the cervix is already ripened physiologically or 
pharmacologically by other drugs. Receptor studies have suggested a 
physiological role of oxytocin in cervical ripening of cattle, but this type of 
evidence has not been found in sheep (see previous section: 1.6.3, page 
44). But, exogenous oxytocin given intravenously dilates the cervix in 
sheep for artificial insemination and for ET (Khalifa et al., 1992). The use of 
this drug was based on empirical observations of this effect and because 
the existence of receptors for oxytocin was predicted at progestogen- 
induced oestrus and following the administration of oestradiol on day 9. 
Studies in Canada using oxytocin for transcervical artificial insemination 
with frozen semen have also shown very good results in penetration of the 
cervix (90%), but poor fertility (Castonguay, personal communication).
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1.8.5 Cytokines: recombinant human IL-8. IL-1-[3 and TNF-g
Recombinant human cytokines have not been used clinically, but their 
apparent physiological role and the results of local application in laboratory 
animals suggests that they may become a treatment in the future, specially 
IL- 8  (Calder, personal communication). One advantage of this treatment 
over PGs is that they do not induce myometrial contractions (El Maradny et 
al., 1994).
Recombinant human interleukin- 8  (Oncogene Science) when 
administered vaginally (suppositories of 100 ng for 5 days) can induce 
cervical ripening in nonpregnant and pregnant rabbits (El Maradny et al.,
1994). Similarly, Chwalisz and colleagues (1994) purified 3 human 
recombinant interleukins (IL-8 , IL-1  p and TFN-a) and confirmed the 
appropriate specific activity of each of them. Local application 
(intracervically) of these interleukins produced cervical ripening in 
advanced pregnant guinea pigs, the IL- 8  and IL-1  p effect being more 
similar to physiological ripening.
1.8.6 Mechanical methods
For decades cervical widening by mechanical means has been known to 
be effective. The mechanism is not fully understood but some clinicians 
have successfully used mechanical devices to dilate the unripe cervix 
alone or combined with pharmacological methods in women (Steiner and 
Creasy, 1983). Similarly, in veterinary practice (sheep, goats and cattle) a 
finger or the hand of the operator has been the most common method to 
solve a dystocia due to failure of the cervix to dilate (Arthur et al., 1989).
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Metal cylinders
The introduction of metal cylinders of increasing diameter is a traumatic 
method that had been used in the past in women (reviewed by Fisher et al., 
1981) and is still used in cattle for ET (Cattoni, personal communication).
Intracervical tents
This is an old fashion method that is still used and is very acceptable in 
obstetrics (reviewed by Gupta and Johnson, 1992; Hayashi, 1993), it was 
first described in the literature in the middle of the nineteen century in 
Glasgow Med J (Sloan, 1863). Intracervical tents are hydrophilic cylinders 
(natural or synthetic) to be introduced into the cervical canal. They work 
partially by attracting water, the tent swells 2-4 times its original size and 
causes the cervix to dilate very effectively, but with considerable discomfort.
Natural tents are kelp (seaweed) stems, measuring 2-6 mm in 
diameter and 60 mm in length, that are cut dried and sterilised. The first use 
of these method describes the use of Laminaria digitata (Sloan, 1863). 
Laminaria japonica, has also been used (Hayashi, 1993). Synthetic 
materials have been developed that act in the same way but faster: Lamicel 
and Dialapan, both registered trade marks, are more hygienic and also 
permit better control of the swelling, they do not elongate unlike the natural 
material and therefore there is not risk of entrapment of cervical tissue or 
neighbouring structures.
Lamicel is a polyvinyl alcohol sponge, impregnated with magnesium 
sulphate and compressed to a long thin cylindrical tent (available in two 
sizes: 3 or 5 mm thick and 75 mm long). When the tent absorbs water it 
swells to four times its original size. Dialapan is made of hypan 
(polymerised, polyacrylnitrate hydrogel). It comes in 3 sizes (4 x 55 mm, 4 x 
65 mm and 3 x 55 mm). It seem to be the fastest and most potent.
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Intracervical tents are effective cervical dilators in women in 
therapeutic abortion (in the first and second trimester) and before the 
induction of labour. Lamicel dilates the cervix at term within 3-4 hours with a 
maximum effect within 6  hours. The mechanism of action of these tents has 
not been fully understood. Apart from the possible passive stretching of the 
cervix, active dilatation seems to be induced by the tent, since the diameter 
of the cervix is greater than the tent after the treatment. Various 
mechanisms so far investigated have not been proven: the tents do not 
seem to exert significant radial pressure, increase plasma prostaglandins 
or cause inflammation. Mechanisms of action by magnesium sulphate, 
relaxing smooth muscle or influencing cervical water balance have also 
been disputed. There are reports of collagen separation observed in 
electron microscopy induced by Lamicel and Dilapan (Norstrom et al., 
1988). We are not aware of the use of this method in livestock or 
companion animals.
Balloon catheter with extra-amniotic saline infusion (BCEAS)
A catheter with a balloon attached to the tip, is inserted into the cervical 
canal until the balloon is located at the internal os. The balloon is then 
distended with water to dilate the canal. The method is effective but is not 
recommended at term because of the risk of infection in women (reviewed 
by Hayashi, 1993).
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1.9 MOLECULAR STUDIES OF THE PROSTAGLANDIN E2 
(PGE2) RECEPTOR (EPR) SUBTYPE EP3
1.9.1 Nomenclature and classification of prostaglandins and  
their receptors
Prostaglandins (PGs) and several related substances, like thromboxane A2 
(TxA2), prostacyclin (PGI2), hydroxyeicosatetranoic acids (HETEs) and 
leukotrienes (LTs), constitute a family of unsaturated fatty acids, all with a 
20-carbon skeleton, collectively known as eicosanoids (from the Greek 
word eicosa, meaning 20). Eicosanoids and platelet activating factor (PAF) 
modulate inflammatory responses and, in those contexts, they are also 
known by the collective name of lipid mediators, because they all derive 
from the membrane phospholipids. Biologically active eicosanoids are 
formed by two major pathways, namely the cyclo-oxygenase and the 
lipoxygenase; in addition a third pathway designated epooxygenase has 
more recently being discovered. PGs, thomboxanes and PGI2 are formed 
by the cyclo-oxygenase pathway, while the lipoxygenase products include 
HETEs and leukotrienes (so named because of their formation in 
leukocytes) (reviewed by Mitchell, 1990; Urich, 1990).
Prostanoids is a term that collectively include the products of the 
cyclo-oxygenase pathway, they are produced in three steps: 1 ) release of 
fatty acid (primarily arachidonic acid), 2 ) conversion of arachidonate to a 
common precursor (PGH2) and 3) isomerization of the individual 
prostanoids. In the first step, arachidonic acid is released from the 
membrane phospholipids by the action of phospholipases. Arachidonic 
acid is then converted to an unstable endoperoxide intermediate (PGH2) by 
the cycloxygenase prostaglandin H synthase, either a constitutive (PGHS-
1) or an inducible (PGHS-2) isoform. The subsequent conversion to the 
prostanoids (PGD2, PGE2, PGF2a, PGI2 and thomboxane A2) from the
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common precursor (PGH2 ) is tissue specific and is determined by the 
presence of synthetases for each prostanoid in some tissues and not in 
others (reviewed by Smith et al., 1992; reviewed by Goetzl et al., 1995).
Cellular recognition and effects of lipid mediators are explained by 
the existence of corresponding receptor(s), which are thought to be G 
protein linked with seven transmembrane domains (reviewed by Cockcroft, 
1994; Goetz et al., 1995; Coleman et al., 1995; annually updated by 
IUPHAR); we will only describe here the prostanoid receptors. These 
receptors have been characterised pharmacologically in many bioassays 
systems, using the naturally occurring prostanoids, agonists and 
antagonists; which have shown differences on ligand affinities and second 
messenger responses. Based on those studies prostaglandin receptors 
(termed P-receptors) were initially classified into five basic subtypes (DP, 
EP, FP, IP and TP). The first letters correspond to the type of natural 
prostanoid that is a major ligand, being at least ten times more potent than 
any of the other prostanoids. Thus a specific receptor has been proposed 
for each prostanoid (PGD, PGE, PGF, PGI and TxA2) and named DP, EP, 
FP, IP and TP receptors respectively. The EP receptors were subclassified 
into at least 3 subtypes initially; termed EP1 , EP2 and EP3 (Coleman et al., 
1990). These subtypes bind PGE2 with similar affinity, but are coupled to 
different intracellular second messenger responses (increase in calcium, 
increase in cAMP and decrease in cAMP respectively). They also present 
differences in their sensitivity to PGE agonists and antagonists. A forth EP 
receptor subtype was subsequently identified (EP4 ) which is also positively 
coupled with cAMP, like the EP2 subtype, but it is differentiable from EP2 
because of its insensitivity to the agonist butaprost and its sensitivity to the 
antagonists AH22921 and AH23848B (Coleman et al., 1994; Coleman et 
al., 1995; IUPHAR, 1996).
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Table 1.1
Prostanoid receptors classification
From Coleman et al., 1994 and the IUPHAR (1996)
PGE2 receptors here and the rest in next page.
Prostanoid receptors cDNA cloned in different species are also 
indicated. The cloning of cDNA for 6  receptors (EP1, EP2, EP3, 
FP, IP and TP) in the mouse has been reviewed by Narumiya 
et al. (1995), cDNA for the EP4 was later incorporated to the 
other 6  (reviewed by Ushikubi et al., 1995) and the DP receptor 
cDNA has been cloned recently (Hirata et al., 1995). (*EP2): 
There was an initial confusion because cDNAs were cloned in 
mouse and man wrongly named as the EP2, the true EP2 was 
later cloned in man (Regan et al., 1994) and the previously 
cloned receptors are now known to be in fact the EP4 
(Katsuyama et al., 1995). The seven human receptors (EP1 , 
EP2, EP3, EP4, FP, IP and TP) are reviewed by Abramovitz et 
al., (1995) and Pierce et al., (1995), except DP cDNA that was 
cloned later (Boie et al., 1995). Receptors cDNA cloning in 
other species has been reviewed by Ushikubi et al. (1995).
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This classification has been validated with cDNA cloning of each 
type and subtype in mice and humans (see table 1 .1 ). Cloning experiments 
have revealed further diversity within the EP3R subtype, this receptor may 
exist in a variety of isoforms, resulting from alternative splicing at the C- 
terminus. Splicing was first reported in cattle (Namba et al., 1993), but it 
was shown later that it occurs in other species and that splicing may be 
species specific (i.e. not all the isoforms found have an homologue in other 
species) (Pierce et al., 1995a). The isoforms are functionally different 
because they couple with different G proteins or with the same proteins but 
with different efficiency; apart from a decrease in cAMP that was the original 
response recognised in the EP3 subtype, other second messenger 
responses (increase in intracellular calcium and increase in cAMP) can be 
transduced by some of these EP3 isoforms (reviewed by Coleman et al., 
1995). The mouse isoforms have been found to be different not only at 
signalling but also in desensitisation and tissue distribution (Negishi et al., 
1995).
1.9.2 Historical background of the discovery of prostanoids and 
their receptors with special emphasis on prostaglandin E z  
(PGE?) and its receptors (EP receptors)
The information of this section has been obtained mainly from reviews by 
Robertson, 1986; Dusting and Stewart, 1990; Urich, 1990; Negishi et al., 
1993; Coleman et al., 1990; Coleman et al, 1994.
The activity associated with prostaglandins (PGs) was first detected 
by two American gynaecologists in the 1930s, they observed that the 
human uterus contracts when exposed to human semen. This observation 
was followed by those of Goldblatt and von Euler in the early 1930s, and 
prostaglandins were named by the latter author after the prostate gland, 
which appeared to be the source in human semen. In the 1950s, the first
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PGs, PGE2 and PGF20C were purified in 1957 and seminal fluid was shown 
to relax the cervix (reviewed by Najak and Hillier, 1970). During the next 
decade the remaining PGs were isolated and named alphabetically from 
PGA2 to PGH2 . It also became clear that prostanoids are synthesised via 
the cyclo-oxygenase pathway in response to extracellular stimuli, they are 
then quickly released and act as local hormones in neighbouring cells. This 
was the first example of paracrine hormonal regulation in tissues. In the mid 
1970s, thromboxane (TXA2 ) and prostacyclin (PGI2 ) were discovered and it 
became apparent that prostanoids have very diverse biological activities, 
which created excitement about the multiple possibilities of their therapeutic 
use. But this also implied proneness to side effects as another limitation to 
be added to their instability. Considerable progress was made in creating 
more stable analogues but not so much in reducing side effects. The use of 
PGE2 in gynaecology for the induction of labour and termination of early 
pregnancy started in the late 1960s towards the beginning of the 1970s 
(reviewed by Keirse, 1990). The first indication was the induction of uterine 
contractions and later the ripening of the unfavourable cervix (reviewed by 
MacKenzie, 1981; Elwood et al., 1981). The initial approach to reduce side 
effects in the induction of cervical ripening by PGE2 was to use local routes 
of administration (reviewed by MacKenzie, 1981).
There was a need to rationalise the multiplicity and ubiquitous 
distribution of prostanoids actions and this started with work on their 
binding sites in the 1970s. Kuehl and Humes (1972) showed the first 
evidence for the existence of prostaglandin E receptors in rat lipocytes 
(reviewed by Negishi et al., 1993). This was followed by other binding 
studies, first with [3 H] PGs E1, E2 and F20C and later with [3 H] PGs D2 and I2 .
These studies showed high affinity (Kd: 1-10 nM) and density (1 pmol/mg
protein) in a wide range of tissues, namely: lipocytes, liver, adrenal cortex,
adrenal medulla, liver, ovary, uterus, kidney, stomach, ileum, thymus, skin,
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brain, lung and blood cells. These findings supported but did not 
demonstrate the existence of functional receptors in those tissues. But later, 
it became clear that some of these binding sites represent functional 
receptors, with the demonstration in the early 1980s, that they can be up 
and down-regulated by exposure to the ligand or inhibitors. Binding site 
studies continued until the present, but in most cases using isolated cells 
and analogues that displace the binding, enabling the differentiation 
between receptor subtypes (Nishigaki et al., 1993; Wise and Jones, 1994).
The development of synthetic prostanoid agonists and antagonists 
allowed the first classification of prostanoid receptors into types for each 
individual prostanoid (i.e. DP, EP, FP, IP and TP) by Kennedy and 
colleagues in 1982 (reviewed by Coleman et al., 1994). Some analogues 
also presented therapeutic advantages and were used for cervical ripening, 
being more specific for uterine tissues and having a longer half life (recently 
reviewed by Bygdeman, 1992). In the 1980s, intracellular second 
messenger studies provided further evidence for the existence of 
prostanoid receptors and revealed the existence of subtypes of EP 
receptors. Prostaglandins of the E series caused increase or decrease in 
cAMP and each of these responses was accompanied with distinct and 
some times opposing functions in platelets and other cells (reviewed by 
Coleman et al., 1990; Coleman et al., 1994). Furthermore, in the 1990s a 
third pathway, the inositol triphosphate (IP3), has been discovered in 
bovine adrenal cromaffin cells (reviewed by Negishi, 1993).
There have been difficulties in the solubilization and purification of 
prostanoid functional receptors, which has retarded the molecular 
characterisation of these receptors. The first attempts to solubilize 
prelabelled PGE2 and PGF2 0 C receptors in the mid 1970s were
unsuccessful, finding that the activity was lost and that the receptors were 
only stable in the presence of the ligand. From the mid 1980s, partial
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solubilization and purification of active PGE2 receptors was achieved from 
several tissues: porcine cerebral cortex, bovine adrenal medulla, canine 
renal medulla and murine macrophage (Yumoto et al., 1986; Neguishi et 
al., 1993; Fernandez-Botran and Suzuki, 1984). The estimated molecular 
weights of those receptors ranged from 95- 110 KDa, with the exception of 
one study, where the canine renal medulla PGE2 receptor was reported to 
be lighter (65 KDa). The solubilization aimed at the purification to further 
characterise these proteins and their sequences, but there were problems 
of low content in detergent extracts compared to other receptors, instability 
and loss of function during purification (Michalack et al., 1992; reviewed by 
Negishi et al., 1993). The human thromboxane A2 receptor (hTPR) is the 
only prostanoid receptor that has been purified so far. It was also the first 
eicosanoid receptor to be purified, this was done from human blood 
platelets, taking advantage of the development of highly potent antagonists 
and their high affinity radiolabelled derivatives (Ushikubi et al., 1989). A 
PGE2 functional receptor was later purified from cardiac sarcolemma 
(Michalack et al., 1992) but we are unaware of further characterisation of 
these receptors.
The first cDNA cloned for an eicosanoid receptor was also the 
human thromboxane A2 receptor, based on the partial amino acid 
sequence of the recently purified protein (Hirata et al., 1991). 
Hydrophobicity analysis of the deducted amino acid sequence and its 
comparison with other rhodopsin-type receptors, led to the conclusion that 
this receptor was a G-protein coupled receptor belonging to the rhodopsin- 
type family. The hypothesis that the TP receptor could belong to a new 
group of receptors contributed to the subsequent cloning of the 
prostaglandin E2 receptor subtype (EP3) in the mouse, based on homology 
screening of cDNA libraries (Sugimoto et al., 1991; Sugimoto et al., 1992). 
The knowledge of those sequences has allowed the cloning of cDNA for
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the rest of the prostanoid receptors group in those species (mouse: Hi rata 
et al., 1994; reviewed by Narumiya et al., 1995; Katsuyama et al., 1995 and 
humans: reviewed by Abramovitz, et al., 1995; Pierce et al., 1995a; Boie et 
al., 1995). Gradually many of these receptors cDNA are being cloned within 
several mammalian species (rat, rabbit, bovine and ovine) (see table 1 .1 ) 
(reviewed by Negishi et al., 1995; reviewed by Ushikubi et al., 1995). 
Cloning has shown that subtypes exist for the EP3 receptor in all the 
species studied and probably in the TP receptor too (reviewed by Negishi 
et al., 1995).
At the beginning of this studies, the only prostanoid receptor and 
gene to be fully characterised was the human TPR (Nursing et al., 1993). 
For other prostanoid receptors, the only sequence information available 
was deducted from cDNAs cloned in a limited number of mammalian 
species, mainly the human and the mouse. Therefore the number of 
reagents available (probes and antibodies) for the study of most prostanoid 
receptors was scant. Antibodies for the EP receptors were beginning to be 
developed at the time of the writing of this thesis based on the deducted 
amino acid sequences from the cDNA sequences (Fujimoto et al., 1995). 
The gene characterisation is still in progress for most prostanoid receptor 
types and subtypes (see next section 1.9.3: gene structure, page 87).
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1.9.3 Molecular biology of the EP receptors and other
prostanoid receptors 
Structure of the proteins and its corresponding mRNAs
The overall homology of the prostanoid receptors with other rhodopsin-type 
G-protein receptors is low, they share 10-20% homology with adrenergic 
and muscarinic receptors. However, several amino acids (of recognised 
importance for the structure and function of rhodopsin-type receptors) are 
conserved in the prostanoid receptors (reviewed by Ushikubi et al., 1995).
The overall homology between prostanoid receptors is not very high 
either (20-30%) and is scattered in the entire sequence, which suggests the 
prostanoid receptors did not evolve from a common gene (Coleman et al.,
1994). The gene localisation in several chromosomes, also supports this 
view (Taketo et al., 1994; Duncan et al., 1995). The homology, however, is 
higher between receptors of similar functions and three groups have been 
defined: 1) the contractile receptors (TP, FP and EPi) which mobilise 
calcium and share 47-48% identity at the transmembrane (TM) region, 2) 
the relaxant receptors (DP, IP, EP2 and EP4) positively coupled with cAMP 
and sharing 39-44% overall homology in the entire sequence and finally 3) 
the inhibitory EP3 receptor, which is less than 30% homologous with other 
groups. Supporting this argument, the homology between the EP subtypes, 
belonging to a different functional group, is lower than 32% (reviewed by 
Narumiya, 1995; Ushikubi et al., 1995).
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Plate 1.3
Diagram of seven transmembrane domain model of the bovine 
EP3 receptor, showing alternative splicing at the C terminal. 
(From Coleman et al., 1994)
EXTRA­
CELLULAR
PLASMA
MEMBRANE
COLEMAN ET AL.
INTRA­
CELLULAR
Splicing
Site
There are two highly conserved areas between all the prostanoid 
receptors: 1) mainly a sequence in the VII TM domain
(LAXAXRXAS/TXNQILDPWVYILR), 2) but also to a lesser extent, two 
sequences in the 2nd extracellular loop (GRYXXQXPGT/SWCF and 
MXFFGLXXLLXXXAMAXER). Therefore it is also possible that they could 
have evolved from a common ancestor gene (Coleman et al., 1994; 
Narumiya, 1995; Pierce et al., 1995a; Ushikubi et al., 1995). These areas 
are unique to the prostanoid receptors and conserved between different 
species, therefore they may participate in ligand binding. Furthermore, all 
the prostanoid receptors have an arginine in the VII TM domain (position 
295 in the TXA2 receptor) which has been demonstrated to have a role in 
ligand binding activity (reviewed by Ushikubi et al., 1995).
The identity between sequences of cDNAs encoding for receptor 
homologues from different species is high; ranging from 79-89% between 
the human and mouse receptors and from 84-97% between the EP3 
receptors in different mammalian species (human, bovine, rat and mouse). 
Despite this high homology, there are functional differences between 
species. Different sizes have also been observed between receptor 
homologues of different species, due to differences in the translation 
initiation site (reviewed by Ushikubi et al., 1995).
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Distribution of the prostanoid receptors and their mRNAs
The distribution of these proteins has been studied in biochemical and 
pharmacological studies, which have shown their ubiquitous expression in 
the body and some of their biological actions (Robertson et al., 1986; 
Coleman et al., 1990; Rao, 1990; Negishi et al., 1993). But these type of 
studies suffered from lack of specificity and sensitivity. The cloning of the 
receptors cDNA allows better characterisation of the distribution of these 
receptors using northern analysis, reverse transcription and polymerase 
chain reaction (RT-PCR) and in situ hybridisation (ISH). In addition, in the 
absence of aminoacid sequences from protein studies for most prostanoid 
receptors, antibodies may be developed from the deducted amino acid 
sequences from the cDNAs, to study the proteins distribution. These type of 
studies have been initiated in the eye (Fujimoto et al., 1995).
Molecular biology studies have shown in recent studies that each 
prostanoid type (Coleman et al., 1994; Abramovitz et al., 1995; Narumiya et 
al., 1995) and subtype (Negishi et al., 1995) has a characteristic pattern of 
mRNA expression in tissues and that expression levels are variable among 
tissues. This pattern is conserved between species to a certain extent only, 
some receptors present in a particular tissue of one species are absent in 
the same tissue of other species (reviewed by Ushikubi et al., 1995). 
Similarly, the localisation of receptors within the kidney may be variable 
between species. The mRNA tissue distribution in most cases is consistent 
with previous studies of the protein, but new localisations and functions 
have also been discovered with this approach (reviewed by Ushikubi et al.,
1995).
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Gene localisation of the prostanoid receptors and structure
The genes for some of these receptors are located in three chromosomes; 
in the mouse these are chromosome 3 (EP3 ), 10 (TP) and 15 (EP4 ) (Taketo 
et al., 1994) and in humans chromosomes 1 (FP and EP3 receptors), 5 (EP2 
R) and 19 (EP-i, TP and IP receptors) (Nursing et al., 1993; Duncan et al.,
1995). In the rat, the gene encoding for the EP3 receptor has been located 
in the chromosome 2 (Takeuchi et al., 1996).
At the beginning of these studies the gene structures of the 
prostanoid receptors were unknown. It is not surprising that the first gene to 
be cloned was also the human thromboxane A2 (Nursing et al., 1993), as 
with protein isolation and cDNA cloning. The human TXA2 receptor gene is 
present as a single copy, spans over 15 kilobases and contains 3 exons 
divided by 2 introns. The larger intron (6.3 kb) is located in the 5'- 
noncoding region and a shorter one (4.3 kb long) can be found at the end 
of the region encoding for the VI transmembrane domain (VI TM). Two 
promoters have been found that lead to alternative splicing of exon 1 , it is 
unclear whether isoforms are produced as a result or not. Some authors 
have reported the production of only one type of protein (Nursing et al., 
1993), whereas others have found two proteins (Kinsella et al., 1995). 
Others have found two TP isoforms with different cytoplasmic tails created 
by the presence or absence of a part of exon 3 (Raychowdhury et al., 1994).
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Figure 1,1
Gene structure of the mouse DP receptor 
From Hirata et al., (1994). The open reading frame consists of 
two exons (open boxes) separated by an intron. The 
localisation of an exon/intron splice site at the end of the VI TM 
is also present in the EPi and TP receptor genes and it may be 
conserved in all prostanoid receptor genes.
exon 1 exon 2
C -ta il
III VIIV V VII
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The next gene to be cloned was the mouse DP receptor (Hirata et 
al., 1994). The structure is similar to the human TP receptor but may be 
simpler, since no alternative splicing has been identified. The open reading 
frame in the mouse DP receptor, also consist of two exons separated by an 
intron at a homologous position (end of the VI TM) to the human TP 
receptor. Observations of the genes of other prostanoid receptors (EP3: 
Regan et al., 1994a; EP2 : Regan et al., 1994b) suggested that the intron at 
the VI TM region could be a common feature of this receptors' group. 
Recent cloning of the gene for human DP (Boie et al., 1995) and the mouse 
EP, receptor (B&tshake et al., 1995) confirm that the intron position and the 
basic structure of two exons are conserved.
In common with the other prostanoid receptors, several authors are 
confirming the initial observations of an intron at the VI TM region in the 
human (Regan et al., 1994a; An et al., 1994) and in rabbit EP3 receptors 
(Breyer et al., 1994; Tamg and Breyer, 1995). The EP3 receptor however, 
appears to have a more complicated and long gene structure than other 
prostanoid receptors, presenting multiple fashions of alternative splicing in 
the area encoding for the C-terminal end, which has been reported in all 
the species studied (Namba et al.,1993; Sugimoto et al., 1993; Takeuchi et 
al., 1993; Breyer et al., 1994). Several and different exons encode for the C- 
terminal in different species. In the rabbit, at least 17 exons encoding for the 
C-terminal of the EP3 isoforms may exist (Tamg and Breyer, 1995).
1.9.4 PGE0 receptors and other prostanoid receptors in uterine 
tissues: myometrium, endometrium and cervix uteri
PGE2 and other prostanoids participate in several functions of the uterine 
tissues of mammals: myometrial contractions, implantation of the embryo in 
the endometrium and cervical ripening. The uterus is contemplated here as 
having three compartments: the myometrium, endometrium, and the cervix;
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because they differ in their responses to prostanoids (reviewed by Rao, 
1990; Coleman et al., 1990). The prostanoid receptors have been more 
extensively studied in the myometrial than in the endometrial and cervical 
functions (reviewed by Rao, 1990). Binding sites for PGE2 have been found 
in the three uterine tissues (Rao, 1990).
Binding site studies of eicosanoid receptors in the myometrium 
started early in the 1970s (reviewed by Rao, 1990). These studies 
suggested that the affinity of prostaglandin receptors was greater for PGE2 
than for FGF2a> which was consistent with the higher potency of exogenous 
PGE2 than PGF201 at inducing uterine contractions (Giannopoulos et al., 
1985; Adelantado et al., 1988). Studies of cellular distribution of binding 
sites found EP receptors in the myometrial smooth muscle, stromal cells, 
glandular epithelium, arterioles and erythrocytes (Chegini et al., 1986; 
reviewed by Rao, 1990). Second messenger studies initiated in the 1980s, 
established that increases in intracellular calcium levels promote 
contraction, whereas cyclic nucleotides (cAMP and cGMP) promote 
relaxation of the myometrium. Pharmacological studies using agonists and 
antagonists have shown which prostanoid receptor type or subtype exist in 
different species and species differences (reviewed by Coleman et al., 
1990). These studies have been expanded recently in the sheep (Garcia 
Villar et al., 1993; Garcia Villar et al., 1995; Crankshaw and Gaspar, 1995). 
Some receptors (DP, EP2, EP4 and IP) mediate relaxation of the 
myometrium, whereas other receptors (EP-i, EP3, FP and TP) mediate the 
contractions. All of these studies provide strong support for the existence of 
certain prostanoid receptors in the myometrium. Abundant mRNA 
expression of all the prostanoid receptors has been detected by northern 
blots in the mouse and human uterus (Abramovitz et al., 1995; Narumiya et 
al., 1995) and by RT-PCR in the human myometrium (Senchina and 
Crankshaw, 1995). Several uterine cDNA libraries have been used to clone
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some of these receptors.
Prostaglandin receptors in the endometrium are independently 
regulated from those in the myometrium (reviewed by Rao, 1990). PGE2 
and EP receptors are involved in the uterine receptivity to the blastocyst 
implantation in several species (laboratory species, man and pig), which is 
time and hormone-dependent and the presence of the receptors is also 
regulated in this fashion (reviewed by Rao et al., 1990). It is interesting that 
in species like sheep and cattle, the endometrium produces PGE2 , before 
implantation, during maternal recognition and some authors think that this 
PG does not act on the endometrium, but on the rescue of the corpus 
luteum , which presents increased numbers of binding sites at that stage 
(Wiepz et al., 1994).
Studies of prostanoid receptors in the cervix are limited to only a few 
binding sites and second messenger studies. Binding studies for PGE2 and 
PGF2a the cervix are not very detailed because they are also aimed at
the study of the myometrial function. Results have been variable, EP 
receptors were either undetectable (Bauknecht et al., 1981) or of a lower 
density (Hoffman et al., 1983; Giannopoulos et al., 1985) and/or affinity 
(Adelantado et al., 1988) in the human cervix than in the myometrium. The 
low density found in the cervix and the high density found in the uterus 
were highly correlated with the smooth muscle content in those two tissues 
(Hoffman et al., 1983; Giannopoulos et al., 1985). The endometrium was 
scraped from the uterine proper samples, but it is unclear whether the 
endocervix was included in those studies or not. The binding sites detected 
in the cervix may or may not represent functional receptors, it is not known 
whether the receptors can be up or down regulated by the ligand and 
regulation by steroids was not obvious either. The existence of subtypes 
has not been investigated with the use of agonists and antagonists either 
(Coleman et al., 1994). The cervix responded to PGE2 with an increase in
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the levels of intracellular cAMP (Norstrom et al., 1983; Norstrom and 
Bryman, 1991). The second messenger cAMP, like in the myometrium, 
appears to be involved in the inhibition of spontaneous contractions by the 
cervix (Norstrom and Bryman, 1991).
But many authors believe that PGE2 causes cervical ripening by 
promoting the degradation of the connective tissue rather than acting on 
cervical contractility (see chapter I). In this sense, although PGE2 and cAMP 
influence collagen metabolism (determined by hydroxyproline 
incorporation) (Norstrom et al., 1983), other more recent studies have 
shown that cAMP inhibited the expression of the proMMP-1 and MMP-3 by 
cervical fibroblasts (Takahashi et al., 1991). Therefore the role of this 
pathway (which may involve the EP2 or the EP4 receptors) in the 
remodelling by metalloproteinases during cervical ripening is unknown. An 
increase of cAMP was considered the typical response of EP2 or EP4 
receptors for some time, but recent studies have shown that the EP3 R may 
mediate increases of cAMP in some tissues too (Irie et al., 1993). Other 
pathways that may involve increases in calcium and the other receptors 
subtypes (EPi and EP3 ) have not been investigated in the cervix uteri. But, 
the administration of PGF2a» IL-1  and protein kinase C (PKC) to cervical
tissue cultures induced an increase in collagenase activity, furthermore 
PKC appears to mediate the effect of PGF2a and IL-1  (Rajabi et al., 1992;
Takahashi et al., 1993). Rajabi and colleagues (1992) have suggested, but 
not demonstrated, a pathway involving FP receptors (through Ins P3, PCK 
and an increase in calcium) in the induction of proMMP-1 synthesis by 
fibroblasts. They also speculate about PGE2 increasing collagenase activity 
by being converted into PGF2ot-
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CHAPTER 2
MATERIALS AND METHODS
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2.1 MICROSCOPIC STUDIES
2.1.1 Light microscopy (LfA)
i) Fixation
Cubes of 1 cm wide were dissected and fixed for 1 week in 4% buffered 
neutral formalin pH: 7.2 (BNF).
BNF
100 ml/l formalin (40% w/v)
4 gr/l sodium dihydrogen ortophosphate
6.5 gr/l disodium hydrogen ortophosphate
It is made up in tab water.
ii) Processing cycle
The following procedure is for processing tissue for embedding in paraffin 
wax. Fixed tissues were placed in cassettes which were loaded in a basket
of the Shandon Elliot automatic tissue processor (Histokinette) and
processed through the following solutions:
1) 70% alcohol for 1 hour and 30 minutes
2) methylated spirits for 1 hour and 30 minutes
3) methylated spirits for 2 hours
4) methylated spirits for 3 hours
5) absolute alcohol for 3 hours
6 ) absolute alcohol for 2  hours
7) absolute alcohol for 1 hour
8 ) alcohol - chloroform (50:50) for 1 hour
9) chloroform - histoclear (50:50) for 2 hours
10) histoclear for 1 hour and 30 minutes
11) paraffin wax for 3 hours
12) paraffin wax for 2 hours and 30 minutes
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The cycle takes 24 hours in total.
iii) Embedding in wax and sections
The processed tissues were blocked out in 60°C paraffin wax, sections 
were cut at 3-5 pm with a Leitz rotary microtome and mounted on glass 
slides.
iv) Staining Procedures
Mounted sections were stained with 3 standard methods: Haematoxylin 
and Eosin (H&E), Periodic acid schiff (PAS) and Alcian blue/ PAS 
(AB/PAS). Two specific methods for the connective tissue were also used: 
Masson's trichrome and Martius scarlet blue (MSB).
2.1.2 Transmission electron microscopy (TEM)
i) Fixation
Tissue was minced in Karnovsky’s fixative (into less than 1 mm3  ) in a Petry 
dish with a razor blade. Then transferred into fresh fixative and left for a 
minimum of 3 hours or overnight at room temperature. The fixative was then 
drained and replaced with 0.1 M Cacodylate buffer for a minimum of 1 hour 
or overnight. Tissue was post-fixed in a fume cupboard in 1 % osmium 
tetroxide. Finally tissue was washed in distilled water.
Modified Karnovsky’s fixative 
2  % paraformaldehyde
2.5 % glutaraldehyde
Made up in 0.1 M sodium cacodylate buffer.
1 0  gr of paraformaldehyde were dissolved in 1 0 0  ml of distilled water, add 
10 drops of 1 N NaOH, cover and heat it in a 60°C oven to dissolve. When 
cool this mixture was added to the stock solution.
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stock solution
0.2 M cacodylate buffer 250 ml
2.5% glutaraldehyde 50 ml
distilled water 1 0 0  ml
2.5 %  glutaraldehyde (for 1 litre of fixative)
21.4 gr of sodium cacodylate 
40 ml of 0.2 M HCI 
100 ml of 25 % glutaraldehyde 
660 ml of water
0.2 M sodium cacodylate buffer (500 ml)
250 ml of 0.4 M sodium cacodylate (21.4 gr/250 ml)
40 ml of 0.2 M hydrochloric acid (HCI)
2 1 0  ml distilled water
ii) Resin processing
All stages of the processing were performed in a fume cupboard.
NB: Resin kit (Emix kit medium, Fisons Scientific Equipment, 
Loughborough) was used which is made up by the following components: 
25 ml of emix resin: low viscosity modified bisphenol A epichlorohydrin 
epoxide; 25 ml of hardener: mixture of several anhydrides coupled with a 
plasticizer, dodecenyl succinic anhydride (DDSA) and 1 ml of accelerator: 
the tertiary amine benzylmiethylamine. These component are mixed with a 
mechanical stirrer for about 1 hour before used, and can be stored in the 
freezer at -20°C.
Dehydration in a graded series of acetone in water
The distilled water was then drained and replaced with 70 % acetone for 10 
minutes or overnight, 90 % for 10 minutes and 100 % two times for 15 
minutes.
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Clearing
The 100 % acetone was then drained and replaced twice with the link 
agent propylene oxide for 2 0  minutes.
Infiltration with resin
Emix resin was added to the last propylene oxide (50:50) and mixed in a 
Taab rotor (20 rpm) for 1 hour. This mixture, was drained and replaced by 
emix resin that was left rotating for 3 hours.
iii) Embedding
Processed samples were then embedded in beam capsules filled with resin 
mix and were left to polymerize in a 60°C oven for 2  days.
iv) Thick sections
Thick sections of 1 pm were cut from each block using an LKB Pyramitone
and after flattening with xylene vapour, stained with Toluidine blue.
Toluidine blue stain
1 % borax (sodium tetraborate) 1 gr
1 % toluidine blue 1 gr
distilled water 1 0 0  ml
staining time was 15 secs.
After examination in a light microscope (Leitz Laborlux II), suitable areas 
were selected to trim the EM blocks.
v) Ultrathin sections
Ultrathin sections in the silver or pale gold range (60-90 nm thick) were cut 
in a LKB MK III ultramicrotome, flattened using xylen vapour and picked up 
on gold mesh grids (Polaron 300). Sections were stained with uranyl 
acetate and lead citrate and examined in a Hitachi HS8  electron 
microscope. Electron micrographs were taken using Ilford Technical EM 
plates, developed in PQ Universal and fixed in Ilford llfodspeed fixer.
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Uranyl acetate
A saturated solution was prepared by dissolving 0.2 gr. of uranyl acetate in 
1 0  ml of distilled water.
Staining time was 5 min.
Lead citrate
1.33 g. of lead citrate and 1.76 of sodium citrate were dissolved in 30 ml of 
distilled water, shaking for 30 minutes. 8  ml of 0.1 M NaOH and distilled 
water were added up to a final volume of 50 ml.
Staining time was 5 min.
2.1.3 Scanning electron microscopy (SEMI
i) Fixation
Before fixing the tissue was washed in buffer to remove surface blood and 
mucous. Samples of tissue were immersed in chilled Karnovsky’s fixative 
for a minimum of 24 hours. Tissue was then trimmed to expose surface to 
be scanned and washed in 0.2 M cacodylate buffer for 4 hours.
ii) Dehydration in a graded series of acetone in water 
70 % for 4 hours or overnight
90 % for 2 hours 
1 0 0  % for 2  hours 
1 0 0  % overnight
iii) Critical point dry
Using CO2 in a critical point drier (Biorad machine)
iv) Mounting
Specimens were mounted in aluminium stubs using silver paint and left to 
dry in a 60°C oven.
V) Sputter coating with gold/palladium
Using an EM Scope SC 500 sputter coater for 4 minutes.
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vi) Scanning and prints
Specimens were examined in a Philips 501 B scanning electron 
microscope operating at 15 Kv. An automatic Rolliflex camera and Ilford 
FP4 120 (125 ASA) film were used.
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2.2 MOLECULAR BIOLOGY STUDIES
2.2.1 Animals and tissue collection
Mouse specimens were obtained from male and female adult animals bred 
in the animal house of the Glasgow Veterinary School, they were sacrificed 
by cervical dislocation.
Sheep specimens were obtained from various sources:
Cervix of periparturient (n=10, 143 and 144 day’s gestation) and of luteal 
phase sheep (n=10, days 9, 10, 12 and 13 post oestrus) were kindly 
supplied by Dr. Elizabeth Scott at The Moredun Research Institute and by 
Dr. Ian Wilmut at Roslin respectively. In both cases the oestrous cycle of the 
ewes was synchronised with progestagen sponges and the reproductive 
stage closely monitored for their own experiments.
Early luteal phase cervix (day 6  after oestrus) and oestrus cervix 
(two days after sponge removal) were collected at the Anatomy Department 
from sheep (n=4) whose cycle had been previously synchronised with 
progestagen sponges containing 60 mg of medroxyprogesterone acetate 
(Veramix, Upjohn). The reproductive status was confirmed by 
ultrasonography of the reproductive tract in these animals (see chapter V 
for more details). Blood samples were collected from all the mentioned 
ewes, plasma was separated and stored frozen to confirm the reproductive 
status with steroid levels (progesterone and oestradiol), if needed.
The other ovine specimens (kidney, uterus, spleen, liver, testes and 
adrenal gland) were collected from either the animals mentioned earlier, 
the post-mortem room in the Veterinary School or from the local abattoir. 
From all tissues, samples of less than 1 gram each, of approximately 1 cm3  
in size, were rapidly dissected, frozen in liquid nitrogen and stored at -70°C 
until the extraction of total RNA was carried out.
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2.2.2 RNA extractions
Total RNA was prepared from individual tissues using the acid- 
guanidinium-phenol-chloroform method (AGPC) described by 
Chomczynski and Sacchi (1987) or its recent modification (Chomczynski, 
1993). Briefly, frozen tissues were placed in sterile tubes with 1 ml of a 
commercial isolation reagent, RNAzol B (Cinna/Biotecx), in most cases or 
TRIzol (Gibco) with a few samples. Tissues were defrosted in the buffer and 
then homogenised using an ultraturrax. The isolation reagents, have potent 
deproteinizing agents like guanidium-thiocyanate, phenol (RNAzol B and 
TRIzol) and mercaptoethanol (RNAzol B), which inactivate RNAses that are 
liberated from the mechanical shearing of the tissue during homogenisation 
and could otherwise degrade RNA. They also contain solubilizing agents 
for RNA, which allow separation from DNA, proteins, etc. After the 
homogenisation, RNA was pelleted and purified according to 
manufacturers’ instructions with slight modifications. To extract the RNA, the 
homogenate was transferred into a sterile eppindorff tube and 1 / 1 0  of its 
volume in chloroform was added and mixed with a vortex for 15 seconds 
and left to set for another 5 minutes on ice (RNazol method) or room 
temperature (Trizol method). This mixture was then centrifuged at 12000g 
for 5 minutes, which resulted in separation of three phases; a colourless 
aqueous phase containing the RNA on top, a DNA and proteins interface 
and the lower phenol-chloroform phase (blue for RNazol or red for Trizol). 
From this point all the efforts were put in maintaining RNase-free conditions 
(use of gloves, use of sterile plastic ware, use of filter tips) when handling 
the RNA. The aqueous phase was transferred to a fresh tube and RNA was 
then pelleted by precipitation with alcohols as follows. The first precipitation 
was carried out by adding an equal volume of isopropanol, storing the 
samples for 1 hour at 4°C (RNazol) or for 10 minutes at room temperature
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(Trizol) and centrifuging at 12000 g for 15 minutes. A white-yellow pellet 
forms at the bottom of the tube that is washed in ethanol; by removing the 
supernatant, adding 75% ethanol, vortexing and centrifuging gently (at 
7500 g for 8  minutes). In the case of the RNAzol method a second 
precipitation in the presence of NaAc (3M, pH=7) and absolute ethanol was 
added to the original protocol. The 75% ethanol is removed and RNA is 
then solubilized in 100 pi of PCR water and mixed with 1/10 volume of 
sodium acetate and 2 volumes of absolute ethanol at -20°C. The mixture is 
stored for 1 to 24 hours at -20°C and then centrifuged at 12000 g for 1 0  
minutes. In both cases, at the end of the procedure, ethanol is removed with 
a filtered tip and a rolled tissue and the RNA pellet is then dissolved in 20 pi 
of PCR water by vortexing, passing through a pipette tip and if necessary by 
incubating at 60°C for 1 0  minutes before storing at -70°C.
The integrity of the RNA was ascertained by running 1.5 pi of the 
resuspended RNA in a non denaturing 1 % agarose gel. Ribosomal RNA 
(rRNA) constitutes most of the total RNA and should be clearly visible with 
the correct mobility. The observation of two bright ribosomal bands (28 S 
and 18 S), corresponding to approximately 5.1 kb and 1.9 kb in eukaryotes, 
is therefore indicative of nondegraded RNA. On the contrary, when RNA is 
degraded it has smaller molecular weight and higher mobility and the rRNA 
is not clearly visible. Smaller molecular weight RNA (0,1-0,5 kb) is 
observed as a smear or as a bright band at the bottom of the gel 
(Chomczynski, 1993, Darling and Brickell, 1994).
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2.2.3 Deoxyribonuclease I (DNase \) incubations
Before the RT-PCRs for the study of mRNA expression, RNA samples were 
treated with RNase-free DNAse I (from bovine pancreas) (Stratagene) to 
remove contaminating genomic DNA (Grillo and Margolis). RNA 
(approximately 5 pg) was incubated at 37°C for 30 minutes under the 
following conditions: 40 mM RNase free Tris-HCI pH 7.6 (Sigma), 6  mM Mg 
Cl2  (Advanced Biotechnologies, filtered through pore size 0 . 2  pm), 1 . 6  
units/pl of RNase inhibitor, (RNasin, Promega) and 1 unit of DNase I 
(Stratagene) in a final volume of 25 pi. The reaction was then heated at 
95°C for 5 minutes to inactivate the DNase I, immediately cooled on ice and 
used in the cDNA synthesis.
The following controls were done to establish the above conditions:
i) Residual RNase activity in the enzyme DNase I (Stratagene) or the rest of 
the individual reaction components.
The integrity of the DNase-treated RNA was evaluated by electrophoresis in 
1 % agarose gels.
ii) DNase I activity
Evaluated by electrophoresis in 1% agarose gels of the digestion of 
molecular weight markers 100 bp ladder (Gibco).
iii) Minus RT controls to monitor for the removal of DNA from RNA samples
2.2.4 RT-PCR
An RT-PCR method was used to isolate a cDNA fragment of the EP3 
receptor. The product was identified by sequencing and Southern blot. The 
mRNA expression of the EP3 receptor was studied by northern blot analysis 
and RT-PCR. A house keeping gene was used as a positive control of the 
integrity of the RNA and also to control for the variability in the RT 
performance. Work was also done in an attempt to develop a
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semiquantitative RT-PCR assay, comparing the levels of EP3R mRNA 
expression relative to 13-actin between different samples.
i) cDNA synthesis by Reverse Transcription (RT)
mRNA was reverse transcribed into single stranded cDNA from total RNA 
with Moloney Murine Leukemia Virus (RNase H') Reverse Transcriptase 
(Superscript, Gibco) in the presence of random hexamers as published by 
others with slight modifications (O'Shaughnessy and Murphy, 1993).
Briefly, RNA template (300 pg/ pi, approximately 0.06-2 pg) was 
added to a reaction mixture consisting of: 50 mM KCI, 10 mM Tris-HCI pH
8.3 (at 25°C), 3 mM MgCI2 (Advanced Biotechnologies Ltd.), 1 mM 
dithiothreitol (DTT), 5 pM random hexamers, 500 pM of each dNTP, 6  units/ 
10 pi RNAse block (rRNasin, Promega) and 3 units/pl M-MLTV reverse 
transcriptase (Superscript RNase H-, Gibco). The buffer (KCI, Tris-HCI and 
MgCI2), water and DTT were previously treated with UV light for 5 minutes. 
The reaction was incubated at room temperature for 5 minutes then at 37°C 
for 1 hour. The cDNA synthesised was stored at -20°C until used as 
template for the PCR reaction.
ii) Cross species PCR for the isolation of a cDNA fragment 
encoding for the EP3 receptor and mRNA expression studies
The isolation and sequencing of an ovine prostaglandin E2 receptor 
subtype (EP3 R) cDNA fragment was done by cross-species RT-PCR, using 
two bovine oligonucleotide primers. Primers were designed from a 
published mRNA bovine sequence of the EP3 receptor (Namba et al., 1993) 
at regions highly conserved between the species published at the time 
(human: Adam et al., 1994; rat: Takeuchi et al., 1993; mouse: Sugimoto et 
al., 1993, and rabbit: Breyer et al., 1994). Minimal degeneration in the code
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was also aimed, specially at the 3’end, to minimise mismatches between 
the bovine primers and the ovine template. Relatively long primers (25 
bases long) were chosen, because this has been reported to be more 
effective when amplifying homologous genes from a different species 
(Dieffenbach et al., 1993). The selected primers were checked for absence 
of homology with other sequences of mammalian species stored in the 
EMBL Gene Bank, especially at the 3’ prime end, using the program GCG.
Apart from those special considerations for cross species PCR, the 
rest of the general criteria in the design of PCR primers (optimal A/T: G/C 
ratio, composition of less than 60% purines, lack of complementarity 
between primer pairs, similar melting temperatures of both primers) were 
also followed; except for the requirement of primers to span one intron, 
since the structure of the gene (intron and exon boundaries) was not 
published for this gene in any species at this time. Primers were also 
chosen to amplify a region larger than 300 bp, since exons greater than that 
size are rare in vertebrates (Gause and Adamovicz, 1994). Bovine EP3 
receptor primers amplified cDNA encoding a fragment of the bovine protein 
between the 2nd intracellular loop to the VI TM region and the size of the 
expected product was 355 bp (from nucleotide 481 to 835 inclusive) (figure 
2.1). The sequences and the nucleotide positions of the sense (P4, Oligo 
Express Ltd) and antisense primer (P5, British Biotechnology Products) are 
indicated in table 2 .1  (second set of primers).
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Figure 2.1
Position of the PCR primers in the cDNA bovine sequence. 
Sense primer (4) is located in the region encoding for the 2 nd 
intracellular loop, between the III and the IV transmembrane 
(TM) domains. The antisense primer (5) is located in the VI TM 
domain. The size of the expected product is 355 bp.
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Initially, low stringency conditions were used in the PCR for the 
isolation and sequencing of a cDNA fragment. The PCR reaction mixture 
consisted of: 20 mM (NH4 ) 2 S 0 4 75 mM Tris-HCI pH 9.0 (at 25°C) 0 .0 1 % 
(w/v) Tween, 3 mM MgCI2 (Advanced Biotechnologies Ltd.), 400 nM of each 
primer, 200 pM of each dNTPs, 8.3 units/ml Taq DNA polymerase 
(Advanced Biotechnologies Ltd.) and 2 pi of cDNA template in a final 
volume of 30 pi. The buffer, MgCI2 and H20 were previously treated with UV 
light for 5 minutes. Mineral oil (30 pi) was overlaid and the reaction began 
with an incubation at 95°C for 3 minutes, followed by 32 cycles of: 
denaturation of double strand (94°C for 20 seconds), primer annealing (50- 
55°C for 30 seconds) and transcript extension (72°C for 1 minute). The 
amplified product was size selected by electrophoresis in a 1 % agarose 
gel, containing ethidium bromide for visualisation with a UV light source 
and using molecular weight markers ( 1 0 0  bp, Gibco) and further identified 
by sequencing.
The following parameters were changed in the previous protocol in 
order to optimise the PCR reaction for mRNA expression studies: 1) taq (IQ- 
25 units/ml), 2) dNTP (20-200 pM), Mg (0.5-2.5), annealing temperature 
(55-72°C), denaturation temperature and time (95-97°C for 60-15 seconds), 
cycle number (28-32) and primer concentration (0.1-0.5 pM). "Hot start" was 
also tested. The optimised PCR reaction mixture consisted of: 20 mM 
(NH4 )2 S 0 4 75 mM Tris-HCI pH 9.0 (at 25°C) 0.01% (w/v) Tween, 3 mM 
MgCI2 (Advanced Biotechnologies Ltd.), 200 nM of each primer, 200 pM of 
each dNTPs, 8.3 units/ml Taq DNA polymerase (Advanced Biotechnologies 
Ltd.) and 2 pi of cDNA template and 30 pi of mineral oil in a final volume of 
30 pi. The buffer, MgCI2 and H20 were previously treated with UV light for 5 
minutes. Mineral oil (30 pi) was overlaid and the reaction began with an 
incubation at 96°C for 1 minute and 30 seconds, followed by 32 cycles of:
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denaturation of double strand (94°C for 20 seconds), primer annealing 
(60°C for 30 seconds) and transcript extension (72°C for 1 minute).
Three sets of primers (Table 2.2) were assessed for suitability as 
housekeeping genes to monitor RNA integrity and the RT reaction, within 
the ovine species. The rat p-actin set was available in the laboratory from 
previous studies in the mouse species. The sequences of the human 
GAPDH set, were obtained from the literature (Baier et al., 1993). The ovine 
p-actin set (Oligo Express Ltd.) was chosen as the most appropriate 
housekeeping gene for mRNA studies. The ovine primers were designed 
from partial codings of an mRNA sequence found in the NCBI Gene Bank 
(accession number U08283) published by Bacich et al., (1994). When 
compared to the complete codings of the rat sequence, this fragment 
corresponded to the region encoding for aminoacids 300 to 354 (Nudel, 
1983). General criteria in the design of primers were followed (described 
earlier in section 2.2.4ii), including the existence of an intron (124 bp) 
between the primers at least in the rat. The expected size for the RT-PCR 
products was 162 bp and approximately 286 bp in the event of genomic 
DNA contamination.
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iii) Semiquantitative RT-PCR of EP3 mRNA
Total RNA was extracted as described before (in section 2.2.2) from tissues 
in which the EP3R was known to have a function (kidney, liver and uterus) 
and from the cervix at different stages (oestrus, early luteal and prepartum). 
The RNA to be used ( 6  pi) was pre-treated with RNase-free DNase I as 
described before in section 2.2.3.
First-strand cDNA was synthesised from this pre-treated RNA as 
described before (section 2.2.4i). A semiquantitative PCR method was used 
to quantify mRNA expression encoding for the ovine EP3R. The method, 
originally developed for the quantification of steroidogenic sequences by 
others (O'Shaughnessy and Murphy, 1993), was based on previous studies 
(Murphy et al., 1990).
The semiquantitative RT-PCR method is designed to measure the 
ratio of gene expression between EP3R and the housekeeping gene B- 
actin, the later is used as an internal standard. B-actin is a valid RNA 
standard, because it is constitutively expressed in most cells and its levels 
of expression do not vary significantly with physiological changes (Gause 
and Adamovicz, 1994). The measurements are carried out in the 
exponential phase of the PCR, when the efficiency of the PCR is maximal 
(usually between 15-30 cycles, depending on the amount of starting 
material) and therefore the initial amount of target sequence is doubled on 
each amplification round. Doubling would occur in a PCR working with a 
100% efficiency, but in practice only a 70-80% efficiency can be expected 
(Murphy et al., 1990; Ferre et al., 1992; Gause and Adamovic, 1994).
The exponential phase was determined for the EP3R and B-actin 
cDNA amplifications. This was between 16 to 21 cycles for ovine B-actin 
and between 20-28 for the EP3R. Eight PCR reactions were prepared for 
each sample, four identical PCR reactions for the EP3R and another four for
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the house keeping gene, during different cycle numbers over the 
exponential phase. To measure product formation [3 2 P] a-dATP (1.5 pCi, 
specific activity of 3000Ci/nmol, ICN Flow) was added to each PCR reaction 
tube, prepared as described before (in section 2.2.4ii). PCR products were 
resolved in a 1% agarose gels, dried and autoradiographed. Bands were 
cut in a UV transiluminator using the ethidium bromide staining and the 
autoradiographs. Other areas, of the size of the bands, were also cut from 
the gel for determination of background levels. Radioactive incorporation 
was counted by liquid scintillation.
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2.2.5 Isolation and characterisation of cDNA encoding the ovine 
E P 3 receptor isoforms using 3' end RACE (RAPID 
AMPLIFICATION OF cDNA ENDS).
RACE is another of the multiple applications of the PCR. It can be used for 
the isolation of novel sequences instead of the more tedious preparation 
and screening of libraries. The main strategy of this method is shown in a 
simplified diagram of the original diagram from Frohman et al., 1988 (Fig. 
2.2.). Conventional PCR amplifies cDNA between two stretches of known 
sequences (primers), separated typically by 300-400 bp. But RACE, aims at 
a harder task; the amplification of cDNA knowing only a single stretch of the 
sequence to obtain the whole sequence, directing the extension of the 
primer to either the 5' end or the 3'end (RACE). In this study, because the 
EP3 R mRNA experiences alternative splicing at the C terminal, the use of 
3’end RACE was particularly relevant to study the different isoforms 
produced. Other names for the technique includes "one sided PCR" or 
"anchored PCR", because the PCR is performed between a single gene 
specific primer and a adapter primer, the latter have to be anchored to the 
first strand during the RT. The adapter primer consists of a known sequence 
and can be used universally to isolate any novel sequence.
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Figure 2. 2.
3' End rapid amplification of cDNA ends (RACE) diagram. 
Synthesis of 1st strand cDNA is performed with the (T)i7 
adapter primer and reverse transcriptase. During the RT the 
(T)i7 anneals to the polyA tail and the adapter sequence gets 
incorporated into the new cDNA. A PCR is then carried out 
using a gene specific primer and the adaptor primer.
mRNA AAAAAAAA
RT
(T)i7-ADAPTOR
cD N A (T) 17-ADAPTOR
GENE SPECIFIC  
PRIMER
PCR
ADAPTOR
PRIMER
PCR
product
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In short (see Fig 2.2), mRNA was reverse transcribed into single 
strand cDNA from total RNA with Moloney Murine Leukaemia Virus RNase 
H- Reverse Transcriptase (Superscript, Gibco) and the reaction was 
primed by an hybrid primer (oligo-dT 17 -adapter), that consists of an oligo- 
dT of 17 residues linked to a unique sequence of another oligonucleotide. 
The strategy depends on the priming of the RT reaction by annealing of the 
oligo-dT part to the poly-(A) tail that most mRNAs have and also the 
incorporation of a known sequence (adapter part of the RT primer) at the 
5’end of each cDNA created. The PCR is carried out with a sense primer 
which is gene specific for the target sequence and the adapter primer which 
is non-specific and is the antisense primer (Frohman, 1988 & 1990). In the 
first round of amplification the extension of the gene specific primer, 
working on the first strand of cDNA should create templates for the adapter 
primer. From this point the PCR between the gene specific and the adapter 
primer should work like any ordinary PCR (Figure 2.2). Three sets of three 
primers each were used in these experiments (Table 2. 1 and Figure 2.3).
In the first set of primers, the sense primer or gene specific primer 
(P3) was designed from the bovine sequence of the EP3 receptor (Namba 
et al., 1993) following similar criteria as explained in section 2.2.4ii. But at 
this early stage only bovine, mouse and rat sequences were available. The 
selected primer was checked for absence of homology with other 
sequences of prostanoid receptors published, but other mammalian 
species stored in the EMBL Gene Bank were not available to us at that time. 
The adapter primer (P2) is used in this method as an antisense primer 
(Frohman, 1988). The RT (1 ) and sense primer (P3) were obtained from 
Oligo Express Ltd. Positions and minimal sizes of expected PCR products 
are shown in Table 2.1 (page 107). Expected sizes are only orientative and 
were calculated from the longer and shorter bovine isoforms, and variable
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length of the alternative transcripts of the EP3R can be expected in different 
species. In addition, the size of the expected products is variable because 
the dT region before the adapter can have variable lengths, depending on 
where the RT primer is incorporated at the poly- (A) tail of the mRNA 
(Taniguchi et al., 1993).
The sense primer (P4) previously used in ordinary RT-PCR with an 
internal antisense primer (set 2, described earlier in section 2.2.4) was 
used with two sets of RACE primers (either P1 and P2 or P6  and P7). The 
adapter (external antisense, P6 ) primer and the RT primer (P7) sequences 
were those of Frohman’s original protocol (Frohman et al., 1988), they were 
obtained from British Biotechnology Products. Positions and minimal sizes 
of expected PCR products are indicated in table 2.1 (page 107).
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120
Figure 2.3
Position of the primers used in RACE experiments, relative to 
the bovine cDNA sequence. Two sets of RACE primers were 
used, either 1 and 2 or those of Frohman's original protocol ( 6  
and 7). RT primers are 1 and 7. Adaptor primers are 2 and 6  
and gene specific primers are 3 and 4.
Because of the alternative splicing, products of different sizes 
were expected.
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i) cDNA synthesis by Reverse Transcription (RT) in the RACE 
method
Briefly, RNA template (1,5 pg/ pi, approximately 0.03-1 pg) was added to a 
reaction mixture (20 pi) consisting of: 50 mM KCI, 10 mM Tris-HCI pH 8.3 (at 
25°C), 4 mM MgCI2 (Advanced Biotechnologies Ltd.), 1 mM dithiothreitol, 
0.025 pg/pl of primer (oligo-dT + adapter), 100 mM of each dNTP, 0.6 
units/pl RNAse block (rRNasin, Promega) and 3 units/pl M-MLTV reverse 
transcriptase (Superscript RNase H", Gibco). The buffer (KCI, Tris-HCI and 
M gC y, H20 and dithiothreitol were previously treated with UV light for 5 
minutes. The reaction was incubated at room temperature for 5 minutes 
then at 37°C for 1 hour. The cDNA synthesised was stored at -20°C until 
used as template for the PCR reaction.
ii) RACE PCR: between gene specific and adapter primers
The PCR reaction mixture consisted of: 20 mM (NH4 )2 S 0 4i 75 mM Tris-HCI 
pH 9.0 (at 25°C) 0.01% (w/v) Tween, 2.5 mM MgCI2 (Advanced 
Biotechnologies Ltd.), 400 nM of each PCR primer, 200 pM of each dNTPs,
8.3 units/ml Taq DNA polymerase (Advanced Biotechnologies Ltd.) and 3 pi 
of cDNA template and in a final volume of 30 pi. The buffer, MgCI2 and H20 
were previously treated with UV light for 5 minutes. Mineral oil (30 pi) was 
overlaid and the reaction was begun with an incubation at 95°C for 3  
minutes, followed by 32 cycles of: denaturation of double strand (94°C for 
20 seconds), primer annealing (50-60°C for 30 seconds) and transcript 
extension (72°C for 1 minute and 30 seconds or 2 minutes).
The amplified product was electrophoresed in a 1% agarose gel, 
containing ethidium bromide for visualisation with a UV light source and
1 2 2
using molecular weigh markers (plasmid pUC or 100 bp ladder). Further 
identification of the products obtained with the 1 st set of primers was done 
by sequencing and of those obtained with the 2nd set by Southern blot 
analysis, using an internal fragment amplified by PCR (second set of 
primers in Table 2.1) as the probe.
iii) Control experiments with mice
The feasibility and the conditions of RACE were studied in a known system 
(O’Shaughnessy and Murphy, 1993; O’Shaughnessy et al., 1994) before 
starting the experiments with the ovine EP3 receptor. The mRNA expression 
of gonadal proteins of different abundance (P450scc» ABP, P45017a) and a 
housekeeping gene (p-actin) in the mouse gonad were studied, using 
primers that work for ordinary RT-PCR. The 1st set of RACE primers were 
tested in the mouse testis and in the mouse ovary. The RT of RACE was 
compared with other methods of Reverse Transcription (random hexamers 
and oligo-dT) and the 3’ end RACE PCR was compared with ordinary PCR 
(using the 2 specific primers for the above mentioned genes). Two most 
likely limiting factors of RACE were investigated: maximal size of the 
product and minimal abundance of the target sequence.
2.2.6 Northern blot analysis
Northern blot analysis was carried out following the method of Sambroock 
et al., (1989).
i) Gel electrophoresis of RNA
A stock solution of sterile (by autoclaving) 10x MEA buffer (pH 7.0, adjusted 
with NaOH) was prepared consisting on 0.4 M MOPS, 0.01 M EDTA and 
0.17 M sodium acetate. Samples of total RNA (5-30 pg per lane) from each
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tissue were denatured in 3 vols. of sample buffer (10 ml of 10x MEA, 35 ml 
of 37% formaldehyde and 100 ml of formamide) and incubated for 15 
minutes at 65°C. A denaturing 1 % agarose gel was prepared in 1 x MEA 
buffer and made 6.4 % with respect to formaldehyde. Prior to loading 
samples, 0.2 volumes of 6 x loading buffer (50% glycerol, 1 mM EDTA, 
0.25% bromophenol blue and 0.25% xylene cyanol FF) and 2 pi of ethidium 
bromide (1 mg/ml in DEPC treated water) were added. The denaturing gel 
was placed in the electrophoresis tank with 1x MEA buffer and pre-run at 5 
volt./cm for 5 minutes. The RNA samples were then loaded and 
electrophoresed at 1.5-2 volts/cm for 24 hours (until the bromophenol blue 
had migrated 8  cms from the wells) in 1x MEA buffer.
ii) RNA transfer
The gels were photographed with a ruler under UV light for size 
determination using the ribosomal bands (18S and 28S). Gels were then 
blotted to Biotrans (+)™  nylon membranes of pore size 0.45 pm (ICN) in 
20x SSC by capillary elution. The RNA was fixed to the membranes by 
cross-linking with UV light, using the “UV Stratalinker 2400” at the setting 
for optimal cross linking. Membranes were stored wet (2x SSC) and 
wrapped in Whatman paper in the fridge until hybridisation.
iii) Radiolabelled probe making
3 2 P-labelling of cDNA probes was carried out using a random primer 
labelling kit (Prime-it ™  II, Stratagene). A 355 bp cDNA obtained by PCR 
(see section 2.2.4 RT-PCR) was labelled with 50 pCi [a 3 2 P]-dATP (ICN) in 
a 50 pi reaction, according to manufacturers’ instructions. Template was 
prepared as for sequencing (see later section 2.2.7) and the amount of 
DNA estimated by electrophoresis in a 1% agarose gel stained with
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ethidium bromide (10 ng of DNA give a clear band). Briefly, 25 ng (1-23 pi) 
of template were mixed with 10 pi of random 9-mer primer (27 OD units/ml) 
to a final 32 ml reaction and boiled at 96°C for 8  minutes. After a brief 
centrifugation the following reagents were added on ice and mixed by 
pipetting: 10 pi of 5x dATP primer buffer (buffering solution containing 0.1 
mM of each dNTP), 5 pi of [a 3 2 P]-dATP (3000 Ci/mmol) (ICN) and 1 pi of 
Exo(-) Klenow (5 units/pl). The reaction was incubated at 37°C for 10 
minutes and stopped by adding 2 pi of stop mix (100 pi 0.5 EDTA, pH 8.0).
The labelled cDNA was purified and the unincorporated [a 3 2 P]- 
dATP removed by chromatography on a 1 ml column (Sephadex G50 DNA 
grade, NICK ™  columns, Pharmacia) and stored on ice until used.
iv) Hybridisation
The membranes were prehybridised in 1 0  mis of buffer (6 x SSC, 50% 
formamide, 5x Denhardt’s solution 100 pg/ml of herring sperm previously 
boiled) for 2 hours at 42°C in Hybaid bottles in a Hybaid oven. The cDNA 
probe was denatured by heating it at 95°C for 5 minutes and added to the 
prehybridisation buffer. The membranes were incubated with this solution, 
overnight at 42°C.
v) washes
The membranes were washed with 50 mis of 2x SSC/0 . 1  SDS at 42°C for 
15 minutes, followed by the more stringent 50 mis of 0.2 x SSC/0.1 SDS at 
the same temperature and a final wash of 0 . 1  x SSC/0 . 1  SDS. To remove 
excessive background, three more washes of 2 0  minutes each with the 
solution of 0 . 1  (w/v) SDS at room temperature were done.
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vi) stripping of blots
A solution of 0.1 % CDC (w/v) at 95°C was poured over the blot for 5-10 
minutes (up to 30 minutes if necessary).
vii) autoradiography
The blot was covered with cling film and placed against a sensitive X-ray 
film (Hyperfilm-MP, Amersham Int pic., CEA AB, Sweden) in a cassette 
(Amersham) with an intensifying screen. The film was exposed at -70°C for 
36 hours and was processed in an automatic X-ray processor.
2.2.7 Cvcle sequencing
The sequences of the isolated cDNA fragments by 3’end RACE (1st set of 
primers) and by RT-PCR were determined in both directions by cycle 
sequencing using a kit (Cyclist ™ Exo-Pfu DNA sequencing kit, 
Stratagene). This method is based on a PCR variation (linear amplification) 
and Sanger’s dideoxy chain termination enzymatic method for sequencing 
modified for single strand DNA. Electrophoresis was carried out in a 0.4 mm 
thick polyacrilamide gel.
i) Template preparation
The PCR products to be sequenced were excised from the agarose gel and 
the DNA was recovered by electrolution and precipitation. Dialysis 
membranes were prepared according to Sambrook et al., (1989) and filled 
with 500 }il of 0.5M TAE buffer. The excised band was inserted and the 
membranes closed hermetically. The DNA was allowed to migrate out of 
the agarose and into the dialysis membranes in an electrophoresis tank 
containing 0.5 M TAE buffer at 80 mA for 30 minutes, and for 5 minutes with
1 2 6
reverse polarity. The DNA recovered in the TAE buffer was then 
precipitated in the presence of 1/10 vol. of sodium acetate (pH 5.2) and 2 
volumes of absolute cold ethanol (-20°C). The DNA pellet was 
resuspended in 5 pi of TE buffer (pH 8 ), 1 pi was run in an agarose gel to 
evaluate the amount of DNA present and the rest was stored at -20°C. To 
obtain a large quantity of DNA, one or two reamplifications were done, 
depending on the initial amount. To do this a dilution (1/100) of the template 
was reamplified by PCR in a 100 pi reaction (protocol as the 1 st PCR). 20 pi 
of the reaction were run in a 1 % agarose gel to check that the 
reamplification was successful. The other 80 pi (future sequencing 
template) was purified by precipitation in the presence of sodium acetate 
(pH: 5.2) and ethanol, resuspended in 20 pi of TE buffer and run in 1% 
agarose gel. The sequencing template was recovered from the agarose gel 
by electrolution and precipitation, resuspended in 5 pi of TE buffer (pH: 8 ) 
and stored at -20°C until used for sequencing.
ii) Sequencing reactions
8  sequencing reactions, 4 each for the 2 primers and one each for the 4 
dideoxynucleotide (ddNTPs), were prepared according to manufacturers’ 
instructions of the kit (Cyclist ™ Exo-Pfu DNA sequencing kit, Stratagene) 
for each template.
Each sequencing reaction (total volume 10 pi) consisted of:
1 x sequencing buffer (20 mM Tris-HCI (pH 8 .8 ), 10 mM KCI, 2 mM MgS04  
100 pM (NH4 )2 S04i 0.1 % Triton, 0.1 mg/ml bovine serum albumin (BSA), 2 
pM dATP, 5 pM dCTP, 5 pM dGTP and 5 pM dTTP), 106 nM of template, 
250 pCi/ml of [a3 5 S] dATP, 62.5 U/ml of Exo"Pfu DNA polymerase, 0.1 pi 
dimethyl sulphoxide (DMSO), 100 nM of one of the two primers, 7.5 mM of 
one of the 4 ddNTPs and 15 pi of mineral oil.
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The reactions were begun with an incubation at 95°C for 3 minutes, 
followed by 30 cycles of: denaturation of double strand (94-95°C for 20 
seconds), primer annealing (60°C with RACE primers P45-P8 and 55°C 
with PCR primers P58-P61) for 30 seconds and transcript extension (72°C 
for 1 minute). The reaction were terminated with 5 pis of “stop solution”, 
consisting on 80% formamide, 50 mM Tris-HCI (pH 8.3), 1 mM EDTA, 0.1 % 
bromophenol blue and 0.1% xylene cyanol. The reactions were stored 
frozen at -20°C until the moment of loading them in a sequencing gel.
iii) Electrophoresis
Making the sequencing gel
The following recipe was used for a 75 ml gel: 15 ml of 40% acrylamide 
(38% acrylamide and 2% N’N’bis acrylamide), 15 mis of TBE buffer, 18 ml 
of double deionized water (dd^O ), 36 grams of urea, 0.75 ml of 1 0 % 
ammonium persulphate and 22.5 pi of N ,N ,N \N ’ tetramethyl- 
ethylenediamine (TEMED). The 40% acrylamide, TBE buffer, ddH20  and 
urea were dissolved in the microwave by heating to a maximum of 37°C 
and allowed to cool to room temperature. When ready to pour the gel, the 
polymerisation agents were added: freshly prepared 1 0 % ammonium and 
TEMED. Holding the casting apparatus at an angle of 45° the solution was 
quickly poured down one corner at a steady rate, using a 50 ml syringe. 
The gel was returned to an almost horizontal position (5°) and an even 
levelled border was created by inserting a reversed comb up to 3-5 mm 
deep. The gel was allowed to polymerise overnight at room temperature, 
keeping the top moist and being covered with Saran wrap.
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Running the ael
Before loading the gel was pre-run for 1 or 2 hours with 0.5 TBE buffer at 
1850 volts to heat the gel and the buffer to its running temperature 50°C. 
The sequencing reactions were heated to 95°C for 3 minutes to denature 
and concentrate the samples and 2  pi of sample were quickly loaded in the 
order GATC GATC for each primer. The samples of the first loading were 
run for 6  hours and then two more loadings were done separated 2 and 5 
hours from the first loading.
Fixing and drvina the ael
The gel was fixed with 3 litres of a solution (v/v) 10% methanol/10% acetic 
acid for 5 minutes and left to dry over filter paper in a vacuum gel-dryer at 
80°C for 3 hours.
iv) autoradiography
The gel (supported by the filter paper) was placed in a cassette with film 
(Kodak). Film was exposed for 72 hours at -70°C and developed using an 
X-ray processor.
2.2.8 Southern blots
Southern blots were carried out according to O'Shaughnessy et al. (1993).
i) DNA transfer
The RT-PCR electrophoresis gels were photographed with a ruler under UV 
light for size determination using DNA molecular markers (100 bp, Gibco). 
Gels were then blotted to Biotrans (+)™  nylon membranes (ICN) in 20x 
SSC by capillary elution. The DNA was fixed to the membranes by baking 
at 80°C for 15 minutes. Membranes were stored wet (2 x SSC) and 
wrapped in Whatman paper in the refrigerator until hybridisation.
1 2 9
ii) Hybridisation
The membranes were prehybridised in 10 mis of buffer (5x SSC, 0 . 1  % 
SDS, 5x Denhardt's solution, 100 pg/ml of herring sperm) for 1 hour at 
63°C in Hybaid bottles in a Hybaid oven. The cDNA probe was denatured 
by heating it at 98°C for 5 minutes and added to the prehybridisation buffer. 
The membranes were incubated with this solution, overnight at 50°C. 
3 2 P-labelling of cDNA probes was carried out using a random primer 
labelling kit (Prime-it™ II, Stratagene) as described earlier for northern blot 
analysis (2 .2 .6 ).
iii) washes
The membranes were washed with 50 mis of 2x SSC/0.1 SDS at 55°C for 
15 minutes, followed by the more stringent 50 mis of 1 x SSC at the same 
temperature.
iv) autoradiography
This was done as for the northern blots (2.2.6) exposing the film for 1, 2 and 
24 hours.
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CHAPTER 3
THE USE OF PROSTAGLANDIN E2 (PGE2) TO INDUCE 
CERVICAL RIPENING IN EARLY LUTEAL PHASE SHEEP
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3.1 INTRODUCTION
3.1.1 Use of PGEgfor the induction of cervical ripening during the cvcle 
and pregnancy
The usefulness of prostaglandins for the induction of labour at term or for the 
therapeutic termination of pregnancy in early gestation in humans were first 
documented in the late 1960s and early 1970s. Initially, the rationale of using 
these drugs was the discovery in the 1930s, that prostaglandins could induce 
uterine contractions. Later, it was discovered that doses insufficient to induce 
uterine contractions, induced cervical softening (reviewed by Keirse, 1990; 
Robinson et al., 1991). In the 1970s and 1980s, the ovine cervix was used as 
an experimental model to investigate further the effect of prostaglandins in 
the cervix (Fitzpatrick, 1977; Fitzpatrick and Liggins, 1980). Several 
experiments demonstrated that prostaglandins softened the cervix by a direct 
effect rather than the induction of uterine contractions. Initially PGF2a was
used for the induction of labour in humans, but later the uterotonic superiority 
of PGE2 became evident. Because of the previous clinical experience with 
the E series in the uterus, in most countries PGE2 has also been used more 
than PGF2a for cervical ripening, except in Australia where PGE2 was not 
licensed until recently (MacLennan, 1990). There are only two studies 
comparing both PGs, the results of these studies may not be absolutely 
convincing (reviewed by Keirse et al., 1990) but support the superiority of the 
PGE2 for the induction of cervical ripening, a view held by most clinicians 
(Calder, 1990).
Clinical experience has shown that the intravaginal or endocervical 
routes are preferred in comparison with other local routes (intraamniotic) or 
the general routes (oral and intravenous). Lower doses can be used with the 
local routes, minimising side effects and cost (Calder and Greer, 1992;
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Calder, 1994). The naturally occurring prostaglandins are rapidly catabolized 
in a single passage through the lungs, but synthetic analogues of PGE2 and 
PGF201 have been developed with the intention of prolonging their half life 
and increasing their potency. These molecules have also been designed to 
have a more selective action on the reproductive tract, reducing their side 
effects (Hess et al., 1979; Coleman et al., 1990).
Prostaglandin E2 (PGE2) analogues are used to induce preoperative 
cervical ripening in humans, before termination of pregnancy at the 2 nd and 
3rd trimesters (Bygdeman, 1992). Another very common indication for PGE2 
has been the ripening of the unfavourable cervix at term, in this case the 
natural compound is usually preferred. The E series has been widely used 
clinically during pregnancy for these purposes, but its use during the cycle is 
far less documented and results at this stage are not very clear (reviewed by 
Uldbjerg, 1989; Calder and Greer, 1992). Early reports suggested that PGs 
have a similar effect at both reproductive stages (Rabe, 1985). More recent 
works have shown that cervical ripening with prostaglandins can be induced 
in non-pregnant women; but results are either poorer than during pregnancy 
or undifferent when compared with placebo (Sulprostone: Lueken and 
Lindermann, 1979; Ulbrich and Bartels, 1979; Gemeprost: Elder and Lewis,
1991).
In sheep it is clear that PGE2 is effective inducing cervical ripening 
during late pregnancy (120-140 day gestational age) and it is less effective in 
animals with high levels of progesterone (Fitzpatrick, 1977; Stys et al., 1981; 
Owiny and Fitzpatrick, 1990). Recently there has been an interest in the use 
of this drug during the superovulated luteal phase (day 6  after oestrus) in 
order to develop a transcervical embryo transfer technique but the results 
have been variable. Some authors reported very successful embryo 
collection in South Africa (Barry et al., 1990) and others have reported 
variable results in Scotland (Audicana, 1992; Mylne et al., 1992). Partial
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ripening and incomplete catheterization in anoestrous sheep has been 
reported (Rickords and White, 1988).
3.1.2 The microscopic changes of cervical ripening induced bv PGE*> or 
other ripening drugs
The mechanism of action of PGE2 in the induction of cervical ripening is not 
fully understood. During physiological ripening, microscopic changes have 
been reported in sheep (Parry and Ellwood, 1981; Aughey et al., 1981; 
Fosang et al., 1984; Owiny et al., 1987), women (Danforth, 1960; Junqueira 
et al., 1980; Manabe and Yoshida, 1990; Knudsen et al., 1991), and other 
species. The changes consisted of separation of collagen fibres and is 
associated in most reports with the presence of inflammatory cells, these 
changes have been explained in detail in chapter I.
Similar studies have shown that the mechanism of cervical ripening 
when induced by PGE2 and its analogues resemble those of physiological 
ripening in sheep and other mammals (sheep: Owiny et al., 1987; women: 
Uldbjerg et al., 1981; Rath et al., 1987; monkey: Shimizu et al., 1994 and the 
rabbit: Rayburn et al., 1991). Microscopic changes have also been reported 
following treatment with other prostaglandins, (PGF2tt: Theobald et al., 1982; 
MacLennan et al., 1985; Owiny et al., 1987; PGF2tt analogue: Manabe and 
Yoshida, 1990; PGE1 analogues: Manabe and Yoshida, 1990; Greer et al.,
1992). Similarly, these changes can be induced by other cervical ripening 
drugs in late pregnant women and experimental animals (relaxin: 
MacLennan et al., 1985; antiprogestagens: Hegele-Hartung et al., 1989; 
interleukins: Chwalisz et al., 1994). Changes in all the cases are similar to 
those reported during physiological cervical ripening.
There is biochemical evidence supporting that collagenolysis occurs in 
the periparturient period, during both physiological and pharmacological 
ripening induced by PGE2 . Collagenolysis may be responsible for the
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increased spaces between collagen fibres observed in sections. Collagenase 
and elastase activities are increased following PGE2 treatment, the effect is 
so rapid as to suggest a release from PML granules rather than new 
synthesis. The PML is known to store collagenase (MMP-8 ) and elastase, 
and therefore it is a potential source of these enzymes during PGE2-induced 
cervical ripening (Rath et al., 1993; Doherty and Janusz, 1994). Others 
however have found that PGE2 increases the synthesis of collagenase in the 
cervix in vitro (Goshowaki et al., 1988), which suggests the involvement of 
the macrophage or the fibroblast, which do not store but synthesise 
collagenase de novo (Woessner, 1994). Active PMLs, macrophages and 
fibroblasts have been observed in the cervix, following PGE2 administration, 
but it has not been demonstrated which cell(s) and enzyme(s) cause ripening 
(Greer et al., 1992; Rayburn et al., 1994). Leukocyte elastase has been 
localised in PMLs following treatment with the PGE2 analogue Gemeprost, 
but the authors did not find good correlation between the number of PMLs 
and the degree of cervical ripening (Greer et al., 1992). The author of this 
thesis is not aware of similar studies of fibroblast (MMP-1) or PML 
collagenase (MMP-8 ).
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During the cycle, not only are there very few clinical studies of the 
effect of PGE2 in the cervix, but also there is no information on the 
mechanism of action of PGE2. Unlike during pregnancy, there are no 
morphological, mechanical or biochemical studies following the 
administration of PGE2 or other drugs in sheep or other species. The aims of 
this study were therefore twofold:
1) The clinical assessment of intravaginal human preparations of 
PGE2 for the purpose of facilitating passage of the cervix with a catheter, 
during the cycle and early pregnancy in sheep (experiment 1). This 
experiment was carried out to study the possibility of using PGE2 to develop 
a non surgical (transcervical) embryo transfer technique.
2) The investigation of whether in the luteal phase, PGE2 can induce 
microscopic changes similar to those observed during physiological ripening 
immediately before labour (experiment 2 ).
3.2 MATERIALS AND METHODS
3.2.1 Animals, oestrus induction, superovulation and matinas
Adult cast Scottish Greyface were used for the present experiments. The 
sheep were bought from a dealer and accommodated in a covered straw- 
bedded house for the duration of the study.
Oestrus was synchronised in the ewes using a 12-day regimen of 
fluorogestone acetate intravaginal sponges (Veramix, Upjohn). Oestrus was 
expected in these sheep 48 hours after sponge removal. Rams were 
introduced 48 hours after sponge removal and kept for 2-3 days. Ewe/ram 
ratio was always within the recommended 1 0 : 1  or less.
Superovulation was induced by a single intramuscular (IM) injection of 
1500 I. U. of equine chorionic gonadotrophin (eCG) (PMSG, Intervet) in 
some sheep and was administered on the day of sponge removal. Oestrus
136
was expected in these sheep 24 hours after sponge removal and eCG 
injection. Rams were introduced 24 hours after sponge removal and kept for 
2-3 days.
3.2.2. Experiments
Experiment 1: Transcervical catheterization of sheep following 
treatment with intravaginal PGE2 pessaries
15 superovulated and mated sheep were examined at day 18 after oestrus. 
Pregnancy status was established by measuring plasma progesterone 
concentrations on day 16 using an ELISA kit (Ovucheck, Cambridge Life 
Sciences) according to Eckersall and Harvey (1987). The animals were 
allocated into 4 groups described later. Sheep were restrained as for Al for 
evaluation of the cervix and administration of the PGE2, the hind quarters of 
the ewes were lifted and placed over a rail. The effect of the treatment was 
evaluated by probing the cervix with a 0.5 cm diameter insemination pipette 
with an angled tip and divisions of 1 cm. The depth scored was recorded 
before and after the treatments and the control group were examined at 
corresponding times (+4.5 and 24 hours) following mock insertion of 
pessaries. The resulting data were analysed using a two way analysis of 
variance.
1 ) group C: control group that received no treatment (n=4)
2) group E: received 0.25 mg of oestradiol benzoate injected intramuscularly 
(n=3 ), the effect of this treatment was evaluated 2 0  hours later.
3) group P: PGE2 group, received either one or two intravaginal pessaries 
containing 10 mg of Dinoprostone (Propess, Roussel Lab) (n=5). This was a 
new form of intravaginal administration, designed for slow release, at a 
steady rate of less than 1 mg per hour and therefore for approximately 1 2  
hours in vitro (Rayburn et al., 1992). They were kept at -20°C until 
immediately before use. The effect of the 1st pessary was evaluated 4 hours
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and 30 minutes and 24 hours later. A second pessary was inserted in 3 of 
these sheep 24 hours after the 1st and the effect was evaluated 4 hours later 
(+28 hrs) together with those sheep that had only received one pessary.
4) group PE: This group (n=3) was given one pessary of PGE2 that was 
evaluated 4 hours and 30 minutes later, at this time the ewes were given an 
IM injection of 0.25 mg of oestradiol benzoate. The effect of oestradiol was 
evaluated 24 hours later, which was followed by the administration of a 
second pessary to be evaluated 4 hours later (+28 hrs) and the next day 
(+48 hrs).
Experiment 2 : Microscopic study of the cervix following PGE2 
treatment
In two trials, two intravaginal preparations of PGE2 (4 mg of a gel or 10  mg of 
a vaginal controlled release pessary) were administered on day 6  of the 
cycle to ordinary (T-, n=6 ) or superovulated animals (T+, n=6 ). The effects 
were evaluated after different exposures (24 hours and 1 week) in the 
ordinary luteal phase and (8,16 and 24 hours) in the superovulated animals. 
Control groups were available at day 6  of the normal cycle (C-, n=2 ) and of 
the superovulated cycle (C+, n=3) (Table 3.1).
Sheep were sacrificed with an intravenous injection of 20% 
pentobarbitone sodium (Euthetal, RBM). In trial 1, before the euthanasia 
some sheep (n=3) were anaesthetised with 6 % pentobarbitone sodium 
(Sagatal, RMB) and catheterization with a catheter of 2 mm diameter was 
attempted. In trial 2, this was omitted to be able to differentiate between 
microscopic changes due to PGE2 or the catheterization.
Specimens were collected immediately postmortem from the 4 groups 
(see Table 3.1), at the cranial vagina, and at three areas of the cervix 
(external os, mid cervix and internal os) to be processed for light microscopy 
(LM), transmission (TEM) and scanning electron microscopy (SEM) (see 
chapter I I ).
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Trial Group n= day -1 
(eCG)
day 6 
(PGE2)
sacrifice
day
2 C - 2 — — day 7 
(n=2)
1 C + 3 1500 IU — day 7 
(n=3)
2 T - 6 gel 
(4 mg)
day 7 (n=3) 
day 12 (n=3)
1 T + 6 1500 IU pessary 
(10 mg)
day 6 and
* 8 hrs (n=2) 
16 hrs (n=2)
* 24 hrs (n=2)
Table 3.1: Treatment groups in trials 1 and 2. of Experiment 2 
(Microscopy)
Trial 2: None of the sheep were superovulated (C- and T-). The control group 
(C-) received no further treatment and the treated group (T-) were given an 
intravaginal gel containing 4 mg of Dinoprostone (Prostin, Upjhon) on day 6  
of the cycle (oestrus: day 0). Trial 1: All the sheep were superovulated (C+ 
and T+) with an IM injection of eCG on day -1 (day of sponge removal). The 
treated group (T+) received another preparation of PGE2 on day 6  of the 
cycle, intravaginal pessaries containing 10 mg of Dinoprostone (Propess, 
Roussel Lab). Only in this trial sheep (*3/6) were attempted to be 
catheterized under general anaesthesia before sacrifice.
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3.3 RESULTS
3.3.1 Catheterization of the cervix and softening
Complete catheterization was not possible in any of the ewes at day 18 with 
a catheter of 5 mm in diameter (experiment 1: Tables 3.2, 3.3 and 3.4). In 
experiment 2  (at day 6 , under anaesthesia and with 2  mm catheter, 
catheterization was incomplete in the ewes (n=3) (trial 1), measurements 
were not recorded because the samples had to be collected fast for 
microscopy (results therefore are not shown). The consistency of the cervix 
was softer in PGE2-treated sheep than in control sheep.
The cervix in the luteal phase of control sheep of the breed Scottish 
Greyface was 7-10 cm long (observed postmortem: Plate 3.1). The maximal 
depth of catheterization in control sheep in vivo was variable ranging from 
0.1 to 3 cm, these differences were not significant statistically. Variation was 
observed when probing the cervix of the same ewe at different times and 
between ewes. Deeper catherization (>3 cm), was observed with the 
following treatments: oestrogen after 20 hours (in 1/3 ewes) or a single 
pessary of PGE2 after approximately 4 hours and 30' and after 24 hours (1 / 5  
and 5/5 respectively). Only the treatment with PGE2 after 24 hours was 
significant (p<0.001). The maximal depth achieved was 5 cm in a single 
animal (1/6) after receiving a second pessary of PGE2. Oestradiol priming 
did not improve the effect of a single or two pessaries of PGE2i the statistical 
anlysis showed that if any oestradiol had a negative effect on the PGE2 
treatment.
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ewe pregnant
Cervical depth (cm)
0 hr 4.30 hr 24 hr
C1 yes 3 0 . 1
C2 yes 3 3 1
C3 yes 0 . 1 2.5 1
C4 no 0 . 1 2.5 1
Table 3.2 Cervical depth measured at time intervals following 
mock pessary insertion in control group.
ewe pregnant
Cervical depth (cm) 
minus minus 0  hr 
28 hr 24 hr
plus 
2 0  hr
E1 yes 3 0.5
E2 yes 3 3 1 2.5
E3 yes 0 . 1 3 1.5 4
Table 3.3 Cervical depth measured at time intervals 
following oestrogen treatment (Group E)
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Plate 3.1
Complete catheterization of a reproductive tract post-mortem, 
reaching the right uterine horn (asterisk).
% J
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Plate 3.2
In contrast with the previous specimen, another tract shown 
here where one of the mucosal folds occludes the cervical 
canal completely.

3.3.2 Microscopic changes produced bv PGE2
Both groups of control sheep (C+ and C-) presented a similar epithelium and 
subepithelium. The vagina was lined by stratified squamous epithelium and 
the endocervix by a stratified squamo-columnar epithelium at the external os 
and a columnar epithelium in mid cervix and at the internal os. The mucosa 
of the vagina and endocervix consisted of dense connective tissue, the 
collagen fibres were compactly arranged and contained very few cells 
(fibrocytes and white blood cells). Eosinophils and PMLs were seen 
occasionally (1 per field) in the endocervix and were inactive (no 
degranulation). Extravascular RBCs were not observed in these groups 
(Plates 3.3-3.12).
An inflammatory response was observed in the two PGE2 treated 
groups (T+ and T-), localised in the subepithelial connective tissue and 
epithelium of the cranial vagina (Plates 3.3.-3.6J and in the endocervix of the 
external os (3.7-3.13). This response was less obvious at the mid cervix 
(Plates 3.14-3.16) and the internal os (Plates 3.17-3.19). Light microscopy 
showed an infiltration of inflammatory cells in the subepithelial connective 
tissue and across the epithelium into the lumen. Blood vessels in the 
subepithelium were enlarged and contained abundant red blood cells 
(RBCs). There were areas of looser collagen, mainly in the endocervix but 
also in the fibromuscular wall of the cervix and there was an increase in the 
ground substance between the collagen fibres.
TEM showed that the inflammatory cells were PMLs, eosinophils, 
mast cells, platelets, macrophages and RBCs that were very abundant in 
blood vessels or in the connective tissue. The PMLs and the eosinophils 
were present in great numbers (>5 cells/field), both intravascular, leaving 
blood vessels and extravasated into the extracellular matrix. They showed 
haloes of collagenolysis around them, the collagen fibres were less densely 
arranged than in control animals. Transepithelial migration into the lumen
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and degranulation was observed. Some eosinophils were phagocytosed by 
macrophages in the extracellular matrix. It was also common to find activated 
mast cells and platelets in the vicinity of PMLs and eosinophils.
SEM of these specimens showed the presence of RBCs and 
inflammatory cells, desquamation of epithelial cells and threads of mucus or 
fibrin (Plates 3.4 and 3.8). This inflammatory response was more intense in 
ewes that had longer exposure to PGE2 and was localised in the cranial 
vagina and the most caudal parts of the cervix. The inflammatory response 
was reversible after one week in 2 out of 3 ewes. Microscopic results are 
summarised in Table 3.5.
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Plate 3.3
Light micrographs of the cranial vagina 
Upper Control animal showing a stratified squamous 
epithelium. Magnification x20
Lower. Treated animal showing an inflammatory response in 
the epithelium (open arrows), in these areas white blood cells 
and red blood cells can be observed. The epithelial border 
(closed arrow) also presents infiltration of red blood cells and 
desquamation. Magnification x20
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Plate 3.4
Scanning electron micrographs of the cranial vagina 
Upper Control animal showing a stratified squamous 
epithelium. A few red blood cells is a normal finding. 
Magnification x1440
Lower Treated animal showing an inflammatory response in 
the endocervix. Note desquamation of the epithelium, and 
presence of WBCs (arrow) with strands of mucus (Mu). x1440
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Plate 3.5
Transmission electron micrographs of the subepithelium 
of the cranial vagina
Upper Control animal showing dense collagen (Co), a 
fibroblast (Fb) and absence of WBCs. Magnification x8 K 
Lower Treated animal showing a subepithelial inflammatory 
response with presence of polymorphonuclear leukocytes 
(PMLs) and eosinophil (Eo). Fibroblast (Fb) also present. 
Magnification x8 K
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Plate 3.6
Transmission electron micrographs of the subepithelium 
of the cranial vagina
Upper Treated animal showing subepithelial free granules of 
PMLs (open arrow) under the epithelial border (closed arrow). 
x10K
Lower Treated animal showing a macrophage with 
phagocytosed eosinophilic granules. Note that it is not an 
eosinophil because it has a monocytic nucleus (Ma) and the 
granules are stored in vacuoles (open arrow). x16K
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ElateAZ
Light micrographs of the external os of the endocervix 
Upper Control animal showing a transitional epithelium 
between columnar (c) and squamous (sq). Magnification x10 
Lower Treated animal showing a subepithelial inflammatory 
response (open arrow), with the presence of white blood cells 
(WBC) and red blood cells (stained in yellow in the open arrow 
area). Note desquamation of the epithelium (closed arrow). 
Magnification x10
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Plate 3-8.
Scanning electron micrographs of the external os of the 
cervix
Upper Control animal showing a stratified squamous (sq) and 
columnar epithelium (c). Magnification x2813. note the 
presence of red blood cells (RBC)
Lower Treated animal showing an inflammatory response in 
the epithelium. Note the mucus and the presence of RBCs, 
squam (sq) and WBCs (arrows).Magnification x2813

162
Plate 3.9
Transmission electron micrographs of the external os of 
the cervix
Upper Epithelial border (arrow) of a control animal showing 
secretory granules (SG) of mucus. Magnification x8 K 
Lower Epithelial border (arrow) of a treated animal showing 
eosinophilic granules (EoG). Magnification x8 K
■fdTM
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Plate 3.10
Transmission electron micrographs of the endocervix at 
the external os
Upper Control animal showing dense collagen (Co) and a 
blood vessel (BV) with a few RBCs Magnification x5.4K 
Lower Treated animal showing less densely arranged collagen 
(Co), extravascular RBC and an enlarged blood vessel with 
presence of a red blood cells, platelets (Pt) and an eosinophil 
(Eo). Magnification x5.4K
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Plate 3.11
Transmission electron micrographs of the endocervix at 
the external os comparing control with treated.
Upper Observe the density of the collagen fibres (Co). 
Magnification x8 K
Lower An eosinophil (Eo) surrounded by a "halo of 
collage no lysis", ground substance with very little collagen(Co). 
Magnification x8 K


Plate 3.12
Transmission electron micrographs of the endocervix at 
the external os comparing control with treated.
Upper Control animal showing a blood vessel (BV) and 
surrounding connective tissue with collagen (Co). 
Magnification x8 K
Lower Note the extravasation of a PML from the adjacent 
blood vessel (BV) and the dispersion of collagen fibres (Co) in 
this treated animal when compared with control. x8 K
V *»
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Elate 3:1.3
Transmission electron micrographs of the endocervix at 
the external os in treated sheep.
Upper Extravasation of PMLs and red blood cells (RBC) and 
adjacent blood vessel (BV). This finding was only present in 
treated animals. Magnification x9K 
Lower Eosinophil aggregation, in this field, 3 cells can be 
observed. Note the separation of collagen fibres (Co) around 
the eosinophils and the presence of a fibroblast (Fb). x5.4K
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Plate 3.14
Light micrographs of the mid cervix
Upper Control animal showing a columnar epithelium (arrow).
Magnification x20
Lower Treated animal showing an inflammatory response in 
the epithelium (open arrow). White blood cells, red blood cells 
(stained in yellow) and desquamation (closed arrow). Presence 
of mucus (Mu) that contains red and white cells.
Magnification x20
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Plate 3.15
Scanning electron micrographs of the mid cervix 
Upper Control animal showing a columnar epithelium with 
secretory (sc) and ciliated cells (cc).
Magnification x5625
Lower Treated animal showing some inflammatory cells 
(arrows) in the epithelial surface apart from the secretory (sc) 
and ciliated (cc) cells.
Magnification x5625
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Plate 3.16
Transmission electron micrographs of the endocervix of 
the mid cervix
Upper Control animal showing dense collagen (Co) and 
smooth muscle cells (SM), these are more prominent cranially. 
Magnification x13.5K
Lower Treated animal showing a similar appearance as the 
control group, collagen (Co) and smooth muscle cells (SM). 
Magnification X13.4K
m m
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Plate 3.17
Light micrographs of the internal os of the cervix 
Upper Control animal showing a columnar epithelium (arrow). 
Magnification x20
Lower Treated animal showing a similar epithelium (arrow) 
compared to control animals. No inflammatory reaction was 
observed in this part of the cervix. Magnification x20
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Ptete 3,18
Scanning electron micrographs of the internal os of the 
cervix
Upper Control animal showing the typical columnar epithelium 
of this region with secretory (sc) and ciliated cells (cc). x6250 
Lower The epithelium in treated animals was not different from 
controls in this portion of the cervix. Note the secretory (sc) and 
ciliated cells (cc) x6250
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Plate 3.19
Transmission electron micrographs of the endocervix at 
internal os
Upper No inflammatory response was observed in the 
epithelium of treated groups at this site of the cervix. 
Magnification x8 K
Lower The subepithelium of treated animals without presence 
of white cells, note the presence of a fibroblast (Fb) x8 K

3.4 DISCUSSION
A suitable PGEg regime for transcervical ET in sheep: route, form and 
dose.
Partial catheterization of the cervix was achieved using two vaginal 
preparations of PGE2, indicating a degree of softening of the external os of 
the cervix. Microscopic examination of the vagina and the cervix showed 
collagen separation in the cranial vagina and around the external os of the 
cervix, but dense collagen in the mid to internal os regions of the cervix. The 
cervix is much longer in sheep than in humans (i.e. 5-10 cm versus less than 
1 cm) and therefore it is possible that only low concentrations of PGE2 
reached the mid cervix and internal os in.the present experiments. In 
pregnant sheep, vaginal PGE2 is more effective on the caudal cervix, it is 
suggested that the dosage reaching the uterus is lower than in women when 
using vaginal or intracervical preparations (Fitzpatrick and Liggins, 1980; 
Stys et al., 1981). The pregnant sheep cervix is much longer than during the 
cycle, with lengths of 17.5-29 cms (Aughey, unpublished results).
Partial catheterization using an intravaginal suppository was also 
observed in anoestrous sheep by Rickord and White (1988), these authors 
proposed using the intracervical route as an alternative. However due to the 
difficulty of catheterising the cervix during the cycle, the administration of 
prostaglandins by this route is limited. Catheterization up to 4-5 cm, achieved 
using PGE2 intravaginaly in some cases in the present study, may be 
enough to reach the uterus in some breeds of sheep with short cervices, 
where a mean of 5-6.7 cm has been reported during the cycle (Ward, 1968; 
Halbert et al., 1990a). Most anatomy text books also talk about lengths of 4-6 
cm (Sisson, 1975; Habel, 1989). The incomplete catheterization of this study 
may be explained by the long cervix observed in non-pregnant Scottish
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Greyface (length of 10 cm). It may be worth looking at breed differences in 
the length of the cervix in vivo, for example using ultrasonography (see 
chapter IV).
For these reasons, the use of PG analogues administered by general 
routes may be more appropriate in sheep breeds with "long cervices". In 
addition, these compounds are more potent than the natural PGE2 with lower 
side effects generally, therefore being preferred as abortifacients in early 
pregnancy and during the cycle in women (Bygdeman, 1992). Sulprostone 
could be injected intramuscularly or intracervically, apparently the later route 
is well tolerated by women (Wiechell, 1979; Lueken and Lindermannn, 
1979). Misoprostol by the oral route is another alternative, additional 
advantages are the lower price of this drug and that it does not require 
refrigeration (see chapter I). Drugs administered by the oral route in 
ruminants however require a full investigation of possible interferences with 
the ruminal contents, to achieve an effective treatment and not to upset the 
normal digestion (Jenkins, 1988).
An additional problem of using intravaginal pessaries here was that 
some ewes (5/14) lost them. The intravaginal gel (used in trial 2) was a 
viscous preparation and therefore this was not a problem. The gel comes in 
a syringe, the nozzle had to be extended 6  mm with endotracheal tube to 
reach the external os in the sheep. The author suggests that an extended 
embolus may be also helpful in order to push all the gel out of the syringe.
Doses used in this work were those recommended by medical 
pharmaceutics and are the same as those used during pregnancy in sheep 
(Fitzpatrick and Liggins, 1980; Stys et al., 1981). It is possible that the 
second pessary could be more effective when administered 1 2  hours after 
the first, because the whole dose was probably released by then at a rate of 
1 mg per hour. Here a 24 hours interval was chosen instead, for
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convenience, in order to accommodate the evaluation of the PGE2 effect with 
staff working patterns.
2. Mechanism of action of PGEg during the cvcle
These morphological studies have shown for the first time that PGE2 induces 
an inflammatory response on day 6  of the cycle and that in addition to 
pregnancy, it can modify the connective tissue of the cervix at this stage. In 
the next section the possible role of the inflammatory cells observed in 
treated groups here will be discussed.
The PML and fibroblast
The observation of PML activation following PGE2 treatment here, is 
consistent with the idea that PML degranulation is involved in PGE2-induced 
cervical ripening supported by the evidence of a rapid and transitory increase 
in the activities of collagenase and elastase in women (Osmers et al., 1991b; 
Rath et al., 1993).
It has been suggested that PGE2 could exert its proinflammatory 
effect in the cervix and in the skin by acting as a vasodilator on EP2 and EP4 
receptors of the smooth muscle of blood vessels. This action is synergistic 
with IL- 8  which activates the PMLs. IL- 8  is suppressed by progesterone 
during pregnancy and increases at labour with the progesterone withdrawal 
(Kelly, 1996). The action of PGE2 during the cycle (under the influence of 
high progesterone and therefore in the absence of other proinflammatory 
mediators) may be better explained by a direct action of PGE2 on PML 
receptors (Armstrong, 1992).
Fibroblasts, rather than fibrocytes were also observed and therefore it 
cannot be ruled that the fibroblast could be another source of collagenase 
(Goshowaki et al., 1988). However the role of this cell is unclear because, 
although PGE2 and cAMP induce the synthesis of mRNA for proMMP-1 in
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fibroblasts of other tissues, in the cervical fibroblasts the administration of 
cAMP inhibited mRNA synthesis of proMMP-1 and proMMP-3 (Takahashi et 
al., 1991).
Presence of activated eosinophils in PGE^treated ovine cervix
Apart from the PMLs, here it was observed an increased number and 
degranulation of eosinophils following PGE2 treatment. This is consistent 
with observations made during physiological and PGE2-induced ripening in 
late pregnant sheep (Liggins et al., 1981; Fosang et al., 1984; Fitzpatrick and 
Liggins, 1980).
Eosinophilic granules may be sources of collagenolytic enzymes or 
cationic proteins. Haloes of collagenolysis have been observed here and by 
others in late pregnancy (rat: Luque et al., 1989; women: Knudsen, 1991). 
Like the PML, eosinophils may store several proteinases, including leukocyte 
elastase (Lungarella et al., 1992), a collagenase that degrades the main 
collagen types of the cervix, namely type I and III (Hibbs et al., 1982) and 
gelatinase B (St&hle-Backdahl and Parks, 1993). This however remains as 
an hypothesis and it is unknown whether collagenase and elastase are 
released from eosinophilic granules during cervical ripening. Furthermore, 
recent reports are questioning the presence of elastase in the eosinophil 
granules (Wiedow et al., 1996). Release of cationic proteins during 
degranulation is another possibility, eosinophilic major basic protein has 
been observed during cervical ripening in rats (Duchesne and Badia, 1992).
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Platelets and mast cells
Eosinophil activation involves an increase in the intracellular calcium levels 
and so far only negative responses to PGE2 (involving increases in cAMP) 
have been described (Giembycz and Barnes, 1993). The eosinophil 
activation by PGE2 treatment observed here may be an indirect action on 
other cells that can be activated by the EP3 R, such as the PML, mast cells or 
platelets (Wheeldon and Vardey, 1993; Nishigaki et al., 1993; Mathews and 
Jones, 1993; Kunapulli, 1994; Blockmans et al., 1995). Mast cells have been 
suspected to be involved in the activation of eosinophils during physiological 
cervical ripening (Knudsen, 1991). Our results are also consistent with this 
view while also suggesting a possible role for platelets in PGE2-induced 
ripening.
Platelet aggregation was observed in blood vessels near eosinophils 
and PMLs. Other signs of platelet activation, changes in shape and 
degranulation, were not seen. Platelets are sources of cytokines for 
eosinophils as discussed earlier (Herd and Page, 1995). Degranulating mast 
cells were observed, this is consistent with observations during physiological 
(sheep: Aughey, personal communication; human: Lo Stumbo, 1970) or IL- 
induced, and antiprogestagen- induced cervical ripening (Hegele-Hartung et 
al., 1989; Chwalisz et al., 1994). The role of this cell in cervical ripening has 
been suggested to be the recruitment and activation of eosinophils (Knudsen 
et al., 1991). They can liberate chemotactic factors for eosinophils and PMLs 
and they are considered the initiators of acute inflammatory responses (Galli, 
1993; Galli and Costa, 1995; Galli and Weshil, 1996). They also contain very 
large amounts of tryptase (in humans) and chymase (in murines), which 
participate in extracellular matrix degradation in other tissues (Caughey, 
1994).
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Macrophages
The macrophages seen in the present study appear to contain eosinophilic 
particles in them (Plate 3.6). This has also been described in other situations, 
like oestrus, asthma and other inflammatory responses (Ross and Klebanoff, 
1966). Macrophages/monocytes are known to be involved in the 
phagocytosis of apoptotic eosinophils and PMLs, thus removing the detritus 
of the inflammatory reactions (Savill and Haslett, 1995). This role is 
consistent with the observations of this study.
It has recently been reviewed that PGE2 is crucial for the production of 
metalloproteinases by macrophages (Goetzl et al., 1996). Besides, 
monocytes also contain an elastase that is cross-reactive with the PML 
enzyme and it is lost in mature macrophages. Unlike the eosinophilic 
enzyme, the presence of HLE in monocytes, appears to be well established 
(Kargi et al., 1990; Campbell et al., 1991c; Caughey, 1994). It is not 
surprising that a hypothetical role in the degradation of the cervical 
extracellular matrix by these cells in PGE2-induced cervical ripening has 
been suggested (Rayburn et al., 1994). The morphological studies carried 
out here neither support nor discard this hypothesis.
Other authors have reported increased numbers of macrophages in 
physiological and other drug-induced cervical ripening (Fosang et al., 1984; 
Hegele-Hartung et al., 1989; Chawalisz et al., 1994). Macrophages are the 
most important source of PGE2 in inflammatory reactions (Coleman et al., 
1990; Corcoran et al., 1995). Another possible role of this cell in 
physiological ripening may be the synthesis of PGE2 which could explain 
why here, where the PGE2 was administered exogenously, increased 
numbers of these cells were not observed.
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Red blood cells (RBCs) and blood vessels
As in this study, extravasation of RBCs has been observed during 
physiological ripening by Fosang (1984). This could be due to elastase 
activity, inducing vascular damage and causing haemorrhage, this has been 
observed in the lung (Fletcher et al., 1995). These authors prevented the 
haemorrhage by inhibiting the activity of leukocyte elastase. The role of 
RBCs in cervical ripening, if any, has not been discussed. Red blood cells 
within blood vessels participate in the margination of leukocytes, which is the 
start of extravascular migration (reviewed by De Jongh et al., 1996). Recent 
work however, showed that PGE2 can have an effect on RBCs enzymes, 
suggesting that PGE2 could promote oxygenation of the tissue (Neves et al., 
1996). Certainly, binding sites for PGE2 have been reported in the RBCs of 
many tissues (corpus luteum, uterus and peripheral blood) and vertebrate 
species (bovine, frog and human: Robertson, 1986; Chegini et al., 1986; 
Rao, 1990).
Vasodilatation was observed here following PGE2 treatment. For 
many years this was though to be the only proinflammatory effect of PGE2 
(Liggins, 1981). PGE2 could cause vasodilatation by several mechanisms: 1 ) 
relaxing the smooth muscle of blood vessels, 2 ) acting on endothelial cells or 
3) acting on PMLs, which in turn cause exudation (Armstrong et al., 1995).
Epithelial changes as part of the inflammatory response
An increase in the production of mucus, desquamation and keratinization of 
cells in the epithelium occurred following PGE2 treatments. These changes 
may be also part of the inflammatory response. In other non-reproductive 
mucosae, the epithelium also participates in the inflammatory response. One 
example of this is the denudation of the bronchial epithelium in asthma and 
may be due to cationic proteins of the eosinophils and/or nitric oxide 
(Butterfield and Leiferman, 1993; Galli and Costa, 1995). There are different
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inflammatory mediators, produced by the white cells mentioned earlier that 
can increase the secretion of mucus: cationic proteins from the eosinophil, 
the serine proteinases chymase, leukocyte elastase and cathepsin G 
(Venge, 1993; Caughey, 1994).
Summary
The findings were consistent with the induction by PGE2 of an acute 
inflammatory response, characterised by 1 ) edema, 2 ) leukocyte migration of 
the acute type (mainly PMLs and eosinophils without lymphocytes and 
macrophages) and 3) short duration and the reversibility of the inflammatory 
response after a week. Resident cells of the connective tissue, such as mast 
cells and fibroblasts also participated, evidence of cell activation was 
observed: 1) PML degranulation and aggregation, 2) eosinophil 
degranulation, 3) platelet aggregation and 4) mast cell degranulation. 
Inflammatory reactions in the mucosal surfaces characterised by 
hypersecretion of mucus and desquamation or denudation of the epithelium 
were also observed here.
During physiological ripening collagenase, gelatinase and leukocyte 
elastase activities appear to be crucial for the softening of the cervical tissue 
by breaking down collagen fibres and other components of the extracellular 
matrix. There is now good evidence that these activities can be attributed to 
the degranulation of the PML, with the release of MMP-8 , MMP-9 and 
leukocyte elastase (Kanayama and Terao, 1991; Osmers et al., 1995). The 
PML is the only known source of MMP- 8  (Woessner, 1994) and the main 
source of leukocyte elastase (Doherty and Hanusz, 1994). PMLs must be 
activated to release these enzymes and there is evidence of activation during 
labour (Okamura et al., 1988; Kanayama and Terao, 1991; Osmers et al., 
1992; Owiny et al., 1995) and also that PMLs activators like interleukin- 8  (IL- 
8 ) and the bacterial substrate (N-formyl-methionyl-leucyl-phenilalanine
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FMLP) (Baggiolini et al., 1992; Baggiolini et al., 1993) can induce ripening (El 
Maradny et al., 1994 and 1995).
In PGE2-induced cervical ripening, the same enzymatic activities as in 
physiological ripening have been found, i.e. collagenase, gelatinase and 
elastase (Osmers et al., 1991b; Rath et al., 1993; El Maradny et al., 1996). 
The cell origin is not yet clear but the rapid release of collagenase and 
elastase strongly supports the role of enzymes stored in PMLs (Osmers et 
al., 1991b; Rath et al., 1993). Elastase has been localised in PMLs and not in 
other leukocyte following treatment with Gemeprost (Geer et al., 1992). The 
release of collagenase is transitory, activity cannot be found 24 hours after 
treatment (Osmers et al., 1991b; El Maradny et al., 1996), this may also 
exclude a role of an induced MMP-1 by fibroblasts and macrophages. In 
contrast, the release of MMP-1 is maximal following a 24 hour incubation in 
those cells (Corcoran et al., 1992; Rajabi et al., 1990). In conclusion it is an 
attractive hypothesis that PGE2 could induce cervical ripening by activating 
PMLs. Activation responses should include chemotaxis, degranulation and 
release of oxygen intermediates, to explain the presence of these cells in the 
cervix, the release of MMP-8 , MMP-9 and leukocyte elastase and the 
activation of these proteinases respectively (Doherty and Hanusz, 1994). 
Chemotaxis and degranulation were observed here, other responses and the 
release of enzymes need further investigation.
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CHAPTER 4
STUDIES OF THE OVINE PROSTAGLANDIN E2 (PGE2) 
RECEPTOR (EP3R) cDNA.
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4. 1 INTRODUCTION AND AIMS
The purpose of this thesis is to gain some understanding of the sensitivity of 
the ovine cervix to the ripening effect of PGE2 during the luteal phase, 
which could allow the development of pharmacological regimes for 
transcervical Al and ET. This chapter deals with a possible approach to this 
problem, which is the study of the presence of PGE2 receptors in the ovine 
cervix at different reproductive stages. The sensitivity of the cervix during 
the cycle appears to be lower than during the prepartum stage in sheep 
and women (Owiny and Fitzpatrick, 1990; Mylne et al., 1992; Uldbjerg and 
Ulmsten, 1990; see also chapter III). These differences may be due to the 
endocrine and paracrine environment in which PG have to act. During the 
luteal phase and due to the negative influence that progesterone has in 
cervical ripening, the lowest sensitivity may be expected.
The effects of PGE2 in different tissues, including the reproductive 
tract and the immune response, are very complex and often contradictory. 
Recent studies have shown the existence of at least four receptor subtypes 
(EP1-EP4 ) and several isoforms for the EP3 subtype. It is anticipated that the 
diversity of receptors found, will explain the actions of PGE2 in different 
tissues and cells and will make possible the development of more specific 
drugs to control these actions (Narumiya et al., 1993). This may be also true 
for the understanding of the PGE2 role in cervical ripening and the 
development of new PGE2 analogues for this purpose.
Prostanoids are formed locally and act on specific G protein linked 
receptors in a paracrine manner in several tissues (Coleman et al., 1994). 
Similarly, previous studies support the existence of PGE2 receptors in the 
cervix, since they have demonstrated local synthesis of PGE2 by the cervix, 
a pharmacological action of local PGE2 preparations, the existence of PGE2
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binding sites and second messenger responses in vitro to the 
administration of PGE2 (Eilwood et al., 1981; Nostrom et al., 1983; 
Adelantado et al., 1988; Rao, 1990; Uldbjerg and Ulmsten, 1990). But it is 
unknown which receptor subtype(s) may be present in the cervix or which 
cell(s) bear the receptors. At the beginning of these studies, antibodies 
were unavailable for any of the four prostaglandin E2 receptor subtypes 
(EP1-EP4 ) and the only sequence available was from cDNA cloned for two 
subtypes in a few mammalian species, the EP3 receptor and the EP2 
receptor that later resulted to be in fact the EP4 receptor (see chapter I). In 
the absence of ovine reagents for the detection or quantification of these 
receptors, the study of the EP3R cDNA was chosen as a first step in the 
study of the PGE2 receptors (EPRs) in the cervix. Pharmacological 
approaches are less sensitive or specific, since complete agonist and 
antagonists do not exist for the four EP receptors. Another limitation of that 
approach is that the isoforms of the EP3R cannot be differentiated either 
(Coleman et al., 1990; Coleman et al., 1994).
The 4 receptor subtypes (EP1-EP4 ) and the EP3 R isoforms are 
functionally different, and the investigation of their involvement in cervical 
ripening is probably interesting in all the cases, but it is a too big task for a 
PhD chapter. In this thesis the EP3R was chosen because its cDNA was 
better known than the other three subtypes and its function appeared to be 
compatible with current theories about the physiological cervical ripening. 
Some commercial PGE2 analogues frequently used for cervical ripening 
(Bygdeman, 1992) are potent EP3 agonists in other tissues (Coleman et al., 
1990; Qian et al., 1994). It is also interesting that the EP3R may be 
implicated in the activation of PMLs. Namely on chemotaxis and release of 
LTB4, which is in itself a potent activator of other PMLs and immune cells 
(Armstrong, 1992; Wheeldon and Vardey, 1993). An attractive hypothesis
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therefore, is that the EP3R may mediate the cervical ripening effect of PGE2 
and its analogues by priming the PML. Local administration of PGE2 during 
pregnancy induces a rapid increase in the activity of collagenase and 
elastase, which is probably due to the degranulation of PMLs (Rath et al., 
1993). In physiological ripening there was also evidence of PML activation, 
with release of collagenase, elastase and oxygen mediators (Junqueira, et 
al., 1980; Parry and Ellwood, 1981; Kanayama and Terao, 1991; Osmers et 
al., 1992). The degranulation of PMLs following PGE2 administration 
(observed in the previous chapter), is also compatible with this hypothesis.
In contrast, the literature in other disciplines is dominated by 
literature on the negative effects of PGE2 on all the aspects of PML priming. 
This action may be mediated by an increase in cAMP, since the direct 
activation of cAMP by other agents has an inhibitory effect on PML priming 
(Reibman et al., 1990; Harvath et al., 1991; Gryglewsky and Salvemini,
1992). The PGE2 receptors coupled positively with cAMP are the EP2 and 
EP4, which may be inhibitor receptors for PML functions, and from this point 
of view, these receptors may not be of interest in the study of cervical 
ripening. Recent evidence has shown that PGE2 is not only coupled 
positively with cAMP, but also with increases of calcium in the cell, through 
the EP3 receptor (Coleman et al., 1994) and the increase of intracellular 
calcium by other agents can actually prime the PML (Baggiolini et al.,
1993). At the beginning of these studies, the second messenger of the EP<\ 
subtype, the sequence and its possible participation in PML functions were 
completely unknown, which also contributed to the choice in this thesis to 
study the EP3 R.
Alternative splicing occurs at the 3' end of the EP3R cDNA of several 
mammals studied. Therefore, the initial aim of this work was to isolate and 
sequence EP3R 3'end cDNAs, using an RT-PCR (RACE) method and
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bovine primers, designed from conserved areas. The objectives being to 
obtain sequence information and to perform mRNA expression studies of 
the isoforms of the EP3 receptor. A semiquantitative assay would then allow 
study of mRNA expression of the different receptor isoforms in cervical 
tissue collected at different stages (oestrus, early luteal and peripartum).
As the work progressed, the objectives were redefined. A method 
technically more simple, using two bovine primers in a normal RT-PCR, 
would be used to:
1) Isolate and sequence a fragment of cDNA encoding for the ovine EP3 R
2) Study the mRNA expression pattern by northern analysis or the more 
sensitive method, RT-PCR and to identify a rich source for the cloning of this 
receptor using RACE
3) Study the presence and the quantity of mRNA expression in cervical 
tissue collected at different reproductive stages (oestrus, early luteal and 
peripartum), using quantitative northern analysis, RT-PCR or Southern 
analysis, depending on the sensitivity required.
4.2 EXPERIMENTAL PROTOCOLS
4.2.1 RACE using mRNA from mouse testis
Initially cDNAs expressed in the mouse testis were used. This involved 
steroidogenic enzymes like cholesterol side chain cleavage (CSCC) and 
cytochrome P450 17a-hydroxylase, the androgen binding protein (ABP) 
and p-actin. The primers had been designed and used for semiquantitative 
studies in this laboratory by others (O'Shaughnessy and Murphy, 1993), 
and therefore they could be used as a well known model to test the 
limitations of the 3'end RACE technique, which, like in other RT-PCR 
experiments, are mainly the size of the expected product and the
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abundance of the target sequence. The mouse testis model offered several 
advantages over the study of the ovine EP3R cDNA, because the following 
parameters were known from previous studies: that the primers worked, that 
the PCR products were actually expressed in those organs, the expected 
sizes of the products and also the relative abundance of these products in 
those organs (O'Shaughnessy and Murphy, 1993)
The amplification of those cDNAs in the mouse gonads were also 
used to set up the optimal conditions and to control for the well functioning 
of the technique at later stages. The efficiency of the RT of the RACE 
method was compared with other RT methods (random hexamers and 
oligodT), by amplifying with PCR, carried out with two gene-specific 
primers. The limitations of the PCR of the RACE method was then studied 
by amplifying cDNAs of different abundances in the testis and fragments of 
different lengths.
4.2.2 RACE using mRNA from ovine tissues
The kidney and the uterus were selected as potential rich sources of the 
EP3R message, based on mRNA studies in other mammalian species. The 
studies of the ovine EP3R were initiated in the kidney because it was 
reported as the richest source in the mouse (Sugimoto et al., 1992). Unlike 
in those studies, the whole kidney could not be used for RNA extraction in 
sheep. Studies were initiated, using the renal cortex and later continued in 
the external medulla. This was based on new information showing 
sublocalisation of the EP3R mRNA and EP receptors mainly in the external 
medulla (Takeuchi et al., 1993; Breyer et al., 1993; Sugimoto et al., 1994).
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RNA was extracted from those tissues and the conditions of RACE, 
established in the mouse experiments, were used as a starting point to 
amplify with a bovine gene-specific primer. Further work was done to 
optimise the conditions in the ovine samples. Several parts of the kidney, 
two gene-specific primers and two sets of RACE primers (hybrid and 
adapter) were tested. Following the demonstration of EP3R mRNA 
expression in several ovine tissues by RT-PCR, RACE was also performed 
in those tissues, using the 5' end primer as the gene specific primer.
4.2.3 RT-PCR
PCR, using bovine primers from areas conserved in other species, was 
used to isolate a cDNA fragment of the ovine EP3 R. This cDNA fragment 
was sequenced by cycle sequencing to confirm its identity as the ovine 
homologue of the EP3 R cDNA. The cDNA once isolated, allowed the 
production of probes for mRNA expression studies. Because low levels of 
expression were suspected, RT-PCR and Southern analysis were used to 
study the mRNA distribution in ovine tissues. The fragment to be amplified 
was intronless and therefore RNA incubations with DNase I were required 
before the RT-PCR to show mRNA expression.
Attempts were made to develop a semiquantitative RT-PCR assay, 
mRNA levels could be compared between the cervix and other tissues in 
which the EP3R has a known function. Comparisons could also be made 
between cervices in several hormonal contexts: oestrus, early luteal phase, 
and peri parturient stage. Work was carried out towards the development of 
this assay, finding a suitable housekeeping gene and optimising the 
reactions.
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4.3 RESULTS
4.3.1 Attempts to isolate and sequence the 3* end of ovine EPq 
receptor mRNA isoforms bv RACE
Mouse studies
In the mouse testis model, the reverse transcription primer of RACE worked 
well, as indicated by the amplification in a normal PCR of fragments internal 
to the cDNA of the genes: f3-actin, cholesterol side-chain cleavage (CSCC), 
cytochrome P-450 17a-hydroxylase and androgen binding protein (ABP). 
However results were better using a conventional method for the reverse 
transcription, such as random hexamers, rather than the RACE primer. 
Different conditions for the RT (mainly concentrations of primer, DTT and 
dNTP) were tested in this system and the optimum conditions were those 
described in Materials and Methods.
Using the RACE primer with a gene specific primer in the PCR, clear 
bands of the expected size were only amplified in the case of cytochrome 
P-450 17a-hydroxylase (1200 bp). Shorter products (1400 bp) than 
expected (1600 bp) were obtained with the p-actin primer, and a faint band 
of the expected size (650 bp) was obtained with ABP primers.
The conclusion was that the RACE method could work, but there will 
be limitations when attempting to amplify target sequences of low copy 
numbers, like ABP in the testis, and/or target sequences longer than 1200 
bp. The next step was to choose an ovine tissue where mRNA encoding for 
the EP3R was expected to be abundantly expressed. The size of the 
product did not appear to be a problem because the expected size(s) of the 
product(s) were between 947-1037 and therefore, under the limit (1200 bp),
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at least for abundant sequences.
Ovine studies
i) Accidental amplification of a mitochondrial sequence, when attempting to 
isolate the 3 cDNA ends of the ovine EP3R.
At high temperatures (55-60°C), a 585 bp band was often amplified from 
total RNA extracted from both the cortex and the external medulla of kidney. 
The product was shorter (585 bp) than the estimated expected size (872- 
1037 bp), and therefore controls omitting the adapter primer (P2) in the 
reaction, i.e. using the gene specific primer on its own (P3), were done and 
showed mispriming. However, because of the alternative splicing the 
expected sizes could be variable, and sequencing of the product from the 
renal medulla was done.
The comparison of this sequence with others stored in the Data 
Bank (Genbank/ EMBL), using the FASTA program of the GCG package, 
revealed very high homology (8 6 .6 %, Fig. 4.1) with the bovine 
mitochondrial cytochrome oxidase, subunit II (COM) (accession number 
M10544). This is the terminal enzyme of the electron transport chain of the 
inner membrane of mitochondria. It is involved in the generation of energy 
in the cell and therefore is very abundant in active cells (Anderson et al., 
1982; Alberts et al., 1994b). Because the increase in the annealing 
temperature (up to 65°C), did not stop the mispriming to COXII cDNA, it was 
concluded that the PCR could not be optimised to obtain the EP3 and a new 
gene specific primer was needed.
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Figure 4.1
Sequence comparison of a fragment of the ovine (Scottish 
Greyface) mitochondrial cytochrome oxidase isolated here (in 
low case) with the corresponding bovine sequence (in upper 
case).The fragment isolated corresponds to positions 7560- 
7710 of the bovine mitochondrial genome (Anderson et al., 
1982; accession numbers: J01394 and V00654).
1 acaatcttaaccattctaccagccattatcttaattatggattgctcttc 50
l l l l l l l  M I N I M  I I  M i l l  M I N I M I  I 1111111111
756 0 ACAATCTGAACCATTCTGCCCGCCATCATCTTAATTCT.AATTGCTCTTC 7608 
51 catccttgcgaatcctatacataatggatgaaatcaacaaccc.tctctc 99
I I I  I I  M i l l  1 1 1 1 1 1 1 1 1 I I  I I I 1 1 I I I I I I  M i l l  M i l l
7609 CTTCTTTACGAATTCTATACATAATAGATGAAATCAATAACCCATCTCTT 7658 
100 acagtgaagacc.tggggcatcaatgatactgaagctatgaatatacaga 148
M i l l  I I  I I I  I I I  M i l l  I I I 1 1 I I 1 1 1 1 1 1 1 1 1 1  11111111
7659 ACAGTAAAAACCATAGGACATCAGTGATACTGAAGCTATGAGTATACAGA 77 0 8
149 at 150
I
7709 TT 7710
ih RACE products of the expected size
Using the RACE primers P3 and P2 and an annealing temperature of 55°C, 
a long band (between 955 and 734 bp) within the range of the expected 
size was observed on a single occasion. Work was not pursued with these 
primers because, as mentioned earlier (section 4.3.1 i), higher temperatures 
favoured the amplification of the mitochondrial sequence rather than the 
EP3 R cDNA. Similarly, using a new gene specific primer (P4), an annealing 
temperature of 60°C for a long time (one minute) and an extension time of 
1 'SO" in the PCR reaction, 3 faint bands of the expected size (700, 800 and 
1 0 0  bp) were observed on a single occasion, within a smear going from 
1200 to 200 bp. In other occasions, only the smear was visible. Using 1' 
extension time a smear and two shorter faint bands were observed of 700 
bp and 400 bp. Controls for mispriming, using the gene specific primer on 
its own, did not produce any band or smear.
iii) RACE with a second set of RACE primers (P6  and 7)
The 1st set of RACE primers (P1 and 2), for the RT and the adapter primer 
of the PCR, were not identical to the original protocol (Frohman et al., 1988; 
Frohman, 1990) and we were unsure of their efficiency. Most authors were 
using the original sequences (P6  and 7), therefore they were tested but 
were also unsuccessful. No product was obtained using agarose gels or 
Southern blots (see next section) as detection methods. The total RNA used 
in these studies was extracted from the external medulla of the kidney, 
uterus, liver and adrenal gland.
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4.3.2 Isolation of a cDNA fragment bv RT-PCR
It was reasoned that the isolation and sequencing of a short fragment of the 
ovine EP3 receptor by RT-PCR, would allow the design of ovine gene 
specific primers to improve the RACE method, as suggested by Walker and 
colleagues (1992). Knowing a stretch of the target sequence in the middle 
could theoretically allow the sequence of the full length cDNA to be 
obtained by using the RACE method in both directions, 3'end and 5'end 
(Walker et al., 1992; Olkkonen et al., 1994). It could be also useful to make 
probes for northern analysis to identify tissues expressing high levels of the 
receptor. Probes for Southern blotting could be used to screen the RACE 
products (specially in the case of no product or smears) for higher 
sensitivity and to identify the correct products before sequencing. Because 
of the alternative splicing, the RACE RT was expected to yield products of 
variable sizes, which may not be detectable as a band by normal gel 
electrophoresis, but as a "smear” (Taniguchi et al., 1993).
A bright band of the expected size (355 bp) was obtained from the 
external medulla of the ovine kidney using primers 4 and 5 at 55°C. The 
DNA from the PCR band (Plate 4.1) was isolated, re-amplified and 
sequenced, which allowed us to obtain a sequence of 267 nucleotides. 
This sequence was 98% homologous with the bovine EP3 receptor cDNA 
(4 nucleotides different) and > 76% homologous with cDNAs of the rest of 
mammalian species published (Table 4.1 and Fig. 4.2). The deduced 
amino acid sequence only differed in 1 amino acid (1/89) with the bovine 
sequence (Fig. 4.3).
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Plate 4.1
Ethidium bromide-stained agarose gel of RT-PCR product 
showing the isolation of a cDNA fragment of the ovine EP3 
using bovine primers (lane!;1). Lane 3: molecular weight 
markers and lane 2 is a blank.
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Table 4.1
Similarities between the ovine EP3R cDNA sequence 
and other species published.
species nucleotide 
level (%)
aminoacid 
level (%)
bovine 98.5 98.9
human 87.6 87.6
rabbit 83.9 85.4
mouse 76.8 77.5
rat 76.4 79.8
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ovine GGC GTA TGG CTG GCG GTG CTC GCC TTC GCC
bovine . . . . . . . • •
human ..G ..C • • •
rat ..G T .T ..G
mouse ..G T .T ..G
rabbit ..G ..A . . .
ovine CTG TTG CCG GTG CTG GGC GTA GGT CAG TAT
bovine • ■ . . . . . . • • • • • • • • . . . . . .
human • • C .. . . . • • • ..G ..C . , . ..C
rat ..C . . . . .T . . . ..G ..C .GC ..C
mouse c . . • • • . . c .GC ..c
rabbit . . . C.A ..T . .T ..G . . c . . . ..c
ovine ACT ATC CAG TGG CCC GGG ACT TGG TGC TTC
bovine . . . • . • • • • • . • • • •
human ..C G .. • • • • • • ..G
rat .GC G.G • • • ..C ..G
mouse .GC G.G ..G ..C ..G
rabbit . .C . . . . . . . . . ..G
ovine ATT AGC ACT GGG CCT GGG GGC AAC GGG ACT
bovine . . . ..C ... ... ... , , . ... ...
human ..C ..C • • • .GA « • • » • • . . . . . .
rat . . c ..C • • • ..G .C. • • . .A. ..G
mouse . . c ..C . , . ..G .C. ... .A. . .A
rabbit . . c ..C ..A .GA . . . .A. . . . . .G
ovine AAC TCC CGG CAA AAT TGG GGC AAC GTT TTC
bovine • • • • • . . • . . . . .C . . . . .. , . . . ..
human .G. ..T TC. ..T ..C • • • , . . C .. . . .
rat G .. . .T GC. .GG ..G CC. .G. ..G GC.
mouse G .. . .T GC. .GC G .G CC. .G. ..G GC.
rabbit .G. . .T TCA ..C ..C . . . . . . C .. . . .
ovine TTC GCT TCT GAC TTT GCC ATC CTG GGG CTC
bovine •  • • . • • • • .C. • • • . • • ... ...
human • • ..C • • . .C. . • • T . . ... ... ...
rat ..T ..c ..C .C. ..C TGT ..A ..C T.G
mouse ..T ..c ..c .C. ..C TG. T . . . .C T.G
rabbit . . . ..c ..c AC. . . . T .. . . . . . c
ovine TCG GCG CTG GTG GTC ACC TTC GCC TGC AAC
bovine • • • • . ... ... ... ...
human .T. • • . ACA . . . ..T T . .
rat CT. ..T • • • . , . ..T ...
mouse CT. ..T ... ..G ..T ...
rabbit .T. . . . .cc A .. . . . . . .
ovine CTG GCC ACC ATT AAG GCC CTG GTG TCC CGC
bovine •  • . .. ... ... ... ...
human •  • . .. . , . ... ... ... ...
rat T .. ..G ..C ..A ... ..A . ..
mouse •  ■ ..G ..c ..A ... ...
rabbit . . . . . . . . . . . . . .T . . .
ovine TGC AGG GCC AAG GCG ACG GCG TCG CAG
bovine • •  . . , . . .C ... ... ...
human C .. • . • . , . . .C ... . .A ..T ...
rat ..C ..A ..C G. C ..C ... ...
mouse
rabbit
. .T C ..
C .. . .A
..A ..C G.C 
G. A
..C
..A ..A
. . .
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Figure 4.2i
Alignment of nucleotides, comparing the partial codings of the 
isolated ovine EP3R cDNA with other species. Dots indicate 
identical nucleotides. The position of the partial sequences 
shown correspond to nucleotides 537-801 of the bovine 
sequence (Namba et al., 1993).
Ovine sequence has Genbank Accession number U37148.
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Figure 4.3
Alignment of deducted aminoacids, comparing the ovine EP3R 
with other species. Dots indicate identical aminoacids. The 
position of the partial sequences shown correspond to 
aminoacids 179-267 of the bovine sequence (Namba et al.,
1993).
ovine G V W L A V L A F A
bovine
human . .
rat • S •
mouse S .
rabbit. • • •
ovine L L P V L G V G Q Y
bovine . .
human .
rat . R
mouse R
rabbit • •
ovine T 1 Q W P G T W C F
bovine m
human V
rat S V
mouse S V
rabbit • 1
ovine 1 s T G P G G N G T
bovine
human R . . .
rat A . E
mouse A E
rabbit R • D •
ovine N s R Q N W G N V F
bovine . . .
human S S H L
rat D m A R E P S V A
mouse D p A R E P s V A
rabbit S • S H • • • L •
ovine F A S D F A 1 L G L
bovine A .
human A F
rat A C
mouse A C
rabbit T F
ovine S A L V V T F A C N
bovine m
human L T S
rat L . . .
mouse L
rabbit L A 1 •
ovine L A T 1 K A L V S R
bovine
human
rat
mouse
rabbit
ovine C R A K A T A s Q
bovine # m
human m
rat
mouse
• ■ • • • A
A V
rabbit A
212
4.3.3 Studies of the mRNA expression of the ovine EP-. receptor 
bv RT-PCR and Southern blotting.
Initially, northern analysis was carried out, using a probe prepared from the 
PCR product (primers 4 and 5) to study mRNA expression in several tissues 
(cervix, uterus and different segments of the kidney), but no signal was 
observed in any of the membranes or the tissues tested. Expression has 
been found using northern analysis in the uterus and the kidney of other 
species by others and therefore it was thought unlikely that the sheep did 
not express the receptor. Low levels were suspected that may be 
undetectable by northern analysis. It was decided that RT-PCR, being 
1000-10,000 times more sensitive than northern blotting (O’Shaughnessy, 
personal communication; Liu et al., 1996), may be more suitable to detect 
expression of this receptor in ovine tissues.
4.3.3i DNase I incubations to eliminate genomic DNA 
contamination
Initial studies looking at EP3 R expression by RT-PCT appeared to show 
expression in all tissues tested. Controls missing the RTase from the RT 
and treatments with DNAse I confirmed the suspicion that DNA 
contamination of an intronless fragment was creating a problem of false 
positives. But, following DNase incubations, results for EP3 R mRNA 
expression turned negative in all tissues tested.
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A series of studies followed, aiming at the investigation of whether or 
not the negative results were artefacts due to RNA degradation during the 
DNase incubations (chapter II). It was found that some RT buffers had 
RNase activity which degraded RNA during the DNase incubation (Plate 
4.2A). In subsequent studies, the use of RNAse-free Tris (Sigma), Mg 
filtered in a 0.2 mm Millipore and the control of the pH (6 .8-7.2) were 
enough to prevent RNA degradation (Plate 4.2B).
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Plate 4.2
A) Degradation of RNA during the first DNase I incubations 
due to RNase activity in common RT buffers.
RNA samples run in an ordinary 1% agarose gel. In lanes 1 to 
4 RNAs are completely degraded (the ribosomal bands 18S 
and 28 S cannot be seen) after incubation with several buffers. 
In lanes 5 to 7, RNAs are intact when mixed with the buffers but 
omitting the incubations. Lanes 8  to 10 are RNAs without 
buffers or incubations and they are clearly intact.
B) Undegraded RNAs following DNase I incubations under 
optimal conditions.
Lanes 1 to 7: RNA samples run in agarose gel, they are intact 
(shown by clear ribosomal bands; arrows) following DNase 
incubations under optimal conditions 
Lane 8 : DNA molecular weight marker for size comparison.
A)
-  28 S 
18 S
1 2 3 4 5 6 7 8 9  10
1 2 3 4 5 6 7 8
Despite the optimization of the DNAse incubations, which did not 
degrade RNA, mRNA expression could not be demonstrated in any of the 
tissues tested, as illustrated in the next plate (Plate 4.3). To exclude the 
possibility that ethidium bromide was not sensitive enough to detect the EP3  
signal Southern blots were carried out, with the same results. Another 
possibility was that the ovine tissues investigated here (kidney, uterus and 
cervix uteri) did not express mRNA encoding for the EP3 R, unlike other 
species. Other ovine tissues were investigated as alternative sources, 
bovine adrenal medulla, ovine adrenal medulla, ovine ovary and ovine skin 
with subcutaneous tissue, but results remained negative.
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Plate 4.3
False negative results
A) Ethidium bromide-stained agarose gel of RT-PCR products 
showing lack of mRNA expression of the ovine EP3 receptor 
cDNA. Amplification of template following an incubation with or 
without DNase and reverse transcriptase (RT+/-). The 
molecular weight marker was 100 bp ladder (Gibco). The 
presence of a band in the RT-/DNase- indicates contamination 
by genomic DNA. The absence of a band in the DNase+/RT+ 
represents negative result for the expression of mRNA, which 
were initially obtained.
B) Amplification of ovine B-actin used as a positive control to 
demonstrate the integrity of the RNA and that the RT reaction 
apparently worked.
600 bp
EP3R (355 bp)
1 0 0  bp
DNAse
RT
1500 bp
600 bp
actin (162 bp)
DNase
RT
The successful amplification of actin cDNA following the digestion 
with DNase I showed that RNA was not degraded and nor was the RT 
affected by the DNase incubations. The amplification of the EP3R cDNA 
from genomic DNA (i.e. without DNase incubations) showed that primers 
and the PCR conditions were working.
4.3.3ii Demonstration of mRNA expression of the ovine EP3R in 
the cervix and other tissues
If there was a technical problem causing false negatives, it was "pre-PCR", 
either RNA degradation or failure of the RT, since the PCR primers appear 
to work, being able to amplify genomic DNA. The problem only affected 
some target sequences (ovine EP3 R cDNA) whereas it did not affect the 
amplification of other abundant sequences, mainly steroidogenic enzymes 
by other people in the laboratory or the ovine (3-actin by the author.
It was discovered that by mistake a batch of low concentration of 
dNTPs had been used in the laboratory for several months. It was thought 
that this could have affected the reverse transcription of fragments longer 
than ovine B-actin or sequences of low copy numbers. A number of tissues 
were tested with the corresponding RT minus and RNase free DNase I 
minus controls, correcting the dNTP concentration and positives were found 
for mRNA expression in the following ovine tissues: kidney external 
medulla, liver, uterine body, oestrous cervix, luteal cervix and skin (Plates 
4.4 and 4.5). Therefore all the tissues tested were positive, with the 
exception of prepartum cervix (within 1-2 days of labour). But using 
Southern blotting to increase sensitivity, cDNA was shown to be present in 
these samples too (Plate 4.5). The RT-minus controls were negatives, 
demonstrating that DNase I still worked well and the product in the 
DNAse+/RT+ reaction was in fact mRNA and not genomic DNA.
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Plate 4.4
Ethidium bromide-stained agarose gel of RT-PCR products 
showing expression of the ovine EP3 receptor mRNA in the 
liver (lane 1). Using this method, expression was also found in 
the kidney, uterus, adrenal gland and skin. False negative 
results in the previous plate were due to suboptimal conditions 
in the RT reaction.
Expression of the ovine EP3 receptor
EP3 (355bp)
DNase + +
Reverse Transcription + - +
1 2  3 4
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Plate 4.5
Ovine EP3 receptor cDNA amplified from cervix during the 
oestrus cycle. The molecular weight marker (mw).
A) amplification of EP3R cDNA from cervix at oestrus (lane 1) 
and dioestrus (lane 5). The absence of genomic DNA 
contamination is shown in lanes 2 and 6 . Lanes 3, 4, 7 and 8 , 
show the presence of genomic DNA when DNase I is omitted. 
Lane 9 is a blank.
B) Southern blot analysis of RT-PCR products showing 
expression of the EP3 receptor in the ovine cervix at peripartum 
(lane 1) and oestrus (lane 2). Lane 3 is a blank.
DNAse
RT
B)
4.3.3iii Attempts to quantify mRNA expression by RT-PCR
Work was done to reduce the sources of variation which might affect the RT- 
PCR technique. The absence of RNA degradation was confirmed by 
visualisation of the ribosomal bands in agarose gels and controlled for by 
simultanous amplification of a suitable housekeeping gene. The latter also 
controlled for the variability in performance of the RT. The PCR was also 
optimised to reduce the strong primer dimer observed with the initial 
conditions and to improve the consistency of the signal (see materials and 
methods for more details).
When reducing the cycle numbers in the PCR of the EP3R (P4 and 
5), the bands were not clearly visible in agarose gels or after 
autoradiography, which made cutting the bands for scintillation difficult. 
Probably because of low levels of the product and also because the RT- 
PCR was not completely optimized, yielding primer dimmer on some 
occasions. Because the usual procedures for optimization were already 
attempted in every step of the reaction: RNA extraction, RT and PCR (Innis 
and Gelfand, 1990; Kid and Ruano, 1995; Roux, 1995), this was not 
pursued any further. Despite these problem, the actin and EP3R cDNA 
bands were cut and counts were read, but those from the EP3R reaction did 
not show exponential increases and therefore quantification was not 
possible.
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4. 4 Discussion
4.4.1 Isolation of a cDNA fragment bv RT-PCR and confirmation 
Qf its identity
This study reports the successful isolation of a fragment of ovine cDNA 
encoding for the EP3R by RT-PCR, from RNA extracted from the external 
medulla of the kidney and using relatively long (25 bp) bovine primers. This 
fragment is part of the functional EP3R mRNA, which is supported by the 
following evidence: (1 ) the high degree of similarity between its sequence 
and that published for the bovine, and other mammalian species, (2 ) the 
detection of mRNA expression following DNase I incubations, (3) the similar 
pattern of mRNA expression found in sheep tissues when compared with 
other species. These points will be expanded in the next paragraphs.
Receptors and other genes usually exhibit high degree of 
conservation through evolution in vertebrates, and in most cases the 
aminoacid and nucleotide sequences are conserved across species 
(Watson and Girdleston, 1995; Sealfon, 1995; Anderson et al., 1996). We 
have observed here an homology ranging from 76.4 to 98.5% between the 
ovine EP3R cDNA and other species of mammals published, which is 
comparable to homologies found in ovine studies of other GPCRs and 
several cytokines (Stewart et al., 1993; O'Brien, 1994; Reppert et al., 1994). 
The very high homology observed between the bovine and ovine EP3R 
cDNAs (98.5%) is not surprising, due to the closeness of these species 
phylogenetically and the conservation of prostanoid receptors within 
mammals (Toh et al., 1995). Studies on evolutionary genetics, have shown 
that goat and sheep, diverged from the cow relatively recently, about 7-10 
million years ago. Other mammals (pigs, rodents, humans), whose 
sequences are often used to amplify ruminant sequences diverged 60-100
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million years ago (Irwin et al., 1991; Hiendleder et al., 1991).
Some authors however, have the opinion that the identity of a 
receptor cannot be based on high homology with other species only, due to 
the existence of pseudogenes (Sealfon, 1995). Pseudogenes can have 
very high homology (70-90%) with the corresponding gene. They are 
common in multigene families, and several ones have been found among 
GPCRS, including one of the prostaglandin E2 receptors in humans (the 
EP4 R pseudogene) (Ahuja et al., 1992; Sealfon, 1995; Foord et al., 1996). 
The cDNA fragment isolated here is unlikely to be a pseudogene because: 
1) mRNA expression was found, and although some pseudogenes are 
transcribed, most of them, including the EP4 R, are not expressed (Foord et 
al., 1996). 2) Furthermore, Southern blots have only been able to detect a 
single copy of the EP3R gene in other species, and therefore there are no 
reported pseudogenes of the EP3R gene so far (An et al., 1994).
To further support the identity of the isolated cDNA, it was important 
to confirm that this mRNA was expressed and that its localisation in tissues 
was similar to other species. In order to do this, DNase I incubations of the 
RNA were required because it was found in these studies, that the ovine 
gene encoding the EP3R between the second intracellular loop and the 
beginning of the VI TM domain is intronless, as reported in other species 
too (Regan et al., 1994a; An et al., 1994; Breyer et al., 1994; Tarng and 
Breyer, 1995). When intronless fragments are amplified, contaminating 
DNA is non-differentiable from cDNA which can create false positives, as 
seen here initially. Following DNAse incubations, mRNA distribution was 
shown in several ovine tissues (liver, kidney, uterus, adrenal medulla and 
skin). This pattern of mRNA expression is consistent with that from other 
species (man, rat, rabbit and mouse: Namba et al., 1993; Takeuchi et al., 
1993; Sugimoto et al., 1993; Adam et al., 1994; Breyer et al., 1994; Negishi
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et al., 1995), which further confirms the identity of the cDNA isolated as the 
ovine EP3R homologue. Although the ultimate confirmation involves more 
complex experiments of transfection of cells with the cloned cDNA to 
demonstrate the appropriate ligand binding and/or signal transduction 
coupling (Ushikubi et al., 1995; Sealfon, 1995).
Summarising, some publications claim to have isolated or cloned the 
homologue of certain cDNA in a new species, based on sequence 
homology only (Radford et al., 1991; O’Brien et al., 1994; Sealfon, 1995). 
Here, apart from this evidence, mRNA expression is also demonstrated to 
further support that the cDNA isolated is in fact part of the functional ovine 
EP3 R cDNA. This sort of evidence has also been used by others with 
another GPCR (Stewart et al., 1993). This work therefore has provided new 
reagents for the study of the EP3 R, "universal primers" and a cDNA 
sequence that may be used to clone a full ovine EP3R or to study the 
receptor in other species of veterinary interest. It would be interesting to see 
how "universal" the primers are, very high sequence homology and 
antibody cross reactivity may be expected between the ovine and caprine 
EP3 R and high homology within Ungulates in general and other mammals. 
An interesting challenge would be now the cloning of cDNA from non 
mammalian species (see more in General Discussion: chapter VI).
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4.4.2 The experience gained using RACE for the isolation of the
3’end of the ovine EP^R cPNAs
In this work, we were unable to isolate any ovine cDNA using RACE. 
Restrictive parameters for the success of this method, like with other PCR 
methods, are whether the sequence of the protein is known, the GC/AT ratio 
of the target sequence, the abundance of the mRNA message in the 
selected source and the size of the cloned cDNA. But obviously to amplify 
cDNA with a single gene specific primer is harder than using two primers, 
and mispriming is more likely to occur (Sambrook et al., 1989; Zullo et al., 
1993; Simonsen and Lodish, 1994; Frohman, 1994).
During these studies, RACE has not been used by others to amplify 
the 3'ends of the EP3R on any new species, but there are reports of the 
successful amplification of this and other prostanoid receptors, knowing 
part of the gene sequence (Tarng and Breyer, 1995; Ogawa et al., 1995; 
B&tshake et al., 1995). Similarly, there are several reports on the use of 
RACE to obtain species homologues or members of a gene family. RACE 
can work in those cases, but other parameters need to be favourable 
(reviewed by Frohman, 1994). These works by others suggest that the 
isolation or cloning of ovine EP3R cDNAs by RACE, may also be feasible 
although some knowledge of the sequence may be helpful. Not knowing 
the sequence and having to use a single primer may reduce the specificity 
and efficiency of the PCR considerably. In RACE, the gene-specific primer 
could not be located too far apart from the C-terminal, or the product may be 
too long to be amplified efficiently and not knowing the target sequence 
was a further limiting factor in the design of this primer to avoid mismatches 
(see Materials and Methods about the requirements at the 3 prime end).
The importance of the gene specific primer in relation to the 
abundance of the message is highlighted by the amplification of a
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mitochondrial sequence, due to mispriming. Cytochrome oxidase, subunit II 
(COX II), is encoded by the mitochodrial genome, which is intronless. The 
mRNA encoding for COX II is likely to be more abundantly expressed in 
cells than the EP3 R, because the former is part of the respiratory chain that 
generates energy in the cell (Alberts et al., 1994b). In addition, 
mitochondrial DNA (mtDNA) is 1000 times more abundant than nuclear 
DNA in somatic cells (Zullo et al., 1993; Hecht, 1990), which therefore 
constitute most of the DNA contaminant in RNA samples. The 
coamplification of mitochondrial DNA and mRNA can occur if there is 
homology with a single primer, because of much higher abundance in the 
cell when compared to any nuclear sequence (Zullo et al., 1993). 
Mispriming to mitochondrial sequences is a common artefact of nuclear 
DNA amplification and also of cDNA libraries construction (Zullo et al., 
1993; Wenger and Gassmann, 1995). Since the mitochondrial genome is 
not very large (about 16 kilobases) and it has been completely sequenced 
in many species now (Hecht et al., 1990; Broad and Hill, 1994); mispriming 
can be prevented by checking the primers against the gene bank for the 
absence of homology with mtDNA (Kidd and Ruano, 1995).
To increase sensitivity and specificity, the original RACE protocol has 
incorporated recently the use of nested primers, either for one primer (the 
gene specific primer) or both (Frohman, 1994). These approaches were not 
used here, but they may increase the chances to clone isoforms of the 
ovine EP3R by RACE. The use of nested homologous primers could have 
contributed to the success in the amplification of 3'end of other prostanoid 
receptors by others (Ogawa et al., 1995; B&tshake et al., 1995). The partial 
ovine cDNA sequence obtained here, whose accuracy can be confirmed, 
may be used to design one or two nested ovine gene-specific primer(s).
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To isolate cDNA encoding for the ovine EP3 R receptor, it was crucial 
to choose a rich source, logically the higher the concentration of this 
sequence in the starting cDNA, the easier the amplification and isolation. 
Recent estimates of the number of mRNA copies per cell of the EP 
receptors suggest that they fall within the category of "very rare messages", 
since there are only 1 0  or < 1  copies per cell (Sambroock et al., 1989; Tsai 
et al., 1996; Blaschke et al., 1996). Furthermore, when RNA is extracted 
from tissues, as in our case, these consist of several cell types that may or 
may not express the target gene (Sambrook et al., 1989; O'Shaughnessy, 
pers. comm.; Simonsen and Lodish, 1994). A fully optimised RT is important 
to obtain enough first strands of the target sequence for subsequent 
amplification, but this is even more critical when the message is rare. Here, 
after correcting the RT conditions, based on the normal RT-PCR studies, 
several products were obtained, but the work was not pursued any further 
with the identification of these products by sequencing or Southern blotting.
At the beginning of these studies high copy numbers per cell were 
expected in tissues selected as rich sources, because others reported high 
levels of expression by northern analysis which is 1 0 0 0 - 1 0 0 0 0  times less 
sensitive than PCR, which suggested that the message was amplifiable by 
PCR techniques. Later, RT-PCR was used aiming at the identification of 
alternative rich sources of EP3R mRNA and possible sublocalization within 
the kidney. But low levels were detected in all the tissues tested (kidney 
external medulla, kidney cortex, kidney internal medulla, uterus, adrenal 
gland, skin and liver).
A recent abstract suggests that the large luteal cells of a 10 day 
corpus luteum, which was not tested here, may be a good source to clone 
the ovine EP3R (Pierce et al., 1995b), but this information has not been fully 
published and quantitative results in the cow at a similar stage (day 8 ) show
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very low expression in corpus luteum  (Tsai et al., 1996). Until further 
clarification of the level of expression of these receptors is available, it 
appears that cell isolation and enrichment of the mRNA message may be 
necessary for cloning by PCR techniques. This sort of approach is common 
place when cloning local mediators like cytokines (Argyle, 1996). Recent 
studies are suggesting that the EP3R may be upregulated in immature 
animals and that upregulation may be inducible with indomethacine, a 
prostaglandin synthesis inhibitor (Hashimoto et al., 1991; Bonilla and Jiang, 
1996). Obviously the gene characterisation will give more clues as to how 
the expression can be upregulated, to enrich the source for cloning.
In conclusion even those tissues considered as rich sources 
here and by other authors (kidney, uterus, liver, adrenal medulla and 
corpus luteum) appear to express low levels of EP3R mRNA, although this 
needs further clarification. At the moment, it appears that these tissues may 
be suitable sources for cloning with RACE but the task is technically 
demanding. The use of kits may be justified to minimise problems of 
suboptimal reactions and the yield of the RACE may be increased by using 
cell isolation and enrichment of the mRNA message, short cDNA end size 
and homologous nested primers.
4.4.3 expression studies
i) Quantitation
In this work it was intended to quantify EP3R mRNA expression, to compare 
levels between positive controls and the cervix to investigate a possible 
role in this tissue. If expression could be found in the cervix, levels could be 
then compared between different reproductive stages (oestrus, early luteal 
phase and peripartum).
232
It is now known that quantitative mRNA studies for the prostanoid 
receptors are difficult to do by northern blotting and they are best done by 
RT-PCR (Blaschke et al., 1996). Here the RT-PCR assay was able to detect 
expression in those tissues but the low efficiency of the PCR, despite efforts 
of optimisation, did not allow quantification. For the isolation of a certain 
cDNA, primers should be specific, but for semiquantitative assays it is very 
important that they are efficient in the amplification as well. If the PCR works 
efficiently, during the exponential phase the amount of amplicons is almost 
doubling at each cycle, which allows calculations of the number of initial 
copies from measurements of the products (Dieffenbach et al., 1993; Ferre, 
1992).
When mismatched primers are used, spurious products are 
produced that may compete for the primers and other reagents and do not 
allow doubling of the desired amplicons on each cycle. The primers used 
here were relatively long (25 bp). Primers can be as long as 35 bp and their 
use is recommended in cross-species PCRs, because each nucleotide 
increases the specificity four times. But it is difficult to calculate the 
annealing temperature when using long or mismatches primers, which 
makes PCR optimisation more difficult (Dieffenbach et al., 1993; Roux et al.,
1995). In addition, although DNase incubations did not grossly degrade 
RNA, it probably contributed to variability in the amplifications.
In conclusion, assuming that the reactions are optimised, primer 
design is crucial for the success of PCR reactions. The balance should be 
kept between two goals: specificity and efficiency of the amplification 
(reviewed by Dieffenbach et al., 1993). Specificity is the main goal for the 
isolation of new cDNA sequences, this is to amplify the desired sequence 
and not others. But to establish a semiquantitative assay, the efficiency 
should be maximal to obtain exponential amplification. The primers used
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here were not very efficient and quantification was not possible. But it is 
anticipated that this may be possible using a new set of primers, preferably 
ovine, shorter (24 to 18) and located in different exons.
ii) EP3R mRNA expression in the ovine cervix
Our studies have shown EP3 R mRNA expression in the cervix for the first 
time, suggesting a new function in this tissue. Neither the presence of the 
mRNA nor the protein have been reported before in the cervix of any 
species. A number of studies suggest a paracrine role for PGE2 in the 
cervix, based on local synthesis, binding sites, second messenger studies 
and the clinical effect of PGE2 and analogues in the cervix (Ellwood et al., 
1981; Norstrom et al., 1983; Rao, 1990; Uldbjerg and Ulmsten, 1990; Owiny 
et al., 1990; Bygdeman, 1992). None of these studies show, however, 
which EP (EP1-EP4 ) receptor(s) are involved.
The RT-PCR studies reported here are not quantitative but the level 
of mRNA expression in the cervix appears to be very low, specially in the 
samples of late pregnancy where mRNA was only detectable by Southern 
blotting. It is important to consider the possibility of further sublocalisation 
within the cervix. Inflammatory responses are localised mainly in the 
endocervix (see chapter III), where higher levels of the EP3 R may be 
present. Similarly, PGE binding site studies have shown a low density in 
the whole cervix (Rao et al., 1990) which may be due to low receptor 
numbers in the fibromuscular wall.
The EP3R mRNA levels were low in the cervix, irrespective of the 
stage studied. Because no upregulation of mRNA was obvious in oestrous 
or in peri parturient sheep, it is tempting to speculate that oestrogen does 
not appear to upregulate the mRNA expression of this receptor. Logically 
proper quantification of the EP3R mRNA and its protein are required to
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clarify if the number of EP3 RS is highly regulated in the first place and if this 
involves mRNA regulation. The elucidation of the gene structure, 
particularly at the promoter region, can also give clues of the presence of 
regulatory elements for steroids, prostaglandins or other inflammatory 
mediators, as possible candidates. Little is known about the regulation of 
the genes of prostanoid receptors, but proinflammatory response motifs are 
also present in the TR and EP4R genes (Nursing et al., 1993; Foord et al.,
1996). This type of regulation would be consistent with the inflammatory 
theory of the onset of labour and cervical ripening. Other workers, as 
commented before in this discussion have found evidence of the regulation 
of the EP receptors, by the synthesis of PGE2 (Hashimoto et al., 1991; Zeng 
and Goetzl., 1995).
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CHAPTER 5
ULTRASOUND IMAGING OF THE OVINE CERVIX 
DURING THE OESTROUS CYCLE
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5.1 INTRODUCTION
5.1.1 Basic ultrasound principles
This section draws together information from the following sources: Ginther, 
1986; Taverne and Willemse, 1989; Paterson, 1990; Griffin and Ginther, 
1992; Boyd and Omran, 1991; Nyland et al., 1995.
Ultrasonic imaging utilises sound waves of higher frequencies (2-10 
MHz) than the upper range of the human hearing (20 KHz) to produce 
images of tissues and internal organs. The technology is based and follows 
the physics of the reflection that waves experience when they hit the 
boundary between two surfaces of different acoustic impedance, this 
phenomenon is known as "the echo principle". In practical terms, due to 
differences in composition and density, tissues vary in their ability to reflect 
ultrasound waves. Echoes from tissues are obtained, exploiting the 
properties of piezoelectric crystals, which permits the scanning with a 
transducer that is both the generator of sound waves and the detector of 
echoes returning from the tissues. Sound waves are generated in the 
transducer by the vibration of the piezoelectric crystals when they are 
exposed to a high-voltage electric current. Conversely, these crystals can 
also convert the returning sound waves from tissues into an electric current 
that can be measured and displayed as an image in the scanner screen.
Ultrasound scanners used in veterinary reproductive research are B- 
mode (brightness modality) real time scanners, they produce a two 
dimensional display of pixels that represents a real time anatomical image. 
Real time refers to the ability to display image movement as it occurs, which 
is often recorded using videotapes. The brightness of the pixels is 
proportional to the amplitude of the reflected echoes returning to the 
transducer. A grey scale (black to white) is also assigned to each pixel,
237
corresponding to the amplitude or strength of the returning echo. Very low 
intensity echoes are displayed as black (anechoic), mid range echoes as 
varying shades of grey (echogenic), and high-intensity echoes as white 
(hyperechogenic). Tissues are therefore defined by certain ultrasonic 
characteristics (echotexture or echogenicity), which reflect the histological 
characteristics of the tissue.
The ability to image structures lying closely as separate entities 
depends on the resolution of the ultrasound beam which has two 
components, axial and lateral. Axial resolution is the ability to identify closely 
lying structures along the propagated direction of the sound wave (the beam 
axis). This is determined by the length of the wave, which assuming a 
constant velocity in tissues, is inversely proportional to the frequency that the 
transducer generates. Normally, each ultrasound transducer emits sound 
waves of a fixed single frequency and the ultrasonographer therefore has to 
select higher frequencies to achieve short wave lengths and better 
resolution. Lateral resolution refers to the ability to resolve adjacent points 
perpendicular to the axis of the sound beam. This is dependent of the 
ultrasound beam width, the size of the transducer face and the distance 
between the tissue and the transducer. Modern transducers have the ability 
to focus to ensure good lateral resolution. Velocity of ultrasound waves is 
almost constant in soft tissues (1540 m/sec.) but is lower in gas (331 m/sec.) 
and higher in bone (4080 m/sec.), these differences produce various 
artefacts that will be discussed later.
Penetration is another important issue when selecting the transducer 
and the scanning technique to be used. Ultrasound waves progressively 
weaken, losing amplitude (attenuation) as they travel from the transducer 
through tissues, mainly due to absorption, reflection and scattering of the 
sound beam. Lower frequencies suffer less attenuation than higher 
frequencies and therefore are used when deep penetration is required. As
238
explained earlier, low frequency transducers produce poor resolution, so a 
compromise between penetration and resolution has to be found when 
choosing the transducer. Other factors that contribute to attenuation in 
practical terms are the size of the animal and the number of tissues between 
the transducer and the tissue to be imaged. Attenuation may be minimised in 
large animals by introducing the probe inside body cavities rather than using 
a transabdominal approach. For example, transrectal scanning reduces the 
distance travelled by the echoes and has been very useful in reproductive 
studies of large animals, permitting the use of high frequency transducers to 
obtain high resolution images with adequate penetration.
5.1.2 The use of B- mode ultrasonography in the reproductive tract of 
the ewe in comparison with other animal species.
The use of real time B-mode, grey scale ultrasound with transrectal linear 
probes, in veterinary reproductive studies started in 1980 in mares and has 
been used extensively since , both in the field and for research purposes 
(reviewed by Ginther, 1986; Griffin and Ginther, 1992). The technology was 
adapted from human obstetrics, which at the time employed low frequency 
transducers (3.5 MHz) for transabdominal use (reviewed by Paterson, 1990). 
Later more robust transducers became available which were suitable for 
transrectal scanning of mares and cows, but the technology was still 
unsuitable due to the low frequency of the transducers that produced poor 
resolution and unwanted excessive penetration (Omran, 1989; Boyd and 
Omran, 1991). Higher frequency transducers (5 and 7.5 MHz) became 
available later due to veterinary demand for ovarian work in large animals 
(Ginther, 1986; Boyd and Omran, 1991).
Using high frequency transducers transrectally, it is possible to obtain 
very detailed information on the reproductive tract and the ovarian function in 
large species. The large size of the rectum in these species, allows handheld
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transrectal scanning, positioning the transducer over the reproductive organs 
in the longitudinal and transverse axis (Omran, 1989). In large animals three 
linear transducers for endorectal use (3.5 MHz, 5 MHz and 7.5 MHz) are 
commonly employed in the gynaecological examination of the mare and the 
cow (Boyd and Omran, 1991; Griffin and Ginther, 1992). Other animals (e.g. 
llamas and deer) in which rectal palpation is possible can also benefit from 
the experience gained in mares and cattle. Applications of this technique 
include; examination of ovarian structures and determination of the stage of 
the oestrous cycle, investigation of uterine or ovarian pathology, 
improvement of Al technique, early pregnancy diagnosis and studies of the 
embryo/foetal development (reviewed by Ginther, 1986; Omran, 1989; 
Taverne and Willemse, 1989; Boyd and Omran, 1991; Griffin and Ginther, 
1992; Beal et al., 1989).
In sheep, the applications of B-mode ultrasonography in the field 
during the 1980s and early 1990s, had been limited to pregnancy diagnosis 
and the prediction of foetal numbers. This was normally carried out using 
mainly the transabdominal technique and a 5 MHz sector transducer 
(Taverne and Willemse, 1989). In recent years, the endorectal technique has 
also been employed for this purpose, but the technique has not been 
established as in large animals (Kahn, 1994). In small ruminants, research 
has been performed on the determination of the gestational age using the 
transabdominal technique for embryo/fetometry (reviewed by Griffin and 
Ginther, 1992; Picazo et al., 1991). Other applications of the technology,
(e. g. the anatomical study of the non pregnant tract, assessment of ovarian 
activity and the study of genital disorders) have not been exploited in small 
ruminants, as much as in large animals (Griffin and Ginther, 1992; Kahn,
1994).
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The first application of the ultrasonographic imaging of the ovine 
ovaries was the monitoring of the ovarian response to eCG in Booroola 
sheep, utilising sector probes (3.5 and 5 MHz) and the transabdominal 
technique (Bor et al., 1992). Other authors reported the transcutaneous use 
of a 7.5 MHz sector transducer to scan ovine ovaries autotransplanted to a 
site under the skin in the neck. In these studies follicular dynamics were 
described, but sonograms were not shown (Campbell et al., 1991a; 
Campbell et al., 1991b; Campbell et al., 1994).
The transrectal imaging of the non-pregnant reproductive organs in 
small ruminants requires higher resolution than in large animals (Buckrell,
1988). In addition, the small diameter of the rectum does not allow internal 
manipulation of the tract by hand or the orientation of the transducer in the 
transverse plane, making the imaging of the various organs more difficult 
(Kahn, 1994). Because of these difficulties, suitable endorectal probes for 
small animals were not available until the mid 1990s when their use began to 
be documented (Kahn, 1994). Early studies in small ruminants, using a 5 
MHz transrectal transducer designed for mares, concluded that the follicles 
could not be identified (Buckrell, 1988). Similarly, anatomical studies of the 
ovine cervical canal to develop a transcervical Al technique had been 
unsuccessful, although the authors did not give any details about the 
equipment employed (Halbert et al., 1990a).
The type of transrectal ovarian and early foetal studies that appeared 
in the 1980's in large animals has just begun in small ruminants, this is due 
to the availability of small rectal probes and better ultrasound equipment in 
veterinary research institutions. The first practical application of transrectal 
ultrasonography in the small ruminant ovary was the identification of the 
ovarian response to superovulatory treatments (Dorn, 1989). 
Ultrasonographic images of normal ovaries of small ruminants were 
documented in a water bath and by transrectal examination, but it was
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pointed out that the smaller follicles could not be resolved with the 
technology available at the time (Kahn, 1994). Later, two publications 
described follicular dynamics in the ovary of the ewe, using transrectal 
scanning with a 7.5 MHz linear transducer designed for the study of the 
prostate in humans (Schrick et al., 1993; Ravindra et al., 1994). Similarly, the 
examination of the viability of the embryo has been achieved in sheep using 
a transrectal probe of 7.5 MHz (KaulfuO et al., 1994).
New developments in ultrasound transducers has led to the 
introduction of specialised probes that have been designed to examine inside 
body cavities and to allow positioning of biopsy instruments. Intracavital 
ultrasound imaging (transvaginal and endorectal) has benefited recently with 
the design of transducers of low radius curved array (microconvex 
transducers). These probes have a small scanning face with series of 
crystals eccentrically oriented along the longitudinal axis increasing the field 
of view without compromising high resolution (Thaler and Manor, 1990; 
Geliy, 1992). In human obstetrics this has been used for various purposes, 
including the monitoring of cervical ripening (Andersen and Ansbacher,
1991). These transducers have also facilitated aspiration of ova, follicular 
fluids and foetal fluids in cattle (Scott et al., 1994). Transducers for human 
use now have auto-focus and other facilities that improve lateral resolution.
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5.1.3. The Endorectal technique for the gynaecological examination In
ruminants
Equipment used for endorectal scanning
Both linear and sector scanners can be used endorectally in reproductive 
studies, but linear transducers are usually preferred in routine work for large 
animals because they produce a rectangular image that is easier to interpret, 
without distortion of the sonogram in the near field. In general, linear 
transducers have a longer durability and are more economic (Boyd and 
Omran, 1991). In sheep, linear transducers are used endorectally because 
they are more ergonomic than sector (Kahn, 1994). The disadvantage of the 
linear transducers is the large size of the scanning surface which requires a 
large surface of contact with the body, this is more of a problem for small 
animals for two reasons: 1) cross sections obviously cannot be obtained and
2) lateral resolution is poor unless the transducer is focused (Paterson, 
1990). It has been tackled in human urology and gynaecology with the 
design of microconvex transducers, as explained earlier (Geliy, 1992).
Endorectal ultrasonography of the bovine and equine reproductive 
tract, requires transducers of several frequencies (3.5, 5 and 7.5 MHz), 
depending on the detail required and the stage of pregnancy to be studied. 
Experience in these species has shown that a 7.5 MHz transducer is 
preferred to scan the ovary and early conceptus, with the lower frequencies 
employed when greater penetration is required, 5 MHz for over 40 days 
pregnancy and 3.5 MHz in late pregnancy (Boyd and Omran, 1991). The 
situation is similar for transrectal scanning of the pregnant uterus in sheep. 
Authors have reported the use of 5 MHz and lower frequency transducers at 
later stages of pregnancy (Buckrell, 1988; Kahn, 1994). A 7.5 MHz 
transducer has been used transrectally for ovarian studies in small 
ruminants, (Dorn et al., 1989; Schrick et al., 1993; Ravindra et al., 1994) or
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in the autotransplanted ovary, under the skin of the neck (Campbell et al., 
1991a&b, 1994), but a superovulatory response is also detectable with the 
lower frequency transducers (Bor et al., 1992).
Transrectal scanning technique
There are no probes developed specifically for endorectal use in sheep, 
therefore various authors have adapted small probes designed for other 
species to this use. Some have introduced the probes within a rod extension 
to allow external manipulation (Kahn, 1994). Others report the use of human 
transducers (Schrick et al., 1993), which have a hand piece to allow 
positioning of the probe (Spence et al., 1994). The maximal dimensions of 
the probes that can be introduced into the rectum of sheep are: 10-15 cm 
length, 3 cm height and 2 cm width (Kahn, 1994). The animal should be 
properly restrained to avoid injury and the procedure is well tolerated without 
the need of sedation or anaesthesia. The probe is lubricated with Lubrol and 
then introduced for about 15 cm into the rectum, where the urinary bladder 
should become visible. Once the bladder has been identified, the probe is 
advanced and rotated ventrally and laterally to image the uterus. Faeces are 
removed from scanning image, by moving the probe back and forth or 
reintroducing it (reviewed by Kahn, 1994).
Interpretation: terminology and artefacts
On an ultrasound image, fluid does not reflect sound waves and appears 
black on the screen, this is called anechoic, non-echogenic or electrolucent. 
The content of the urinary bladder is normally completely anechoic and 
should be differentiated from other anechoic structures belonging to the 
reproductive tract: follicular fluid, embryonic vesicle and lacunas that may 
exist within the corpus luteum. On the other extreme, bone (pelvis and foetal 
bone) and the dioestrus cervix strongly reflect the sound waves and appear
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white on the screen, being termed as hyperechogenic. The echo patterns 
produced by the different tissues are characteristic, based on the cellularity 
and stromal composition, (increased stromal composition results in increased 
echogenicity). Soft tissues (corpus luteum and endometrium) reflect and 
attenuate sound waves to different degrees producing images of varying 
shades of grey, being termed echogenic with different echotexture. Other 
organs in the pelvic cavity like the hyperechoic bowel gas or fluid filled 
structures and bones can be sources of artefacts (reviewed by Boyd and 
Omran, 1991; Ginther, 1986).
The most commonly found artefacts in the reproductive tract have 
been reviewed in large animals by Boyd and Omran (1991), Ginther (1986) 
and they are the following:
1) Specular reflection
An enhanced echo signal is received when the sound waves meet an 
extensive, smooth surface at the right angle. Examples: amniotic sac, 
surface of large follicle and luminal surface of the vagina.
2) Scatter reflection (non specular)
This occurs when the sound waves are reflected at different angles from 
small interfaces, producing a speckled appearance. Scatter causes the 
majority of diagnostic echoes in cellular organs. Examples: image from a 
transducer submerged in tap water, the scattering is due to small air bubbles 
and the differentiation of a mature corpus luteum from the rest of the ovary.
3) Reverberation
The sound waves are bounced back and forth between two reflective 
interfaces causing repetition of echoes.
Example: pneumovaginitis and gas-filled loop of bowel.
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4) Acoustic enhancement
Structures deep to a fluid (anechoic) structure appear hyperchoic, which 
means more echogenic than its normal echotexture.
Example: follicles
5) Acoustic shadowing
Structures lying deep to hyperechoic structures (bone, etc.) appear as black. 
Examples: pelvis and cervix can cause this artefact.
Ultrasound imaging of the cervix and other structures in the pelvic 
cavity
Cervix, urinary bladder and pelvic bone
Attempts to use ultrasound to study the anatomy of the ovine cervix at 
oestrus were not successful in imaging the cervical canal in vivo and not 
enough anatomical detail was obtained in the water bath (Halbert et al., 
1990a). There is no description of the ultrasonographic appearance of the 
ovine cervix in the literature. For the schematic topographical anatomy of the 
reproductive tract of the ewe see Plate 5.3A.
In the bovine the cervix is anatomically similar to that of the sheep, in 
shape and localisation within the pelvic cavity (Hafez, 1973; Dyce, 1987; 
Ashdown and Done, 1984; Hafez, 1993), a cross section of the cervix is 
obtained by placing the transducer on the floor of the rectum and over the 
cervix, following the longitudinal axis of the animal. On ultrasound 
examination, the cervix of the cow appears as a distinctly echogenic 
structure with various degrees of acoustic shadowing due to the high 
echogenicity of the cervix and especially its mucosal folds or rings. The 
bovine cervix can be found beneath the plica circularum of the rectum and 
above the hyperecogenic pelvic bone. Another landmark is the urinary 
bladder which is found lying cranial in the animal and appears as an
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hypoechogenic (black) area beneath the cervix. In ruminants, a full bladder 
extends cranially along the abdominal floor due to distension and retires 
within the pelvis when empty (Dyce et al., 1987). A full bladder therefore 
shifts to the left of the screen (cranial) in an ultrasonogram (Omran, 1989). 
The appearance of the wall of the bladder changes according to the degree 
of filling. The wall is less obvious with a full bladder, as the distended wall is 
thin and produces only a few echoes. The external os of the cervix is visible 
but the internal os is difficult to image as it appears as an indistinct structure 
from the uterus proper. The cervical canal can be seen lying horizontally in 
the centre of the cervix. The zigzag course of the canal which appears 
anechoic is visible by rotating the transducer through the longitudinal axis 
relative to the canal (Omran, 1989).
Ginther (1986) reports changes in echotexture of the cervix in the 
mare, depending on steroids levels. The echogenicity of the cervix is similar 
during dioestrus and pregnancy and this is due to tissue density. When the 
cervix becomes flaccid during oestrus, it loses its hyperechogenicity and is 
difficult to differentiate from surrounding tissues. Changes in echogenicity 
relating to cervical softening have also been noticed in women (Andersen 
and Ansbacher, 1991).
Vagina
There is no description of the ultrasonographic appearance of the ovine 
vagina in the literature. In the bovine, the collapsed walls of the cranial 
vagina are seen as an hyperechoic line in the longitudinal axis. When the 
vagina is fluid filled, its lumen appears ovoidal and anechoic with 
hyperechoic lines (Omran, 1989). Cervical mucus at oestrus is highly 
echogenic (Beal et al., 1989).
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Non pregnant uterus
The non-pregnant uterus of the ewe can be found inside the pelvis at the 
region of the apex of the urinary bladder. Using transrectal sonography, a 
sagittal section is obtained if the transducer is held dorsally over the uterus. 
The cranial border (greater curvature) can be differentiated as a convex 
structure. Normally there is no fluid within the uterus, and the echogenicity is 
homogeneous (Kahn, 1994).
Qvarie$
There is limited experience in the ultrasonographic imaging of the ovaries in 
the ewe. Images of normal ovaries have been published using excised 
specimens in the water bath and employing transrectal ultrasound (reviewed 
by Kahn, 1994). The ovary can be found cranioventrally to the urinary 
bladder and ventral to the non-pregnant uterus. The echogenicities of 
follicles and corpora lutea (CL) are similar to the ones observed in cattle 
(Boyd and Omram, 1991; Omram, 1989; Kahn, 1994). The corpus luteum is 
hypogenic compared to the rest of the ovary, as in cattle the CL can present 
fluid filled cavities (lacuna) that appear anechoic. Lacunas in the CL may be 
confused with small follicles, which appear round and anechoic, because the 
wall of the CL can be as thin as 1-2 mm. The size of the follicles and CL in 
these species can be sometimes too small (2 mm) for the resolution capacity 
of the transducers usually available for veterinary use. Transrectally, only 
when the follicles reach more than 4 mm, because of superovulation or 
pathological conditions (cystic ovaries) can the ovary be found and follicles 
identified with certainty. Preovulatory follicles, when they reach 5 mm or 
more, can be identify sometimes during normal ovulations.
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5.1.4 Aims of the work
Ultrasonographic studies in large animals have shown the potential of this 
technique (Ginther, 1986; Boyd and Omram, 1991; Griffin and Ginther,
1992), in small ruminants similar studies are beginning to be possible using 
new transducers with better resolution (Kahn, 1994). It is possible that the 
ultrasonic appearance of the whole reproductive tract could also be 
monitored in sheep in the near future, using the appropriate probes and 
scanners. The imaging of the cervix may be helpful in the development of 
transcervical techniques of Al and ET.
The aims of this work were:
1) To test whether the ovine cervix could be imaged using the endorectal 
technique initially employing a probe of 5 MHz, originally designed for both 
endorectal or intravaginal use in humans (Plate 5.2A). Later, to obtain better 
resolution, a 7.5 MHz microconvex intraoperative probe was tested (Plate 
5.2B).
2) To observe possible changes in the echogenicity, canal patency and 
dimensions of the ovine cervix during proestrus, oestrus and the early luteal 
phase.
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5.2 MATERIALS AND METHODS
In the first experiment, the cycle was synchronised in 6 ewes during the 
breeding season, using progestagen sponges for 13 days (see Materials and 
Methods in Chapter III). Sheep were scanned standing without sedation or 
anaesthesia and were restrained during the scanning with two bales of straw 
and one person. Two sonographers scanned the sheep, one operated the 
scanner and the other the endorectal probe. Sheep were scanned at oestrus 
(n=4 ewes) and during the early luteal phase (n=2 ewes) using a endorectal 
5 MHz linear array probe (Toshiba) and a linear scanner (Capasee, Toshiba) 
(Plates 5.1 and 5.2. A). The insertion tip of the probe was sheathed and 
distilled water was injected into the sheath. The probe was lubricated with 
Lubrel and gently inserted into the rectum (Figure 5.3 A). Further water was 
injected to allow good contact between the probe and the wall of the rectum.
The 5 MHz Toshiba Intracorporeal probe (model IVE-506S 
transducer) was originally designed by manufacturers for the examination of 
internal male and female reproductive organs in humans and has been used 
successfully for the diagnosis of prostatic disorders in the dog (Boyd, 
personal communication; Spence et al., 1994). The selection of frequency 
and the amount of distilled water used were based on pervious experience in 
the dog studies. The probe can be focused to different depths, which is an 
advantage for the endorectal scanning of small species.
In the second experiment 12 anoestrous sheep were used. Oestrus 
was induced and synchronised in all of them with progestagen sponges and 
an intramuscular injection of 500 I U of eCG. Three groups of sheep (n=4, on 
each group), namely proestrous, oestrous and early luteal phase (day 7 after 
oestrus) were scanned transrectally on dorsal recumbency, restraining them 
in a rollover crush (Fig 5.3B). The ultrasound equipment utilised were a 
Toshiba Capasee scanner (Plate 5.1) and a 7.5 MHz microconvex 
intraoperative probe (microprobe PVF-738F, Toshiba) mounted in a plastic
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introducer (Plate 5.2B). This type of probe is used in human medicine to 
perform abdominal surgery (Paterson, personal communication) and has 
been successfully used transrectally to image the ovary in sheep in previous 
experiments (Dickie et al., 1997).
The scans were recorded on video tapes (Fuji, SuperVHS). 
Representative photographic prints were made using a colour video printer 
(Sony) feed with black and white paper and a video monitor (Panasonic) 
linked to ATL Apogee sector scanner.
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Plate 5.1
Ultrasound equipment used in this study
The scanner was linear (Capasee, Toshiba)
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Plate 5.2
Ultrasound equipment used in this study
A. Endorectal linear array probe (intracorporeal IVE-506S, 
Toshiba) of 5 MHz
B. Intraoperative microconvex probe (microprobe PVF-738F, 
Toshiba) of 7.5 MHz
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Plate 5.3
Ultrasound scanning techniques
A. standing position
Schematic diagram showing topographical anatomy of the 
reproductive organs and the transrectal technique using the 
endorectal linear array probe (intracorporeal IVE-506S, 
Toshiba) of 5 MHz. Redrawn from Hafez (1993) and Kahn 
(1994)
B. the recumbent position
This technique was used with the intraoperative probe 
(microprobe PVF-738F, Toshiba) of 7.5 MHz. Kindly donated 
by Alison Dickie and Calum Paterson.

5.3 RESULTS
It was possible to obtain ultrasonographic images of the cervix with the 
transrectal technique. Better image quality was achieved with the 7.5 MHz 
microconvex probe than with the 5 MHz linear probe and therefore only 
those images obtained with the former are shown (Plate 5.4). The external 
os and mid cervix could be clearly identified, but the internal os could not be 
readily differentiated from the uterine body. The external os of the cervix was 
identifiable due to the presence of fluid in the lumen of the cranial vagina, 
which contrasted with the hyperechogenicity of the cervix. The cervical canal 
was not clearly identifiable with ultrasound. The cervical length was difficult 
to measure with accuracy due to the tortuosity of the cervix which prevented 
accurate sagittal sections. A poorly defined junction of the internal os with the 
uterus, also prevented accurate measurements of the cervical length.
There was no generalised change in the echogenicity of the cervix 
throughout the cycle. There were changes in the amount of cervical 
convolution and the diameter. During oestrus the cervix appeared shorter 
and broader with less convolutions. During dioestrus the cervix appeared 
longer and more curved making it more difficult to image in longitudinal plane 
(Plates 5.4 A, B and C).
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Plate 5.4
Sonograms of the ovine cervix
Images obtained with the 7. 5 MHz microconvex rectal probe.
A. Proestrus
Left arrow points to the internal os and the right arrow to the 
external os. The external os was easier to recognise because 
of the presence of fluid in the cranial vagina. The cervix was 
recognisable because it appear hyperechogenic. Diameter is 2 
cm.
B. Oestrus
Diameter is approximately 2.5 cm.
C. Early dioestrus
Cervix appears more echogenic and with a slightly narrower 
diameter (2 cm).
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5.4 DISCUSSION
Rectal palpation is not possible in the ewe and the imaging of the tract may 
be extremely useful in all aspects of reproduction of this species. In this 
preliminary work, ultrasonograms illustrate the normal appearance of the 
ovine cervix during oestrus and the luteal phase. These images have not 
been published before. The images obtained in sheep were similar to those 
published of the cow's cervix (Beal et al., 1989; Omran, 1989; Boyd and 
Omran, 1991), except that the canal was not visible in the sheep. Changes in 
echotexture were not observable during the cycle in the sheep. Relaxation of 
the cervix, associated with changes in echotexture has been reported in 
mares (Day et al., 1995). It is not clear if a similar relaxation occurs in the 
ewe (Ward, 1968). It remains to be tested whether the canal and the 
differences in echotexture could be observed in sheep using a higher 
frequency probe.
If suitable catheters and techniques are developed to pass the cervix, 
ultrasound imaging of the ovine cervix may help to guide the catheter without 
damaging of the tract. In cattle, a method using transrectal ultrasound was 
developed to train artificial inseminators. A retrievable echogenic metal bead 
was deposited in the uterine lumen and its location determined (Beal et al.,
1989). This method may be also applicable in the sheep.
Others have reported differences in size and echotexture related to 
stage of the cycle, stage of pregnancy and hormonal changes at preterm 
labour in other species (mares: reviewed by Ginther, 1986; Day et al., 1995; 
women: Andersen and Ansbacher, 1991; Vavra et al., 1993). A systematic 
characterisation of the echogenicity of the cervix at these stages, would allow 
the assessment of the cervix following the administration of ripening drugs. 
Ultrasound used to assess cervical status, has several advantages over 
other methods, it is non-invasive, recordable, repeatable in the same animal
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and can be objective and quantitative. Ultrasonographic studies can be 
correlated with microscopical, mechanical and biochemical studies of the 
cervix and also with the presence of receptors and the peripheral levels of 
hormones. These applications may need to wait until the technology permits 
this type of studies in sheep.
Conclusions:
1) The ultrasonographic appearance of the cervix at oestrus has not shown 
whether there is relaxation of this organ, as in other species (Day et al.,
1995). This has been controversial in sheep (Ward, 1968) and its clarification 
is important for the development of a transcervical Al technique.
2) The echotexture of the luteal phase cervix was not characteristic of this 
stage, when compared to anoestrus or oestrus sheep. Using higher 
frequency transducers, higher resolution may be achieved which allows 
comparison of echotectures following ripening treatments at this stage to 
develop transcervical ET methods.
3) Endorectal ultrasound imaging of the ovine cervix, otherwise inaccessible, 
is possible. At the moment, the technique may be helpful for the 
development of transcervical techniques for Al and ET, possible applications 
are: (1) to test catheters and transcervical techniques of Al and ET, by 
monitoring the progress of a catheter in the cervical canal, (2) to ascertain 
the site of semen deposition, like in previous studies in cattle (Beal et al., 
1988).
4) The endorectal probes were found to be useful not only to image the 
cervix, but also the ovaries with considerable detail. During the writing of this 
thesis, others have also performed ovarian sonography by using tansrectal 
scanning (sheep, goat and pigs: Ginther, 1995) or the autotransplanted 
model (Souza et al., 1996) and have studied follicular dynamics. These 
studies in conjunction with anatomical studies of the cervix, may have a great
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impact in the improvement of MOET (Multiple Ovulation and Embryo 
Transfer) programs. Transrectal ultrasound can contribute to sheep welfare, 
helping to develop transcervical Al and ET techniques and substituting for 
laparoscopy in ovarian studies. It is envisaged that ultrasound may become a 
very valuable clinical and research tool in all aspects of the reproduction of 
the ewe and other small farm animals.
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CHAPTER 6
GENERAL DISCUSSION AND FUTURE PROSPECTS
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Since the late 1960s and 1970s, it has been known that both PGE2 and 
PGF20C play important roles in the expulsion of uterine contents in
mammalian and avian species of veterinary interest, participating in 
parturition and ovoposition (reviewed by Jonston et al., 1990; Bahr and 
Johson, 1991). It is now known that in both groups of vertebrates, local PGE2 
is superior to PGF20C when used clinically to dilate the cervicovaginal region
in cases of dystocia. Human obstetrics have exploited the effects of PGE2  
extensively, but this has not happened in veterinary obstetrics. Human 
preparations have been shown to be effective in several vertebrate species, 
but there is no commercial preparation of PGE2 for veterinary use (Arthur et 
al, 1996). The only drugs indicated for the induction of labour are 
corticosteroids, for a faster delivery of the foetus or the egg, usually oxytocin 
and some times PGF20C are used (Jackson, 1995). The use of these
oxytocics with an undilated cervix however, may lead to uterine rupture or 
shell gland rupture (mammalian: reviewed by Dobson, 1988; avian: reviewed 
by Hudelson and Hudelson, 1996).
Many clinical applications can be found in theriogenology for PGE2 
across the whole spectrum of companion, livestock and wildlife animals. 
Interesting indications for PGE2 in female reproduction may be: 1 ) the 
induction of labour and pregnancy termination in mammals, 2 ) the induction 
of ovoposition in birds and reptiles, 3) treatment of ringwomb, mainly in 
ruminants, 4) treatment of egg-bound birds and reptiles and 5) obstetrical 
interventions in non-gestating females that require access to the uterus, as 
for example transcervical Al and ET in ruminants.
In human obstetrics, the use of PGE2 is more sensible than 
performing a caesarean section, for economical reasons (Aughey, personal 
communication). This has not been investigated in veterinary obstetrics, but 
caesarean sections are not cheap in domestic animals either. In the case of
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the sheep, as an example of the lower range in price, this operation cost an 
average of £50. The cost of prostaglandins of the E series ranges from £4 to 
£26. Apart from the cost, the caesarean section requires aseptic conditions, 
sedation and anaesthesia, this may cause unnecessary delay for some 
emergencies. In very large species, like elephants, a caesarean section is a 
major and highly risky operation that requires general anaesthesia and can 
take several hours. In addition, there are very few vets in the world with 
experience in these animals, which adds to the cost and does not guarantee 
that the cow is going to survive the operation (Lyons, 1997). Eggbound 
problems in birds and reptiles can be also life threatening, since eggs broken 
within the abdomen can cause a fatal peritonitis (Hudelson and Hudelson, 
1993; Jackson, 1995). The development therefore of suitable drugs that 
facilitate birth in animals, will mean a very important improvement in welfare 
for several species.
The experimental work in this thesis was focused on the use of 
intravaginal human preparations of PGE2 to facilitate the development of 
transcervical methods for ET in sheep. With this objective in mind, several 
aspects of cervical ripening have been covered in the literature review and 
investigated (chapters I, III, IV and V). In chapter I, the use of hormones to 
facilitate cervical ripening at several reproductive stages is reviewed to 
illustrate that PGE2 is not the only drug that can be used to induce cervical 
ripening. Several aspects of physiological ripening at term have been 
reviewed because presumably these type of changes may be inducible with 
PGE2 or other hormones during the cycle. PGE2 appears to be the most 
important prostaglandin for the dilatation of the cervix and vagina, 
participating not only in the mammalian birth and avian ovoposition, but also 
in fish spawning and egg laying of insects (Loher, 1981; Staceyne, 1976; 
Urich, 1990; Evans, 1993), which suggests that this function may be 
conserved between vertebrates and some invertebrates. This is important to
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support extrapolations of PGE2 within mammalian species, often used in this 
thesis. However subtle differences may be expected, specially within the 
lower taxa.
The structure of PGE2 and its function in the cervix are well conserved 
certainly within mammalian species and also within many vertebrate species 
(Toh et al., 1995; Bowman et al., 1996). This is interesting for the veterinary 
profession, which, as indicated earlier has to deal with a wide range of 
species. In contrast, relaxin is unusually poorly conserved between different 
mammalian species, therefore it has been difficult to study its function in 
species like sheep and cattle (Sherwood, 1994). Since, porcine relaxin 
appears to induce cervical ripening in these species (see chapter I), it is 
possible however that the receptor is more conserved than the ligand, which 
may offer an opportunity to study the role of relaxin in new species. Although 
oxytocin is used in obstetric cases of ancient species like reptiles, oxytocin 
seem to have appeared between the transition of marsupials and true 
mammals, since some marsupials produce oxytocin, others produce 
mesotocin or both and birds produce arginine vasotocin, rather than oxytocin 
(Hueldenson and Hueldelson, 1993; Ivell and Russell, 1996; Renfree et al., 
1996). The conservation of PGE2 functions within bird and mammals in the 
cervix therefore appears to be quite unique and offers the advantage of 
being effective in a very wide spectrum of species of veterinary interest.
The objective of chapter IV was to gain more insight in the 
understanding of the mechanisms of action of PGE2 in the ewe's uterine 
cervix and its possible applications for transcervical ET. A cDNA fragment 
encoding for the ovine prostaglandin receptor subtype EP3R was isolated by 
RT-PCR. The nucleotide sequence of this fragment was highly homologous 
to the bovine (98%) and other mammalian species (80%). This is an 
expected result because the prostanoid receptor genes, like most GPCRs
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are well conserved between mammals (Ismaa et al., 1995; Toh et al., 1995). 
mRNA expression studies appear to confirm the identity of the receptor and 
also that it may have a function in the cervix. Obviously the full length of the 
cDNA, may have slightly higher or lower homology with other mammalian 
sequences, than the fragment isolated here.
The effect of PGE2 in the cervix will be better understood with the 
study of the EP receptors cDNAs and genes. The present studies on the 
ovine EP3 R are only the beginning of the characterisation of PGE2 receptors 
in the ovine cervix. The cloning and expression of all the ovine EP receptors 
(EP1-4 ) cDNAs and genes will lead to the availability of better reagents: 
oligoprimers, recombinant cDNA, gene and protein and antibodies, which 
would allow the elucidation of the physiological role of PGE2 in cervical 
ripening. This could be beneficial for both human and veterinary obstetrics, 
leading to more specific treatments. Hopefully if the pharmaceutical and 
agricultural industries find a common interest, suitable preparations of PGE2 
analogues for ET in small ruminants, and the other purposes discussed 
above, may be developed. The availability of those molecular biology 
reagents, may also pave the way for physiological studies in other vertebrate 
species.
Interestingly, studies on the molecular evolution of the eicosanoid 
receptors, by computer-assisted sequence comparison of their receptors, 
suggest that the products of the cycloxygenase pathway (PGE2, etc.) and 
their corresponding receptors may have been established before mammalian 
divergence (Toh et al., 1995). It would be interesting therefore to assess the 
role of PGE2 and its four receptors (EPr4 ) in the ovoposition of avian and 
other more primitive species, like fish and reptiles for both evolutionary and 
clinical purposes, since some of these species are gaining importance in the 
veterinary profession. Prostanoid receptors have only been cloned in 
mammalian species, but there is evidence for the existence of EP receptors
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in avian species and amphibians (Lefkowitz et al., 1977; reviewed by 
Hudelson and Hudelson, 1996). Although we do not know how old the 
prostanoid receptors are, some parasitologists think that even invertebrates 
(nematodes, ticks, etc.) and lower organisms like bacteria or yeasts (Belley 
and Chadee, 1995; Bowman et al., 1996; Tizard, 1996; Stanley Samuelson 
and Pedibhotla, 1996), can produce prostaglandins, indicating that they are 
well established early in the evolutionary tree.
It may be possible to use mammalian sequences of the prostaglandin 
receptors to amplify by PCR the homologous receptors in other vertebrates. 
Within vertebrates GPCR homology can range from 60% to 90% and cross­
species cloning has been done between species sharing the lower homology 
(Hall et al., 1993; melatonin: Reppert et al, 1994). Studies of the 3'end of the 
EP3 R in avian and reptiles species, may reveal when in evolution the 
alternative splicing occurred, originating the receptor isoforms that have been 
reported in all mammalian species. Possible modifications of the techniques 
used here (RT-PCR and RACE), have been pointed out for cloning of EP3 R 
and its isoforms in other livestock, companion and exotic species. As far as 
the veterinary profession is concern, the role of PGE2 in ovoposition may 
also be worth tracking back, to treat eggbound problems nonsurgically in 
exotic pets or for conservation purposes. Blocking prostaglandin receptors 
may be a vaccine strategy against those parasites that use the secretion of 
prostaglandins to avoid host defences (Bowman et al., 1996; Tizard, 1996). 
Different veterinary interests may be joined in the characterisation of the EP 
receptors or its evolutionary forerunner of several vertebrates and 
invertebrates; not only in the in the cervix but also in the immune system 
which together may justify economically these investigations.
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In chapter IV, mRNA studies also show that the ovine EP3 R, like in 
other species, is also implicated in the function of other organs that are not 
relevant for the topic of this thesis (ovary, kidney, uterus, adrenal gland, skin 
and liver, etc.), but may have an interest in other disciplines, like reproductive 
biology, internal medicine, parasitology and immunology. Here the 
hypothesis that EP3 R is a proinflammatory receptor is supported, which if 
confirmed could be used therapeutically. Some parasitologists think that 
PGE2 produced by parasites is immunosupressive in the host and in this 
case antiparasite drugs may be developed by blocking receptors in the host.
It is remarkable that there are very few studies of PGE2 receptors in 
the cervix, despite the recognised importance of PGE2 in its function. This 
situation has not changed during these studies, despite a gradual increase in 
the availability of cDNA and gene sequences for these receptors in several 
species. In contrast, these reagents have been rapidly applied to the 
clarification of other ovarian and uterine actions, in the endometrium and 
myometrium. The lack of similar studies in the cervix is probably due to the 
incompleteness of early studies on the characterisation of EP receptors in 
cervical tissue through the cycle and pregnancy. Studies on other tissues 
(ovary, endometrium and myometrium), are taking advantage of more 
detailed binding sites studies, which previously had shown increases in the 
density of these receptors at certain stages and in some cells types. Second 
messenger studies in those tissues are also more informative, not being 
restricted to the study of cAMP and giving clues of which receptor subtypes 
may be involved. In the cervix, therefore these basic questions need further 
clarification.
A recent publication has concluded that cAMP is involved in changes 
in the secretion of GAGs by fibroblasts in vitro, during cervical ripening 
(Carbonne et al., 1996). This and other early works may indicate the 
implication of cAMP and therefore the EP2 or EP4 receptors in cervical
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ripening (Norstrom et al., 1983). However, PGE2 is expected to have 
different signal transduction pathways and effects in different cells, and in the 
cervix many cell types, apart from the fibroblast, are potential targets. 
Furthermore, cAMP had been known since the late 1950s and the 
phospholipase C, has only been discovered in the early 1980s (Ismaa,
1995), therefore cAMP was regarded as the only second messenger for 
PGE2 in early studies. During the 1990s, some works have confirmed a role 
for a transduction pathway positively coupled to cAMP in the smooth muscle 
of the cervix in mammals, but in the avian cervix, low physiological 
concentrations are negatively coupled with cAMP (Molnar et al., 1987; 
Norstrom and Bryman, 1991). Others, using fibroblasts in culture, have found 
evidence against the role of a receptor positively coupled with cAMP, and 
have shown an involvement of the phospholipase C pathway (Takahashi et 
al., 1991 and 1993; Ito et al., 1991 and 1992; Rajabi et al., 1992). Some of 
these works, in mammalian fibroblasts and avian smooth muscle, would 
suggest an implication of the EP3R in cervical ripening. In the cervix, there 
are no in vitro studies on the transduction pathways of the immune cells, 
which may be hypothetical alternative targets for PGE2 (Uldbjerg, 1989; 
Knudsen et al., 1991; Rath et al., 1993).
In chapter III, activation of several immune cells (eosinophils, PMLs, 
platelets and mast cells) was observed following the administration of PGE2. 
These cells were clearly responding to the administration of PGE2, this is 
consistent with the inflammatory theory of cervical ripening and the 
proinflammatory action of PGE2. Research into the role of EP receptors in 
the functions of immune cells is very active at the moment, and in this type of 
in vitro study the EP3 R receptor has been implicated in the activation of 
platelets, PMLs and mast cells (Wheeldon and Vardey, 1993; Nishigaki et al., 
1993; Matthews and Jones, 1993; Blockmans et al., 1995). Because these 
cells participate in the mechanisms of physiological ripening at term, it is
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suggested here that further studies on this receptor in the cervix may be 
productive. According to the hypothesis sustained in this thesis, EP3 
analogues would be suitable for the induction of cervical ripening. A 
complete EP3R agonist is not available yet, but it may be interesting to test 
the classic EP3 R agonists in the ovine cervix (Sulprostone, Misoprostol and 
Gemeprost) and other more specific that are being developed by the 
pharmaceutical industry. Obviously transgenic 'knock-out' mice of PGE2 and 
its receptors or the discovery of specific PGE2-associated pathologies will be 
very informative. Given the importance of these receptors in many 
physiological roles, apart from reproduction, it is possible that these 
transgenic animals may be available in the near future. Several groups are 
carrying out structural studies of EP receptors, using site directed 
mutagenesis, this may lead to the elucidation of the three-dimensional 
structure of these receptors which will ultimately could allow for the design of 
more specific agonists and antagonists.
Immunological research about the role of E P  receptors in the 
functioning of cells is also looking into the stimulation of the synthesis of 
matrix metalloproteinases in several cells, although it is still not clear which 
receptor subtype(s) are implicated on each cell; several subtypes have been 
implicated in the synthesis of MMPs, including the E P 3 R  (Zeng et al., 1996). 
Theories about the involvement of the E P 2 R  in vasodilatation have been 
mainly investigated in the skin (Armstrong et al., 1995). According to these 
hypotheses, this receptor could also be implicated in cervical ripening (Kelly,
1996). Implantation has also been compared with an inflammatory response, 
and both the E P 2 R  and the E P 3 R ,  appear to be upregulated in the 
endometrium, but it is too early to know the precise role of these receptors 
(Katsuyama et al., 1997; Yang et al., 1997). In conclusion, other studies are 
compatible with the initial hypothesis of the involvement of the E P 3 R  in 
cervical ripening. But the role of the E P 3  and E P 2/ E P 4 R s ,  in the different cell
272
populations of the cervix may be further clarified using immunocytochemistry 
and in situ hybridization.
Chapter V deals with the ultrasonographic imaging of the ovine cervix. 
During these studies there have been considerable advances in the 
ultrasonographic study of the reproductive tract in the sheep. It would appear 
that, as in cattle, equipment for the examination of small ruminants will 
become commonplace in institutions dedicated to ET in sheep, to monitor the 
ovarian response. This technique may also be very useful to guide 
intracervical catheters and to monitor cervical responses to ripening drugs.
Thus, the combination of ultrasound studies with recombinant DNA 
technology could advance our understanding of the pharmacological 
induction of cervical ripening in sheep to develop transcervical techniques. 
The identification of the main receptors involved in the physiological 
inflammatory response that occurs during cervical ripening, could lead to a 
more specific pharmacological intervention in the reproductive and in the 
immune systems.
Molecular studies of prostaglandin receptors in non mammalians is 
the next challenge, this is interesting for the scientific community in general, 
to know about the evolution of EP receptors. In addition, this could lead to 
reproductive physiology studies and to pharmacological intervention during 
late pregnancy to facilitate labour or ovoposition in a wide range of species of 
veterinary interest.
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